+关注
Ong2021
暂无个人介绍
IP属地:未知
429
关注
19
粉丝
0
主题
0
勋章
主贴
热门
Ong2021
2021-11-20
[Smile]
NIO Inc. Announces Completion of At-The-Market Offering of American Depositary Shares
Ong2021
2021-10-01
[Cool]
Top 10 stocks that Wall Street’s picks for Q4
Ong2021
2021-12-07
[Smile]
Wall Street regains some ground with help from easing virus fears
Ong2021
2021-10-18
[What]
Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week
Ong2021
2021-10-31
[Smile]
3 Stocks to Buy Hand Over Fist If a Stock Market Crash Occurs
Ong2021
2021-08-11
Good
抱歉,原内容已删除
Ong2021
2021-11-19
[Smile]
Inflation has ‘further to go:’ Goldman Sachs
Ong2021
2021-10-04
[Miser]
Tesla's big quarter does not alter valuation reality - JPMorgan
Ong2021
2021-09-26
Tell me your opinion about this news...
Intel Starts Construction of Two Arizona Computer Chip Factories
Ong2021
2021-09-23
[What]
Novavax surged over 10% in early trading
Ong2021
2021-09-02
[Cool]
Tech stocks send Nasdaq to fresh record close, boost S&P
Ong2021
2021-08-15
Good info
These 10 Standout Stocks Could Be the Next Amazon
Ong2021
2021-12-12
[Smile]
抱歉,原内容已删除
Ong2021
2021-11-28
[Smile]
$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement
Ong2021
2021-11-08
[What]
FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment
Ong2021
2021-10-29
[What]
Microsoft surpassed Apple in market value and became the most valuable company in the world
Ong2021
2021-10-06
[What]
抱歉,原内容已删除
Ong2021
2021-08-25
[Miser]
抱歉,原内容已删除
Ong2021
2021-12-23
[Happy] [Smile]
U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19
Ong2021
2021-12-05
[Smile]
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4087873768935830","uuid":"4087873768935830","gmtCreate":1624770705826,"gmtModify":1626498285663,"name":"Ong2021","pinyin":"ong2021","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":19,"headSize":429,"tweetSize":136,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.67%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.13","exceedPercentage":"60.76%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":698993485,"gmtCreate":1640271902398,"gmtModify":1640271902635,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Happy] [Smile] ","listText":"[Happy] [Smile] ","text":"[Happy] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698993485","repostId":"1192623075","repostType":4,"repost":{"id":"1192623075","kind":"news","pubTimestamp":1640269891,"share":"https://www.laohu8.com/m/news/1192623075?lang=&edition=full","pubTime":"2021-12-23 22:31","market":"us","language":"en","title":"U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=1192623075","media":"SeattleTimes","summary":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea","content":"<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p>\n<p>The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p>\n<p>As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p>\n<p>The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p>\n<p>Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p>\n<p>The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p>\n<p>The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p>\n<p>Some experts question whether there will be much of a role for the Merck drug in the U.S.</p>\n<p>“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p>\n<p>For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p>\n<p>The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p>\n<p>Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p>\n<p>The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p>\n<p>Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p>","source":"lsy1640271591192","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. adds Merck pill as 2nd easy-to-use drug against COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:31 GMT+8 <a href=https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/><strong>SeattleTimes</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug ...</p>\n\n<a href=\"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","PFE":"辉瑞"},"source_url":"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192623075","content_text":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.\nAs a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.\nThe Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.\nKnown as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.\nThe restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.\nThe Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.\nSome experts question whether there will be much of a role for the Merck drug in the U.S.\n“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”\nFor now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.\nThe FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.\nFederal officials have agreed to purchase enough of the drug to treat 3.1 million people.\nThe U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.\nMerck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.","news_type":1},"isVote":1,"tweetType":1,"viewCount":804,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691845519,"gmtCreate":1640174698234,"gmtModify":1640174699162,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691845519","repostId":"1136069751","repostType":4,"repost":{"id":"1136069751","kind":"news","pubTimestamp":1640168636,"share":"https://www.laohu8.com/m/news/1136069751?lang=&edition=full","pubTime":"2021-12-22 18:23","market":"us","language":"en","title":"U.S. Stock Futures Edge Down After S&P 500 Rallies","url":"https://stock-news.laohu8.com/highlight/detail?id=1136069751","media":"Wall Street Journal","summary":"U.S. stock futures crept down, pointing to muted declines after the S&P 500 snapped a three-day losi","content":"<p>U.S. stock futures crept down, pointing to muted declines after the S&P 500 snapped a three-day losing streak.</p>\n<p>Futures for the benchmark stocks gauge, which jumped 1.8% Tuesday, ticked down 0.2% Wednesday. Contracts for the Dow Jones Industrial Average lost 0.1%. Futures for the Nasdaq-100 slipped 0.3%.</p>\n<p>Stocks have been choppy, posting big down days and up days, as investors seek to determine how severe the economic impact of the rapid spread of Omicron will be. Adding to nervousness in the market, investors are preparing for the Federal Reserve to raise interest rates in 2022 and are trimming positions before year-end.</p>\n<p>“Some investors just want to protect some of their profits, I would assume,” said Daniel Egger, chief investment officer at Switzerland-based St. Gotthard Fund Management. “This volatility could spill over into next year.”</p>\n<p>The yield on 10-year Treasury notes fell to 1.473% from 1.487% Tuesday. Yields move in the opposite direction to bond prices. The WSJ Dollar Index, which tracks the greenback against a basket of currencies, rose 0.1%.</p>\n<p>Due at 10 a.m. ET, the Conference Board’s consumer-confidence index is forecast to tick higher, after inflation and the pandemic knocked sentiment in November. Property-market data, due at the same time, are expected to show sales of existing homes rose for a third consecutive month in November.</p>\n<p>Overseas stock markets were mixed. The pan-continental Stoxx Europe 600 ticked up 0.1%, led higher by shares of technology and healthcare companies. In Asia, Hong Kong’s Hang Seng Index rose 0.6%, Japan’s Nikkei 225 rose 0.2% and the Shanghai Composite Index slipped 0.1%.</p>\n<p>Delivery Herorose 5.6% after the German food-delivery firm said it planned to sell its Foodpanda subsidiary’s operations in Japan and shrink them in Germany. Rio Tinto fell 2.4% in London after the mining company said it had agreed to buy an Argentine lithium project for $825 million, seeking to tap into demand for battery minerals.</p>\n<p>A.P. Moller-Maerskrose 0.8% after the Copenhagen-listed shipping giant said it had agreed to buy LF Logistics for around $3.6 billion including lease liabilities, confirming a report in The Wall Street Journal.</p>\n<p>In commodity markets, European natural-gas prices extended a spell of intense volatility as traders brace for potential shortages by spring. Prices for benchmark Dutch gas fell 10% Wednesday after leaping more than 20% to a record high Tuesday. A drop in the volume of gas flowing to Europe from Russia was the catalyst for the latest swings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stock Futures Edge Down After S&P 500 Rallies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stock Futures Edge Down After S&P 500 Rallies\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 18:23 GMT+8 <a href=https://www.wsj.com/articles/global-stock-markets-dow-update-12-22-2021-11640162377?mod=markets_lead_pos1><strong>Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stock futures crept down, pointing to muted declines after the S&P 500 snapped a three-day losing streak.\nFutures for the benchmark stocks gauge, which jumped 1.8% Tuesday, ticked down 0.2% ...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-22-2021-11640162377?mod=markets_lead_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-22-2021-11640162377?mod=markets_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136069751","content_text":"U.S. stock futures crept down, pointing to muted declines after the S&P 500 snapped a three-day losing streak.\nFutures for the benchmark stocks gauge, which jumped 1.8% Tuesday, ticked down 0.2% Wednesday. Contracts for the Dow Jones Industrial Average lost 0.1%. Futures for the Nasdaq-100 slipped 0.3%.\nStocks have been choppy, posting big down days and up days, as investors seek to determine how severe the economic impact of the rapid spread of Omicron will be. Adding to nervousness in the market, investors are preparing for the Federal Reserve to raise interest rates in 2022 and are trimming positions before year-end.\n“Some investors just want to protect some of their profits, I would assume,” said Daniel Egger, chief investment officer at Switzerland-based St. Gotthard Fund Management. “This volatility could spill over into next year.”\nThe yield on 10-year Treasury notes fell to 1.473% from 1.487% Tuesday. Yields move in the opposite direction to bond prices. The WSJ Dollar Index, which tracks the greenback against a basket of currencies, rose 0.1%.\nDue at 10 a.m. ET, the Conference Board’s consumer-confidence index is forecast to tick higher, after inflation and the pandemic knocked sentiment in November. Property-market data, due at the same time, are expected to show sales of existing homes rose for a third consecutive month in November.\nOverseas stock markets were mixed. The pan-continental Stoxx Europe 600 ticked up 0.1%, led higher by shares of technology and healthcare companies. In Asia, Hong Kong’s Hang Seng Index rose 0.6%, Japan’s Nikkei 225 rose 0.2% and the Shanghai Composite Index slipped 0.1%.\nDelivery Herorose 5.6% after the German food-delivery firm said it planned to sell its Foodpanda subsidiary’s operations in Japan and shrink them in Germany. Rio Tinto fell 2.4% in London after the mining company said it had agreed to buy an Argentine lithium project for $825 million, seeking to tap into demand for battery minerals.\nA.P. Moller-Maerskrose 0.8% after the Copenhagen-listed shipping giant said it had agreed to buy LF Logistics for around $3.6 billion including lease liabilities, confirming a report in The Wall Street Journal.\nIn commodity markets, European natural-gas prices extended a spell of intense volatility as traders brace for potential shortages by spring. Prices for benchmark Dutch gas fell 10% Wednesday after leaping more than 20% to a record high Tuesday. A drop in the volume of gas flowing to Europe from Russia was the catalyst for the latest swings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":818,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604262052,"gmtCreate":1639404551506,"gmtModify":1639405084582,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604262052","repostId":"1116850993","repostType":4,"repost":{"id":"1116850993","kind":"news","pubTimestamp":1639401485,"share":"https://www.laohu8.com/m/news/1116850993?lang=&edition=full","pubTime":"2021-12-13 21:18","market":"us","language":"en","title":"Read Why Clear Channel Outdoor Shares Are Trading Higher Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1116850993","media":"Benzinga","summary":"Clear Channel Outdoor Holdings Inc's board authorized a review of strategic alternatives for its Eur","content":"<ul>\n <li><b>Clear Channel Outdoor Holdings Inc's</b> board authorized a review of strategic alternatives for its European business, including a possible sale.</li>\n <li>\"We believe now is the right time to explore options for our European business, which delivered significant improvements in revenue performance in the third quarter, and we now expect Europe revenue in the fourth quarter to exceed our results in the same period of 2019,\" said CEO William Eccleshare.</li>\n <li>As announced back in July, Eccleshare will become the Executive Vice Chairman on January 1, 2022, and Scott Wells will succeed as CEO.</li>\n <li><b>Outlook</b>: Clear Channel Outdoor raised its Q4 2021 outlook from $715 million - $740 million to $730 million - $750 million, versus the consensus of $728.8 million.</li>\n <li>Clear Channel Outdoor reaffirmed America's revenue to be on the higher end of $360 million - $370 million.</li>\n <li>Clear Channel Outdoor raised Europe revenue from $335 million - $350 million to $350 million - $360 million.</li>\n <li><b>Price Action:</b> CCO shares traded higher by 6.23% at $3.24 in the premarket session on the last check Monday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Read Why Clear Channel Outdoor Shares Are Trading Higher Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRead Why Clear Channel Outdoor Shares Are Trading Higher Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 21:18 GMT+8 <a href=https://www.benzinga.com/news/21/12/24566529/read-why-clear-channel-outdoor-shares-are-trading-higher-premarket><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clear Channel Outdoor Holdings Inc's board authorized a review of strategic alternatives for its European business, including a possible sale.\n\"We believe now is the right time to explore options for ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24566529/read-why-clear-channel-outdoor-shares-are-trading-higher-premarket\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCO":"Clear Channel Outdoor Holdings"},"source_url":"https://www.benzinga.com/news/21/12/24566529/read-why-clear-channel-outdoor-shares-are-trading-higher-premarket","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116850993","content_text":"Clear Channel Outdoor Holdings Inc's board authorized a review of strategic alternatives for its European business, including a possible sale.\n\"We believe now is the right time to explore options for our European business, which delivered significant improvements in revenue performance in the third quarter, and we now expect Europe revenue in the fourth quarter to exceed our results in the same period of 2019,\" said CEO William Eccleshare.\nAs announced back in July, Eccleshare will become the Executive Vice Chairman on January 1, 2022, and Scott Wells will succeed as CEO.\nOutlook: Clear Channel Outdoor raised its Q4 2021 outlook from $715 million - $740 million to $730 million - $750 million, versus the consensus of $728.8 million.\nClear Channel Outdoor reaffirmed America's revenue to be on the higher end of $360 million - $370 million.\nClear Channel Outdoor raised Europe revenue from $335 million - $350 million to $350 million - $360 million.\nPrice Action: CCO shares traded higher by 6.23% at $3.24 in the premarket session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604913799,"gmtCreate":1639305191527,"gmtModify":1639305191776,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/604913799","repostId":"2190719916","repostType":4,"isVote":1,"tweetType":1,"viewCount":796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602464659,"gmtCreate":1639059286081,"gmtModify":1639060258876,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602464659","repostId":"1132751506","repostType":4,"repost":{"id":"1132751506","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639058586,"share":"https://www.laohu8.com/m/news/1132751506?lang=&edition=full","pubTime":"2021-12-09 22:03","market":"us","language":"en","title":"Volkswagen ramps up e-mobility spending to $59 bln by 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1132751506","media":"Reuters","summary":"FRANKFURT, Dec 9 (Reuters) - Volkswagen on Thursday said it would ramp up spending for battery-power","content":"<p>FRANKFURT, Dec 9 (Reuters) - Volkswagen on Thursday said it would ramp up spending for battery-powered electric vehicles by around 50% to 52 billion euros ($59 billion) by 2026 as part of the group's far-reaching transformation.</p>\n<p>The investment is part of Volkswagen's new revolving 5-year spending plan, which foresees total investments of 159 billion euros in the 2022-2026 period, compared with 150 billion for the 2021-2025 period.</p>\n<p>($1 = 0.8839 euros)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Volkswagen ramps up e-mobility spending to $59 bln by 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVolkswagen ramps up e-mobility spending to $59 bln by 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-09 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>FRANKFURT, Dec 9 (Reuters) - Volkswagen on Thursday said it would ramp up spending for battery-powered electric vehicles by around 50% to 52 billion euros ($59 billion) by 2026 as part of the group's far-reaching transformation.</p>\n<p>The investment is part of Volkswagen's new revolving 5-year spending plan, which foresees total investments of 159 billion euros in the 2022-2026 period, compared with 150 billion for the 2021-2025 period.</p>\n<p>($1 = 0.8839 euros)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VLKAF":"Volkswagen AG"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132751506","content_text":"FRANKFURT, Dec 9 (Reuters) - Volkswagen on Thursday said it would ramp up spending for battery-powered electric vehicles by around 50% to 52 billion euros ($59 billion) by 2026 as part of the group's far-reaching transformation.\nThe investment is part of Volkswagen's new revolving 5-year spending plan, which foresees total investments of 159 billion euros in the 2022-2026 period, compared with 150 billion for the 2021-2025 period.\n($1 = 0.8839 euros)","news_type":1},"isVote":1,"tweetType":1,"viewCount":823,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602002079,"gmtCreate":1638935153453,"gmtModify":1638935155282,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602002079","repostId":"2189719656","repostType":4,"repost":{"id":"2189719656","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638914193,"share":"https://www.laohu8.com/m/news/2189719656?lang=&edition=full","pubTime":"2021-12-08 05:56","market":"us","language":"en","title":"Wall Street closes higher with Nasdaq boosted by tech rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2189719656","media":"Reuters","summary":"Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some ","content":"<p>Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.</p>\n<p>Intel's announcement of plans to take its self-driving car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.</p>\n<p>The Philadelphia SE Semiconductor index closed up 4.97% after hitting a near <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month low on Tuesday.</p>\n<p>Investors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.</p>\n<p>Before market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.</p>\n<p>That news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.</p>\n<p>\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Michael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"</p>\n<p>He also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.</p>\n<p>\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"</p>\n<p>The Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.</p>\n<p>The CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.</p>\n<p>All of the 11 major S&P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.</p>\n<p>The S&P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.</p>\n<p>In the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.</p>\n<p>Vir Biotechnology closed up 11.9%.</p>\n<p>Merck & Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.</p>\n<p>On U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes higher with Nasdaq boosted by tech rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes higher with Nasdaq boosted by tech rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-08 05:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.</p>\n<p>Intel's announcement of plans to take its self-driving car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.</p>\n<p>The Philadelphia SE Semiconductor index closed up 4.97% after hitting a near <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month low on Tuesday.</p>\n<p>Investors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.</p>\n<p>Before market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.</p>\n<p>That news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.</p>\n<p>\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Michael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"</p>\n<p>He also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.</p>\n<p>\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"</p>\n<p>The Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.</p>\n<p>The CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.</p>\n<p>All of the 11 major S&P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.</p>\n<p>The S&P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.</p>\n<p>In the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.</p>\n<p>Vir Biotechnology closed up 11.9%.</p>\n<p>Merck & Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.</p>\n<p>On U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189719656","content_text":"Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.\nIntel's announcement of plans to take its self-driving car unit Mobileye public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.\nThe Philadelphia SE Semiconductor index closed up 4.97% after hitting a near one-month low on Tuesday.\nInvestors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.\nBefore market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.\nThat news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.\n\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.\nMichael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"\nHe also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.\n\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"\nThe Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.\nThe CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.\nAll of the 11 major S&P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.\nThe S&P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.\nIn the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.\nVir Biotechnology closed up 11.9%.\nMerck & Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.\nThe S&P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.\nOn U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602006591,"gmtCreate":1638935145417,"gmtModify":1638935145647,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602006591","repostId":"2189719656","repostType":4,"repost":{"id":"2189719656","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638914193,"share":"https://www.laohu8.com/m/news/2189719656?lang=&edition=full","pubTime":"2021-12-08 05:56","market":"us","language":"en","title":"Wall Street closes higher with Nasdaq boosted by tech rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2189719656","media":"Reuters","summary":"Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some ","content":"<p>Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.</p>\n<p>Intel's announcement of plans to take its self-driving car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.</p>\n<p>The Philadelphia SE Semiconductor index closed up 4.97% after hitting a near <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month low on Tuesday.</p>\n<p>Investors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.</p>\n<p>Before market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.</p>\n<p>That news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.</p>\n<p>\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Michael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"</p>\n<p>He also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.</p>\n<p>\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"</p>\n<p>The Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.</p>\n<p>The CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.</p>\n<p>All of the 11 major S&P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.</p>\n<p>The S&P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.</p>\n<p>In the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.</p>\n<p>Vir Biotechnology closed up 11.9%.</p>\n<p>Merck & Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.</p>\n<p>On U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes higher with Nasdaq boosted by tech rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes higher with Nasdaq boosted by tech rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-08 05:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.</p>\n<p>Intel's announcement of plans to take its self-driving car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.</p>\n<p>The Philadelphia SE Semiconductor index closed up 4.97% after hitting a near <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month low on Tuesday.</p>\n<p>Investors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.</p>\n<p>Before market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.</p>\n<p>That news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.</p>\n<p>\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Michael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"</p>\n<p>He also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.</p>\n<p>\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"</p>\n<p>The Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.</p>\n<p>The CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.</p>\n<p>All of the 11 major S&P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.</p>\n<p>The S&P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.</p>\n<p>In the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.</p>\n<p>Vir Biotechnology closed up 11.9%.</p>\n<p>Merck & Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.</p>\n<p>On U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189719656","content_text":"Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.\nIntel's announcement of plans to take its self-driving car unit Mobileye public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.\nThe Philadelphia SE Semiconductor index closed up 4.97% after hitting a near one-month low on Tuesday.\nInvestors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.\nBefore market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.\nThat news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.\n\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.\nMichael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"\nHe also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.\n\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"\nThe Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.\nThe CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.\nAll of the 11 major S&P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.\nThe S&P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.\nIn the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.\nVir Biotechnology closed up 11.9%.\nMerck & Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.\nThe S&P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.\nOn U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":927,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606825496,"gmtCreate":1638860285272,"gmtModify":1638860285467,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606825496","repostId":"2189686612","repostType":4,"repost":{"id":"2189686612","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638826608,"share":"https://www.laohu8.com/m/news/2189686612?lang=&edition=full","pubTime":"2021-12-07 05:36","market":"us","language":"en","title":"Wall Street regains some ground with help from easing virus fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2189686612","media":"Reuters","summary":"Dec 6 - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.Of Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminis","content":"<p>Dec 6 (Reuters) - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.</p>\n<p>Of Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminished gains in the healthcare sector .</p>\n<p>While the Omicron COVID-19 variant has caused alarm and some new restrictions around the world, investors appeared to be reassured by Dr. Anthony Fauci, the top U.S. infectious disease official, who told CNN that \"thus far it does not look like there's a great degree of severity to it.\" However, he did say that more study is needed.</p>\n<p>\"People are less worried about the variant,\" said King Lip, chief investment strategist at Baker Avenue Asset Management in San Francisco.</p>\n<p>Lip also cited a boost from news that China's central bank would cut the amount of cash that banks must hold in reserve, potentially boosting overseas companies that sell products in China as well as China's economy.</p>\n<p>The Dow Jones Industrial Average rose 646.95 points, or 1.87%, to 35,227.03, the S&P 500 gained 53.24 points, or 1.17%, to 4,591.67 and the Nasdaq Composite added 139.68 points, or 0.93%, to 15,225.15.</p>\n<p>The S&P 500 Value Index rose 1.5%, outperforming its growth counterpart , which gained 0.9%.</p>\n<p>The economically sensitive Dow Jones Transportation index outperformed the broader market with a 2.3% gain while the small-cap Russell 2000 climbed 2%.</p>\n<p>Wall Street's major indexes have been swinging wildly since Nov. 26 as investors digested news of the COVID-19 Omicron variant and then Federal Reserve Chair Jerome Powell's hawkish comments last week about a speedier tapering of government bond-buying to tackle surging inflation.</p>\n<p>The S&P's finish on Monday was 2.3% below where it traded before investors started reacting to the Omicron virus.</p>\n<p>\"If today's strength in the blue chips can sort of sustain itself, that might give the rest of the market the ability to start to feel confident,\" said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>Still, Goldman Sachs on Saturday cut its outlook for U.S. economic growth to 3.8% for 2022, citing risks and uncertainty around the emergence of Omicron. Investors had also been bracing for a potential hit to corporate earnings, particularly among retailers, restaurants and travel companies.</p>\n<p>The industrials sector's three biggest percentage gainers were airlines led by United Airlines 8.3% gain while the S&P Airline's index closed up 5.5%.</p>\n<p>Other strong gainers in travel related stocks included Norwegian Cruise Line Holdings , which finished up 9.5%. Vacation rental company Airbnb added 8.5%.</p>\n<p>Big decliners included COVID-19 vaccine makers such as Moderna Inc , down 13.5%, and Pfizer, down 5%, as investors anticipated development of vaccines with protections specific to Omicron could take months.</p>\n<p>Nvidia closed down 2%. Investors have been worried about the outcome of regulatory scrutiny of its deal to buy British chip firm ARM Ltd.</p>\n<p>Kohl's Corp shares closed up 5.4% after hedge fund Engine Capital LP said it was pushing the department-store chain to consider a sale of the company or separate its e-commerce division to improve its lagging stock price.</p>\n<p>JJ Kinahan, chief market strategist at TD Ameritrade, said investors may be preparing for a Dec. 17 expiration of options and futures.</p>\n<p>\"You have a lot of firms that have a double mandate right now. You are trying to take off risk, expiration related, while the same time rebalancing your portfolio heading into 2022,\" he said.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.82-to-1 ratio; on Nasdaq, a 1.71-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 20 new 52-week highs and <a href=\"https://laohu8.com/S/AONE.U\">one</a> new low; the Nasdaq Composite recorded 28 new highs and 600 new lows.</p>\n<p>On U.S. exchanges, 11.96 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street regains some ground with help from easing virus fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street regains some ground with help from easing virus fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-07 05:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 6 (Reuters) - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.</p>\n<p>Of Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminished gains in the healthcare sector .</p>\n<p>While the Omicron COVID-19 variant has caused alarm and some new restrictions around the world, investors appeared to be reassured by Dr. Anthony Fauci, the top U.S. infectious disease official, who told CNN that \"thus far it does not look like there's a great degree of severity to it.\" However, he did say that more study is needed.</p>\n<p>\"People are less worried about the variant,\" said King Lip, chief investment strategist at Baker Avenue Asset Management in San Francisco.</p>\n<p>Lip also cited a boost from news that China's central bank would cut the amount of cash that banks must hold in reserve, potentially boosting overseas companies that sell products in China as well as China's economy.</p>\n<p>The Dow Jones Industrial Average rose 646.95 points, or 1.87%, to 35,227.03, the S&P 500 gained 53.24 points, or 1.17%, to 4,591.67 and the Nasdaq Composite added 139.68 points, or 0.93%, to 15,225.15.</p>\n<p>The S&P 500 Value Index rose 1.5%, outperforming its growth counterpart , which gained 0.9%.</p>\n<p>The economically sensitive Dow Jones Transportation index outperformed the broader market with a 2.3% gain while the small-cap Russell 2000 climbed 2%.</p>\n<p>Wall Street's major indexes have been swinging wildly since Nov. 26 as investors digested news of the COVID-19 Omicron variant and then Federal Reserve Chair Jerome Powell's hawkish comments last week about a speedier tapering of government bond-buying to tackle surging inflation.</p>\n<p>The S&P's finish on Monday was 2.3% below where it traded before investors started reacting to the Omicron virus.</p>\n<p>\"If today's strength in the blue chips can sort of sustain itself, that might give the rest of the market the ability to start to feel confident,\" said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>Still, Goldman Sachs on Saturday cut its outlook for U.S. economic growth to 3.8% for 2022, citing risks and uncertainty around the emergence of Omicron. Investors had also been bracing for a potential hit to corporate earnings, particularly among retailers, restaurants and travel companies.</p>\n<p>The industrials sector's three biggest percentage gainers were airlines led by United Airlines 8.3% gain while the S&P Airline's index closed up 5.5%.</p>\n<p>Other strong gainers in travel related stocks included Norwegian Cruise Line Holdings , which finished up 9.5%. Vacation rental company Airbnb added 8.5%.</p>\n<p>Big decliners included COVID-19 vaccine makers such as Moderna Inc , down 13.5%, and Pfizer, down 5%, as investors anticipated development of vaccines with protections specific to Omicron could take months.</p>\n<p>Nvidia closed down 2%. Investors have been worried about the outcome of regulatory scrutiny of its deal to buy British chip firm ARM Ltd.</p>\n<p>Kohl's Corp shares closed up 5.4% after hedge fund Engine Capital LP said it was pushing the department-store chain to consider a sale of the company or separate its e-commerce division to improve its lagging stock price.</p>\n<p>JJ Kinahan, chief market strategist at TD Ameritrade, said investors may be preparing for a Dec. 17 expiration of options and futures.</p>\n<p>\"You have a lot of firms that have a double mandate right now. You are trying to take off risk, expiration related, while the same time rebalancing your portfolio heading into 2022,\" he said.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.82-to-1 ratio; on Nasdaq, a 1.71-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 20 new 52-week highs and <a href=\"https://laohu8.com/S/AONE.U\">one</a> new low; the Nasdaq Composite recorded 28 new highs and 600 new lows.</p>\n<p>On U.S. exchanges, 11.96 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQQQ":"纳指三倍做空ETF","QQQ":"纳指100ETF","DOG":"道指反向ETF","DDM":"道指两倍做多ETF","DJX":"1/100道琼斯","DXD":"道指两倍做空ETF","QLD":"纳指两倍做多ETF",".DJI":"道琼斯","TQQQ":"纳指三倍做多ETF","PSQ":"纳指反向ETF","UDOW":"道指三倍做多ETF-ProShares",".IXIC":"NASDAQ Composite","SDOW":"道指三倍做空ETF-ProShares","QID":"纳指两倍做空ETF",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189686612","content_text":"Dec 6 (Reuters) - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.\nOf Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminished gains in the healthcare sector .\nWhile the Omicron COVID-19 variant has caused alarm and some new restrictions around the world, investors appeared to be reassured by Dr. Anthony Fauci, the top U.S. infectious disease official, who told CNN that \"thus far it does not look like there's a great degree of severity to it.\" However, he did say that more study is needed.\n\"People are less worried about the variant,\" said King Lip, chief investment strategist at Baker Avenue Asset Management in San Francisco.\nLip also cited a boost from news that China's central bank would cut the amount of cash that banks must hold in reserve, potentially boosting overseas companies that sell products in China as well as China's economy.\nThe Dow Jones Industrial Average rose 646.95 points, or 1.87%, to 35,227.03, the S&P 500 gained 53.24 points, or 1.17%, to 4,591.67 and the Nasdaq Composite added 139.68 points, or 0.93%, to 15,225.15.\nThe S&P 500 Value Index rose 1.5%, outperforming its growth counterpart , which gained 0.9%.\nThe economically sensitive Dow Jones Transportation index outperformed the broader market with a 2.3% gain while the small-cap Russell 2000 climbed 2%.\nWall Street's major indexes have been swinging wildly since Nov. 26 as investors digested news of the COVID-19 Omicron variant and then Federal Reserve Chair Jerome Powell's hawkish comments last week about a speedier tapering of government bond-buying to tackle surging inflation.\nThe S&P's finish on Monday was 2.3% below where it traded before investors started reacting to the Omicron virus.\n\"If today's strength in the blue chips can sort of sustain itself, that might give the rest of the market the ability to start to feel confident,\" said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.\nStill, Goldman Sachs on Saturday cut its outlook for U.S. economic growth to 3.8% for 2022, citing risks and uncertainty around the emergence of Omicron. Investors had also been bracing for a potential hit to corporate earnings, particularly among retailers, restaurants and travel companies.\nThe industrials sector's three biggest percentage gainers were airlines led by United Airlines 8.3% gain while the S&P Airline's index closed up 5.5%.\nOther strong gainers in travel related stocks included Norwegian Cruise Line Holdings , which finished up 9.5%. Vacation rental company Airbnb added 8.5%.\nBig decliners included COVID-19 vaccine makers such as Moderna Inc , down 13.5%, and Pfizer, down 5%, as investors anticipated development of vaccines with protections specific to Omicron could take months.\nNvidia closed down 2%. Investors have been worried about the outcome of regulatory scrutiny of its deal to buy British chip firm ARM Ltd.\nKohl's Corp shares closed up 5.4% after hedge fund Engine Capital LP said it was pushing the department-store chain to consider a sale of the company or separate its e-commerce division to improve its lagging stock price.\nJJ Kinahan, chief market strategist at TD Ameritrade, said investors may be preparing for a Dec. 17 expiration of options and futures.\n\"You have a lot of firms that have a double mandate right now. You are trying to take off risk, expiration related, while the same time rebalancing your portfolio heading into 2022,\" he said.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.82-to-1 ratio; on Nasdaq, a 1.71-to-1 ratio favored advancers.\nThe S&P 500 posted 20 new 52-week highs and one new low; the Nasdaq Composite recorded 28 new highs and 600 new lows.\nOn U.S. exchanges, 11.96 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606909105,"gmtCreate":1638804325926,"gmtModify":1638804326153,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606909105","repostId":"1136333497","repostType":4,"repost":{"id":"1136333497","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638803729,"share":"https://www.laohu8.com/m/news/1136333497?lang=&edition=full","pubTime":"2021-12-06 23:15","market":"us","language":"en","title":"Trump SPAC under investigation by federal regulators, including SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1136333497","media":"Tiger Newspress","summary":"Trump stocks slid in morning trading after Trump SPAC investigated by federal regulators including S","content":"<p>Trump stocks slid in morning trading after Trump SPAC investigated by federal regulators including SEC.</p>\n<p><img src=\"https://static.tigerbbs.com/7e33149fd32ab5ae81ddf0f9bda730dc\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/9c7f40575bb308ff6cf235b32c049547\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/1fc30628deb8405d2e0d1ff5723debe1\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>The publicly traded SPAC that has announced plans to merge with former President Donald Trump's new social media company said in a new filing that the SEC and FINRA regulatory agencies have asked for information regarding stock trading and communications with Trump's company before the deal was announced.</p>\n<p>The investigations were disclosed in an 8-K filing by Digital World Acquisition Corp., the special purpose acquisition company.</p>\n<p>\"DWAC has received certain preliminary, fact-finding inquiries from regulatory authorities, with which it is cooperating,\" the company said in the filing.</p>\n<p>\"Specifically, in late October and in early November 2021, DWAC received a request for information from FINRA, surrounding events (specifically, a review of trading) that preceded the public announcement of the October 20, 2021 Merger Agreement,\" the filing said.</p>\n<p>\"According to FINRA's request, the inquiry should not be construed as an indication that FINRA has determined that any violations of Nasdaq rules or federal securities laws have occurred, nor as a reflection upon the merits of the securities involved or upon any person who effected transactions in such securities.\"</p>\n<p>\"Additionally, in early November 2021, DWAC received a voluntary information and document request from the SEC which sought, inter alia, documents relating to meetings of DWAC's Board of Directors, policies and procedures relating to trading, the identification of banking, telephone, and email addresses, the identities of certain investors, and certain documents and communications between DWAC and TMTG,\" DWAC's filing said.</p>\n<p>\"According to the SEC's request, the investigation does not mean that the SEC has concluded that anyone violated the law or that the SEC has a negative opinion of DWAC or any person, event, or security.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trump SPAC under investigation by federal regulators, including SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrump SPAC under investigation by federal regulators, including SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 23:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Trump stocks slid in morning trading after Trump SPAC investigated by federal regulators including SEC.</p>\n<p><img src=\"https://static.tigerbbs.com/7e33149fd32ab5ae81ddf0f9bda730dc\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/9c7f40575bb308ff6cf235b32c049547\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/1fc30628deb8405d2e0d1ff5723debe1\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>The publicly traded SPAC that has announced plans to merge with former President Donald Trump's new social media company said in a new filing that the SEC and FINRA regulatory agencies have asked for information regarding stock trading and communications with Trump's company before the deal was announced.</p>\n<p>The investigations were disclosed in an 8-K filing by Digital World Acquisition Corp., the special purpose acquisition company.</p>\n<p>\"DWAC has received certain preliminary, fact-finding inquiries from regulatory authorities, with which it is cooperating,\" the company said in the filing.</p>\n<p>\"Specifically, in late October and in early November 2021, DWAC received a request for information from FINRA, surrounding events (specifically, a review of trading) that preceded the public announcement of the October 20, 2021 Merger Agreement,\" the filing said.</p>\n<p>\"According to FINRA's request, the inquiry should not be construed as an indication that FINRA has determined that any violations of Nasdaq rules or federal securities laws have occurred, nor as a reflection upon the merits of the securities involved or upon any person who effected transactions in such securities.\"</p>\n<p>\"Additionally, in early November 2021, DWAC received a voluntary information and document request from the SEC which sought, inter alia, documents relating to meetings of DWAC's Board of Directors, policies and procedures relating to trading, the identification of banking, telephone, and email addresses, the identities of certain investors, and certain documents and communications between DWAC and TMTG,\" DWAC's filing said.</p>\n<p>\"According to the SEC's request, the investigation does not mean that the SEC has concluded that anyone violated the law or that the SEC has a negative opinion of DWAC or any person, event, or security.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BENE":"Benessere Capital Acquisition Corp","PHUN":"Phunware, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136333497","content_text":"Trump stocks slid in morning trading after Trump SPAC investigated by federal regulators including SEC.\n\nThe publicly traded SPAC that has announced plans to merge with former President Donald Trump's new social media company said in a new filing that the SEC and FINRA regulatory agencies have asked for information regarding stock trading and communications with Trump's company before the deal was announced.\nThe investigations were disclosed in an 8-K filing by Digital World Acquisition Corp., the special purpose acquisition company.\n\"DWAC has received certain preliminary, fact-finding inquiries from regulatory authorities, with which it is cooperating,\" the company said in the filing.\n\"Specifically, in late October and in early November 2021, DWAC received a request for information from FINRA, surrounding events (specifically, a review of trading) that preceded the public announcement of the October 20, 2021 Merger Agreement,\" the filing said.\n\"According to FINRA's request, the inquiry should not be construed as an indication that FINRA has determined that any violations of Nasdaq rules or federal securities laws have occurred, nor as a reflection upon the merits of the securities involved or upon any person who effected transactions in such securities.\"\n\"Additionally, in early November 2021, DWAC received a voluntary information and document request from the SEC which sought, inter alia, documents relating to meetings of DWAC's Board of Directors, policies and procedures relating to trading, the identification of banking, telephone, and email addresses, the identities of certain investors, and certain documents and communications between DWAC and TMTG,\" DWAC's filing said.\n\"According to the SEC's request, the investigation does not mean that the SEC has concluded that anyone violated the law or that the SEC has a negative opinion of DWAC or any person, event, or security.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":689,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608614650,"gmtCreate":1638710565768,"gmtModify":1638710565874,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608614650","repostId":"2189557676","repostType":4,"isVote":1,"tweetType":1,"viewCount":1148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608308590,"gmtCreate":1638612872918,"gmtModify":1638612873058,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608308590","repostId":"1135581145","repostType":4,"repost":{"id":"1135581145","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638544438,"share":"https://www.laohu8.com/m/news/1135581145?lang=&edition=full","pubTime":"2021-12-03 23:13","market":"us","language":"en","title":"Sea Ltd stock dropped 6% while Grab rallied nearly 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135581145","media":"Tiger Newspress","summary":"Sea Ltd stock dropped 6% while Grab rallied nearly 3% in morning trading.","content":"<p>Sea Ltd stock dropped 6% while Grab rallied nearly 3% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/3f6e1cc599c71ab4b3f021f3f08854e7\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/ad938b19362172c4e42e41557bb259b3\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sea Ltd stock dropped 6% while Grab rallied nearly 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSea Ltd stock dropped 6% while Grab rallied nearly 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 23:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sea Ltd stock dropped 6% while Grab rallied nearly 3% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/3f6e1cc599c71ab4b3f021f3f08854e7\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/ad938b19362172c4e42e41557bb259b3\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd","GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135581145","content_text":"Sea Ltd stock dropped 6% while Grab rallied nearly 3% in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601122550,"gmtCreate":1638499929002,"gmtModify":1638499929147,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/601122550","repostId":"1108760971","repostType":4,"repost":{"id":"1108760971","kind":"news","pubTimestamp":1638499412,"share":"https://www.laohu8.com/m/news/1108760971?lang=&edition=full","pubTime":"2021-12-03 10:43","market":"us","language":"en","title":"Grab SPAC Merger Alert: 8 Things to Know as GRAB Stock Falls 20% on Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1108760971","media":"InvestorPlace","summary":"Southeast Asia ride-hailing and food-delivery company Grab(NASDAQ:GRAB) went public today to a fairl","content":"<p>Southeast Asia ride-hailing and food-delivery company <b>Grab</b>(NASDAQ:<b><u>GRAB</u></b>) went public today to a fairly muted reaction from investors. The Singapore-based company first piqued investors’ attention with its array of super apps across financial, delivery and transportation services. Despite opening at $12.40 this morning, GRAB stock has steadily declined, currently sitting at $8.75 at market close, more than 20% down on the day.</p>\n<p>Grab is one of many highly anticipated companies that have gone public via special purpose acquisition company (SPAC) mergers. Indeed, it’s been a packed field for SPAC mergers this season. More and more companies opt to go public via SPAC nowadays, as it has the potential to save tremendous amounts of time and money in their initial public offerings (IPOs). Not every company thrives off of it, however, as is evident this afternoon.</p>\n<p>Grab Chief Executive Anthony Tan commented onGRAB’s downtrend today. “The price makes no difference to me. I’m going to celebrate tonight and get back to work tomorrow,” Tan said.</p>\n<p>So, what else should investors know about GRAB stock today?</p>\n<p>8 Things to Know as GRAB Stock Slides Today</p>\n<ol>\n <li>GRAB’s backdoor listing comes after an agreement with U.S. tech SPAC, <b>Altimeter Growth Corp</b>.</li>\n <li>The deal saw GRAB raise $4.5 billion in funding, including $750 million from Altimeter.</li>\n <li>Grab is a high-growth contender. Some expect the Southeast Asia digital economy to double by 2025.</li>\n <li>The company began as a Malaysia-based taxi app in 2012. Since then, it’s expanded into various other industries and mobile services.</li>\n <li>Additionally, GRAB has support from some big players. Indeed, <b>Toyota</b>(NYSE:<b><u>TM</u></b>), <b>Microsoft</b>(NASDAQ:<b><u>MSFT</u></b>) and <b>Uber</b>(NYSE:<b><u>UBER</u></b>) each have a stake in the company.</li>\n <li>Unfortunately, Grab had less-than stellar revenue numbers to report this past quarter. Revenue was down 9% year-over-year, mostly attributed to Covid-19-related lockdowns across Southeast Asia, especially Vietnam.</li>\n <li>However, Grab is aiming for profitability by 2023. At that point, the burgeoning Southeast Asian internet economy is expected to have grown substantially.</li>\n <li>The super apps are operational in more than 465 cities across eight countries and offer everything from food-delivery to investment services.</li>\n</ol>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab SPAC Merger Alert: 8 Things to Know as GRAB Stock Falls 20% on Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab SPAC Merger Alert: 8 Things to Know as GRAB Stock Falls 20% on Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 10:43 GMT+8 <a href=https://investorplace.com/2021/12/grab-spac-merger-alert-8-things-to-know-as-grab-stock-falls-20-on-its-nasdaq-debut/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Southeast Asia ride-hailing and food-delivery company Grab(NASDAQ:GRAB) went public today to a fairly muted reaction from investors. The Singapore-based company first piqued investors’ attention with ...</p>\n\n<a href=\"https://investorplace.com/2021/12/grab-spac-merger-alert-8-things-to-know-as-grab-stock-falls-20-on-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"source_url":"https://investorplace.com/2021/12/grab-spac-merger-alert-8-things-to-know-as-grab-stock-falls-20-on-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108760971","content_text":"Southeast Asia ride-hailing and food-delivery company Grab(NASDAQ:GRAB) went public today to a fairly muted reaction from investors. The Singapore-based company first piqued investors’ attention with its array of super apps across financial, delivery and transportation services. Despite opening at $12.40 this morning, GRAB stock has steadily declined, currently sitting at $8.75 at market close, more than 20% down on the day.\nGrab is one of many highly anticipated companies that have gone public via special purpose acquisition company (SPAC) mergers. Indeed, it’s been a packed field for SPAC mergers this season. More and more companies opt to go public via SPAC nowadays, as it has the potential to save tremendous amounts of time and money in their initial public offerings (IPOs). Not every company thrives off of it, however, as is evident this afternoon.\nGrab Chief Executive Anthony Tan commented onGRAB’s downtrend today. “The price makes no difference to me. I’m going to celebrate tonight and get back to work tomorrow,” Tan said.\nSo, what else should investors know about GRAB stock today?\n8 Things to Know as GRAB Stock Slides Today\n\nGRAB’s backdoor listing comes after an agreement with U.S. tech SPAC, Altimeter Growth Corp.\nThe deal saw GRAB raise $4.5 billion in funding, including $750 million from Altimeter.\nGrab is a high-growth contender. Some expect the Southeast Asia digital economy to double by 2025.\nThe company began as a Malaysia-based taxi app in 2012. Since then, it’s expanded into various other industries and mobile services.\nAdditionally, GRAB has support from some big players. Indeed, Toyota(NYSE:TM), Microsoft(NASDAQ:MSFT) and Uber(NYSE:UBER) each have a stake in the company.\nUnfortunately, Grab had less-than stellar revenue numbers to report this past quarter. Revenue was down 9% year-over-year, mostly attributed to Covid-19-related lockdowns across Southeast Asia, especially Vietnam.\nHowever, Grab is aiming for profitability by 2023. At that point, the burgeoning Southeast Asian internet economy is expected to have grown substantially.\nThe super apps are operational in more than 465 cities across eight countries and offer everything from food-delivery to investment services.","news_type":1},"isVote":1,"tweetType":1,"viewCount":341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603974990,"gmtCreate":1638360427552,"gmtModify":1638360427915,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603974990","repostId":"1199099074","repostType":4,"repost":{"id":"1199099074","kind":"news","pubTimestamp":1638358819,"share":"https://www.laohu8.com/m/news/1199099074?lang=&edition=full","pubTime":"2021-12-01 19:40","market":"us","language":"en","title":"Electricity-Market Tech Platform Voltus Going Public in $1.3 Billion SPAC Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1199099074","media":"The Wall Street Journal","summary":"As part of merger with Broadscale Acquisition Corp., Voltus is raising a $100 million private invest","content":"<p>As part of merger with Broadscale Acquisition Corp., Voltus is raising a $100 million private investment in public equity</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fa0b3575a82fd4cb5f0eb58db582acd6\" tg-width=\"1290\" tg-height=\"860\" width=\"100%\" height=\"auto\"><span>Voltus CEO Gregg Dixon says his company’s platform helps deliver more reliable and sustainable electricity to customers and saves them money.</span></p>\n<p>Voltus Inc. is going public by combining with a special-purpose acquisition company in a merger that values the electricity-market technology startup at about $1.3 billion, the companies said.</p>\n<p>Based in San Francisco, Voltus uses software to manage small, decentralized electricity systems known as distributed energy resources for customers such as Coca-Cola Co. and Home Depot Inc. Called DERs, distributed energy resources are anything that consumes, produces or stores electricity and can be connected to a grid. Examples include a store’s electricity demand and electric-vehicle charging.</p>\n<p>By partnering with grid operators in the U.S. and Canada to connect DERs to larger markets, Voltus says it saves corporate customers money and delivers more reliable and sustainable electricity. Chief Executive Gregg Dixon compared Voltus to home-rental firm Airbnb Inc. in that Voltus also makes each DER a financial asset, allowing customers to sell their excess electricity back to the grid.</p>\n<p>Some analysts say widespread adoption of DERs will be critical to reducing the world’s dependence on fossil-fuel-consuming power plants and decarbonizing the economy.</p>\n<p>“We’re at a really incredible inflection point in electricity markets,” Mr. Dixon said.</p>\n<p>Founded in 2016, Voltus is merging with the SPAC Broadscale Acquisition Corp., one of many so-called blank-check firms focused on environmental, social and governance—or ESG—factors.</p>\n<p>Many other startups tied to green energy have recently reached similar SPAC deals, in part because such mergers allow them to make business projections. Those aren’t allowed in traditional initial public offerings. SPAC deals also let companies quickly generate cash and raise their profiles, executives say.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/52feb9d1dc7e271f3b686b1836ea9fcd\" tg-width=\"1050\" tg-height=\"700\" width=\"100%\" height=\"auto\"><span>Voltus says its platform lets companies like Home Depot optimize electricity usage while making money from distributed energy resources they aren’t using.</span></p>\n<p>As part of its SPAC merger, Voltus is raising a $100 million private investment in public equity, or PIPE. PIPE investors include Equinor Ventures, the startup investing arm of Norwegian energy giant Equinor ASA,and Ev Williams, co-founder of Twitter Inc. and Obvious Ventures.</p>\n<p>That money and funds held by the SPAC could be used to accelerate Voltus’s growth globally. The Broadscale SPAC is backed by the investment firms Broadscale Group LLC and Hepco Capital Management LLC and holds $345 million, though investors can withdraw money before the deal goes through. Low share prices often provide an incentive for such withdrawals.</p>\n<p>Also called a blank-check company,a SPAC is a shell firm that raises money and trades on a stock exchange with the sole intent of merging with a private company such as Voltus to take it public. After regulators review the private company’s financial and ownership information and the deal is completed, the private firm then replaces the SPAC in the stock market.</p>\n<p>SPACs have raised more than $150 billion this year, nearly doubling last year’s then-record total, according to SPAC Research.</p>\n<p>To ease concerns about SPAC insiders disproportionately benefiting from such deals at the expense of other investors, Voltus executives and the blank-check company creators have made some of their shares subject to the stock price rising.</p>\n<p>Broadscale Acquisition CEO Andrew Shapiro said Voltus can be “a truly world-changing company” and a good investment because it is a green-energy technology firm that doesn’t need heavy spending or tangible assets to grow.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Electricity-Market Tech Platform Voltus Going Public in $1.3 Billion SPAC Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElectricity-Market Tech Platform Voltus Going Public in $1.3 Billion SPAC Deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 19:40 GMT+8 <a href=https://www.wsj.com/articles/electricity-market-tech-platform-voltus-going-public-in-1-3-billion-spac-deal-11638352800?mod=hp_lista_pos1><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As part of merger with Broadscale Acquisition Corp., Voltus is raising a $100 million private investment in public equity\nVoltus CEO Gregg Dixon says his company’s platform helps deliver more reliable...</p>\n\n<a href=\"https://www.wsj.com/articles/electricity-market-tech-platform-voltus-going-public-in-1-3-billion-spac-deal-11638352800?mod=hp_lista_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.wsj.com/articles/electricity-market-tech-platform-voltus-going-public-in-1-3-billion-spac-deal-11638352800?mod=hp_lista_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199099074","content_text":"As part of merger with Broadscale Acquisition Corp., Voltus is raising a $100 million private investment in public equity\nVoltus CEO Gregg Dixon says his company’s platform helps deliver more reliable and sustainable electricity to customers and saves them money.\nVoltus Inc. is going public by combining with a special-purpose acquisition company in a merger that values the electricity-market technology startup at about $1.3 billion, the companies said.\nBased in San Francisco, Voltus uses software to manage small, decentralized electricity systems known as distributed energy resources for customers such as Coca-Cola Co. and Home Depot Inc. Called DERs, distributed energy resources are anything that consumes, produces or stores electricity and can be connected to a grid. Examples include a store’s electricity demand and electric-vehicle charging.\nBy partnering with grid operators in the U.S. and Canada to connect DERs to larger markets, Voltus says it saves corporate customers money and delivers more reliable and sustainable electricity. Chief Executive Gregg Dixon compared Voltus to home-rental firm Airbnb Inc. in that Voltus also makes each DER a financial asset, allowing customers to sell their excess electricity back to the grid.\nSome analysts say widespread adoption of DERs will be critical to reducing the world’s dependence on fossil-fuel-consuming power plants and decarbonizing the economy.\n“We’re at a really incredible inflection point in electricity markets,” Mr. Dixon said.\nFounded in 2016, Voltus is merging with the SPAC Broadscale Acquisition Corp., one of many so-called blank-check firms focused on environmental, social and governance—or ESG—factors.\nMany other startups tied to green energy have recently reached similar SPAC deals, in part because such mergers allow them to make business projections. Those aren’t allowed in traditional initial public offerings. SPAC deals also let companies quickly generate cash and raise their profiles, executives say.\nVoltus says its platform lets companies like Home Depot optimize electricity usage while making money from distributed energy resources they aren’t using.\nAs part of its SPAC merger, Voltus is raising a $100 million private investment in public equity, or PIPE. PIPE investors include Equinor Ventures, the startup investing arm of Norwegian energy giant Equinor ASA,and Ev Williams, co-founder of Twitter Inc. and Obvious Ventures.\nThat money and funds held by the SPAC could be used to accelerate Voltus’s growth globally. The Broadscale SPAC is backed by the investment firms Broadscale Group LLC and Hepco Capital Management LLC and holds $345 million, though investors can withdraw money before the deal goes through. Low share prices often provide an incentive for such withdrawals.\nAlso called a blank-check company,a SPAC is a shell firm that raises money and trades on a stock exchange with the sole intent of merging with a private company such as Voltus to take it public. After regulators review the private company’s financial and ownership information and the deal is completed, the private firm then replaces the SPAC in the stock market.\nSPACs have raised more than $150 billion this year, nearly doubling last year’s then-record total, according to SPAC Research.\nTo ease concerns about SPAC insiders disproportionately benefiting from such deals at the expense of other investors, Voltus executives and the blank-check company creators have made some of their shares subject to the stock price rising.\nBroadscale Acquisition CEO Andrew Shapiro said Voltus can be “a truly world-changing company” and a good investment because it is a green-energy technology firm that doesn’t need heavy spending or tangible assets to grow.","news_type":1},"isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603975747,"gmtCreate":1638360395988,"gmtModify":1638360396308,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603975747","repostId":"2188758534","repostType":4,"repost":{"id":"2188758534","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638310020,"share":"https://www.laohu8.com/m/news/2188758534?lang=&edition=full","pubTime":"2021-12-01 06:07","market":"us","language":"en","title":"Dow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2188758534","media":"Dow Jones","summary":"Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant\n","content":"<p>Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant</p>\n<p>U.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.</p>\n<p>Equities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.</p>\n<p>How did stock indexes trade?</p>\n<p>The Dow and S&P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.</p>\n<p>For the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.</p>\n<p>What drove the markets?</p>\n<p>Federal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.</p>\n<p>Powell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.</p>\n<p>Powell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.</p>\n<p>In One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&P 500 levels in focus</p>\n<p>\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.</p>\n<p>\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.</p>\n<p>Powell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"</p>\n<p>Investors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.</p>\n<p>Stocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> shares fell 4.4%.</p>\n<p>Bancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.</p>\n<p>\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.</p>\n<p>Analysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.</p>\n<p>Bancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"</p>\n<p>Echoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.</p>\n<p>\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"</p>\n<p>The Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.</p>\n<p>Earlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.</p>\n<p>\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-01 06:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant</p>\n<p>U.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.</p>\n<p>Equities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.</p>\n<p>How did stock indexes trade?</p>\n<p>The Dow and S&P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.</p>\n<p>For the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.</p>\n<p>What drove the markets?</p>\n<p>Federal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.</p>\n<p>Powell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.</p>\n<p>Powell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.</p>\n<p>In One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&P 500 levels in focus</p>\n<p>\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.</p>\n<p>\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.</p>\n<p>Powell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"</p>\n<p>Investors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.</p>\n<p>Stocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> shares fell 4.4%.</p>\n<p>Bancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.</p>\n<p>\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.</p>\n<p>Analysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.</p>\n<p>Bancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"</p>\n<p>Echoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.</p>\n<p>\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"</p>\n<p>The Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.</p>\n<p>Earlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.</p>\n<p>\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯","MRNA":"Moderna, Inc.",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188758534","content_text":"Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant\nU.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.\nEquities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.\nHow did stock indexes trade?\nThe Dow and S&P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.\nFor the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.\nWhat drove the markets?\nFederal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.\nPowell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.\nPowell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.\nIn One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&P 500 levels in focus\n\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.\n\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.\nPowell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"\nInvestors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.\nStocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna $(MRNA)$ shares fell 4.4%.\nBancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.\n\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.\nAnalysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.\nBancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"\nEchoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.\n\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"\nThe Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.\nEarlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.\n\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603975521,"gmtCreate":1638360373169,"gmtModify":1638360373524,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603975521","repostId":"1116877933","repostType":4,"repost":{"id":"1116877933","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638350081,"share":"https://www.laohu8.com/m/news/1116877933?lang=&edition=full","pubTime":"2021-12-01 17:14","market":"us","language":"en","title":"Merck shares jumped 5.3% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1116877933","media":"Tiger Newspress","summary":"Merck shares jumped 5.3% in premarket trading as FDA advisers recommended its COVID-19 pill in close","content":"<p>Merck shares jumped 5.3% in premarket trading as FDA advisers recommended its COVID-19 pill in close vote.</p>\n<p><img src=\"https://static.tigerbbs.com/52b0f147fff1ac74d32cd5d5643fe2b3\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>The Food and Drug Administration advisory committee said Tuesday the benefits of Merck & Co.'s experimental antiviral COVID-19 pill outweigh its risks in a 13-10 vote, with several advisors saying they had concerns about use of the drug in pregnant women.</p>\n<p>The company is developing the pill, which is called molnupiravir, with privately held Ridgeback Biotherapeutics.</p>\n<p>The FDA is now expected to deliver its final decision, likely before the end of the year. The regulator often takes into account the recommendation of its advisory committees but is not required to do so.</p>\n<p>If molnupiravir is authorized by the FDA in the coming weeks, as expected, the treatment will be the first oral COVID-19 pill that patients can take at home.</p>\n<p>Members of the Antimicrobial Drugs Advisory Committee also suggested a safety-monitoring program, expressed concerns about prescribing the drug to those who are immunocompromised, and shared their concerns about the overall efficacy of the pill.</p>\n<p>\"With the continued spread of the virus and the emergence of variants, additional treatments for COVID-19 are urgently needed. That is why we are moving with speed and rigor to pursue authorizations and to accelerate broad global access to this investigational medicine,\" Dean Li, executive vice president and president of Merck Research Laboratories, said in a statement. \"We are grateful to the members of the advisory committee who reviewed our application, as well as to the patients and investigators who participated in our clinical trials, and we will continue to work with the FDA as the agency completes its review.\"</p>\n<p>Some Wall Street analysts had predicted that the advisers would vote in support of authorization, but with a cautious approach.</p>\n<p>\"Despite these reservations, molnupiravir is also likely to be approved, and demand is likely to exceed their 20 [million] course supply in 2022,\" SVB Leerink analysts wrote on Friday.</p>\n<p>Of the COVID-19 treatments that are currently available, most are used to care for very sick, hospitalized people. This includes the steroid dexamethasone and Gilead Sciences Inc.'s Veklury.</p>\n<p>The monoclonal antibodies developed by Eli Lilly & Co., Regeneron Pharmaceuticals Inc. (REGN), and Vir Biotechnology Inc. and GlaxoSmithKline can be used to treat people with mild or moderate cases of COVID-19, but these treatments have to be administered by an infusion in a clinical setting.</p>\n<p>Molnupiravir was once held as a game changer in the course of the pandemic, but its importance has shifted as new data from the clinical trial came out and a competitor stepped up.</p>\n<p>Wall Street's interest in Merck's pill began to wane in November when Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> produced even more compelling results for its COVID-19 drug candidate, demonstrating that Paxlovid reduced the risk of hospitalization and death by a stunning 89% in a clinical trial. The company filed for emergency authorization later in the month.</p>\n<p>Then, last week, Merck shared that its pill reduced the risk of hospitalization and death by 30% in a clinical trial--and not 50% as reported in the interim results. Wall Street is now factoring in growing worries about the omicron variant and the continuing need for new and better treatments for COVID-19.</p>\n<p>\"Concerns over the new omicron variant are increasing expectations on the potential of Pfizer's COVID-19 vaccine Comirnaty and updated data from Merck's oral anti-viral molnupiravir are increasing expectations for Pfizer's anti-viral Paxlovid,\" Mizuho Securities analysts told investors on Monday.</p>\n<p>Analysts were once over the moon about the sales potential of the first oral COVID-19 pill that works, predicting between $5 billion and $7 billion in sales next year alone. But the arrival of new efficacy data dragged down interest in both the drug and Merck's stock.</p>\n<p>Citi on Monday downgraded Merck's stock to neutral, from buy, citing concerns about the company's experimental HIV drug islatravir and about molnupiravir.</p>\n<p>Merck is seeking authorization for molnupiravir in adults who have tested positive for the virus, are experiencing mild or moderate symptoms, and are at high risk for severe disease. Patients are expected to start treatment within five days of symptoms.</p>\n<p>The Phase 2/3, randomized, placebo-controlled, double-blind study only enrolled people who were unvaccinated; however, it's unclear whether the pill could be used to treat vaccinated individuals with breakthrough infections if it is authorized.</p>\n<p>Molnupiravir has already been authorized for use in the U.K.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck shares jumped 5.3% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck shares jumped 5.3% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-01 17:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Merck shares jumped 5.3% in premarket trading as FDA advisers recommended its COVID-19 pill in close vote.</p>\n<p><img src=\"https://static.tigerbbs.com/52b0f147fff1ac74d32cd5d5643fe2b3\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>The Food and Drug Administration advisory committee said Tuesday the benefits of Merck & Co.'s experimental antiviral COVID-19 pill outweigh its risks in a 13-10 vote, with several advisors saying they had concerns about use of the drug in pregnant women.</p>\n<p>The company is developing the pill, which is called molnupiravir, with privately held Ridgeback Biotherapeutics.</p>\n<p>The FDA is now expected to deliver its final decision, likely before the end of the year. The regulator often takes into account the recommendation of its advisory committees but is not required to do so.</p>\n<p>If molnupiravir is authorized by the FDA in the coming weeks, as expected, the treatment will be the first oral COVID-19 pill that patients can take at home.</p>\n<p>Members of the Antimicrobial Drugs Advisory Committee also suggested a safety-monitoring program, expressed concerns about prescribing the drug to those who are immunocompromised, and shared their concerns about the overall efficacy of the pill.</p>\n<p>\"With the continued spread of the virus and the emergence of variants, additional treatments for COVID-19 are urgently needed. That is why we are moving with speed and rigor to pursue authorizations and to accelerate broad global access to this investigational medicine,\" Dean Li, executive vice president and president of Merck Research Laboratories, said in a statement. \"We are grateful to the members of the advisory committee who reviewed our application, as well as to the patients and investigators who participated in our clinical trials, and we will continue to work with the FDA as the agency completes its review.\"</p>\n<p>Some Wall Street analysts had predicted that the advisers would vote in support of authorization, but with a cautious approach.</p>\n<p>\"Despite these reservations, molnupiravir is also likely to be approved, and demand is likely to exceed their 20 [million] course supply in 2022,\" SVB Leerink analysts wrote on Friday.</p>\n<p>Of the COVID-19 treatments that are currently available, most are used to care for very sick, hospitalized people. This includes the steroid dexamethasone and Gilead Sciences Inc.'s Veklury.</p>\n<p>The monoclonal antibodies developed by Eli Lilly & Co., Regeneron Pharmaceuticals Inc. (REGN), and Vir Biotechnology Inc. and GlaxoSmithKline can be used to treat people with mild or moderate cases of COVID-19, but these treatments have to be administered by an infusion in a clinical setting.</p>\n<p>Molnupiravir was once held as a game changer in the course of the pandemic, but its importance has shifted as new data from the clinical trial came out and a competitor stepped up.</p>\n<p>Wall Street's interest in Merck's pill began to wane in November when Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> produced even more compelling results for its COVID-19 drug candidate, demonstrating that Paxlovid reduced the risk of hospitalization and death by a stunning 89% in a clinical trial. The company filed for emergency authorization later in the month.</p>\n<p>Then, last week, Merck shared that its pill reduced the risk of hospitalization and death by 30% in a clinical trial--and not 50% as reported in the interim results. Wall Street is now factoring in growing worries about the omicron variant and the continuing need for new and better treatments for COVID-19.</p>\n<p>\"Concerns over the new omicron variant are increasing expectations on the potential of Pfizer's COVID-19 vaccine Comirnaty and updated data from Merck's oral anti-viral molnupiravir are increasing expectations for Pfizer's anti-viral Paxlovid,\" Mizuho Securities analysts told investors on Monday.</p>\n<p>Analysts were once over the moon about the sales potential of the first oral COVID-19 pill that works, predicting between $5 billion and $7 billion in sales next year alone. But the arrival of new efficacy data dragged down interest in both the drug and Merck's stock.</p>\n<p>Citi on Monday downgraded Merck's stock to neutral, from buy, citing concerns about the company's experimental HIV drug islatravir and about molnupiravir.</p>\n<p>Merck is seeking authorization for molnupiravir in adults who have tested positive for the virus, are experiencing mild or moderate symptoms, and are at high risk for severe disease. Patients are expected to start treatment within five days of symptoms.</p>\n<p>The Phase 2/3, randomized, placebo-controlled, double-blind study only enrolled people who were unvaccinated; however, it's unclear whether the pill could be used to treat vaccinated individuals with breakthrough infections if it is authorized.</p>\n<p>Molnupiravir has already been authorized for use in the U.K.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116877933","content_text":"Merck shares jumped 5.3% in premarket trading as FDA advisers recommended its COVID-19 pill in close vote.\n\nThe Food and Drug Administration advisory committee said Tuesday the benefits of Merck & Co.'s experimental antiviral COVID-19 pill outweigh its risks in a 13-10 vote, with several advisors saying they had concerns about use of the drug in pregnant women.\nThe company is developing the pill, which is called molnupiravir, with privately held Ridgeback Biotherapeutics.\nThe FDA is now expected to deliver its final decision, likely before the end of the year. The regulator often takes into account the recommendation of its advisory committees but is not required to do so.\nIf molnupiravir is authorized by the FDA in the coming weeks, as expected, the treatment will be the first oral COVID-19 pill that patients can take at home.\nMembers of the Antimicrobial Drugs Advisory Committee also suggested a safety-monitoring program, expressed concerns about prescribing the drug to those who are immunocompromised, and shared their concerns about the overall efficacy of the pill.\n\"With the continued spread of the virus and the emergence of variants, additional treatments for COVID-19 are urgently needed. That is why we are moving with speed and rigor to pursue authorizations and to accelerate broad global access to this investigational medicine,\" Dean Li, executive vice president and president of Merck Research Laboratories, said in a statement. \"We are grateful to the members of the advisory committee who reviewed our application, as well as to the patients and investigators who participated in our clinical trials, and we will continue to work with the FDA as the agency completes its review.\"\nSome Wall Street analysts had predicted that the advisers would vote in support of authorization, but with a cautious approach.\n\"Despite these reservations, molnupiravir is also likely to be approved, and demand is likely to exceed their 20 [million] course supply in 2022,\" SVB Leerink analysts wrote on Friday.\nOf the COVID-19 treatments that are currently available, most are used to care for very sick, hospitalized people. This includes the steroid dexamethasone and Gilead Sciences Inc.'s Veklury.\nThe monoclonal antibodies developed by Eli Lilly & Co., Regeneron Pharmaceuticals Inc. (REGN), and Vir Biotechnology Inc. and GlaxoSmithKline can be used to treat people with mild or moderate cases of COVID-19, but these treatments have to be administered by an infusion in a clinical setting.\nMolnupiravir was once held as a game changer in the course of the pandemic, but its importance has shifted as new data from the clinical trial came out and a competitor stepped up.\nWall Street's interest in Merck's pill began to wane in November when Pfizer Inc. $(PFE)$ produced even more compelling results for its COVID-19 drug candidate, demonstrating that Paxlovid reduced the risk of hospitalization and death by a stunning 89% in a clinical trial. The company filed for emergency authorization later in the month.\nThen, last week, Merck shared that its pill reduced the risk of hospitalization and death by 30% in a clinical trial--and not 50% as reported in the interim results. Wall Street is now factoring in growing worries about the omicron variant and the continuing need for new and better treatments for COVID-19.\n\"Concerns over the new omicron variant are increasing expectations on the potential of Pfizer's COVID-19 vaccine Comirnaty and updated data from Merck's oral anti-viral molnupiravir are increasing expectations for Pfizer's anti-viral Paxlovid,\" Mizuho Securities analysts told investors on Monday.\nAnalysts were once over the moon about the sales potential of the first oral COVID-19 pill that works, predicting between $5 billion and $7 billion in sales next year alone. But the arrival of new efficacy data dragged down interest in both the drug and Merck's stock.\nCiti on Monday downgraded Merck's stock to neutral, from buy, citing concerns about the company's experimental HIV drug islatravir and about molnupiravir.\nMerck is seeking authorization for molnupiravir in adults who have tested positive for the virus, are experiencing mild or moderate symptoms, and are at high risk for severe disease. Patients are expected to start treatment within five days of symptoms.\nThe Phase 2/3, randomized, placebo-controlled, double-blind study only enrolled people who were unvaccinated; however, it's unclear whether the pill could be used to treat vaccinated individuals with breakthrough infections if it is authorized.\nMolnupiravir has already been authorized for use in the U.K.","news_type":1},"isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603975630,"gmtCreate":1638360282064,"gmtModify":1638360282455,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603975630","repostId":"2187300942","repostType":4,"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609116189,"gmtCreate":1638251051536,"gmtModify":1638251051638,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609116189","repostId":"2187300942","repostType":4,"repost":{"id":"2187300942","kind":"highlight","weMediaInfo":{"introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"media_name":"GlobeNewswire","id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"pubTimestamp":1638248400,"share":"https://www.laohu8.com/m/news/2187300942?lang=&edition=full","pubTime":"2021-11-30 13:00","market":"us","language":"en","title":"Uxin Announces Inclusion in MSCI Global Small Cap Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2187300942","media":"GlobeNewswire","summary":"BEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Uxin Limited (“Uxin” or the “Company”) (NASDAQ: UXIN), a ","content":"<p>BEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Uxin Limited (“Uxin” or the “Company”) (NASDAQ: UXIN), a leading nationwide online used car dealer in China, today announced that it will be included in the MSCI Global Small Cap Index - China Index, effective after the U.S. market close on November 30, 2021.</p>\n<p>Mr. John Lin, Chief Financial Officer of Uxin, commented, “Uxin’s inclusion in the MSCI Global Small Cap Index - China Index represents another key milestone, and a strong testament to the success of our business transformation into an inventory-owning model since last year. Uxin was the first Chinese used vehicle company to be publicly listed in the U.S. Over the past decade since our inception, our unwavering passion and laser-focused mission has been to empower people to easily purchase the car of their choice online. Our customer-centric practices continue to drive the optimization of our business model and we are committed to innovate and provide the best products and services that have made us who we are today. This milestone also reflects the confidence of investors in the Company’s long term growth strategy and solid nationwide leadership. We thank all our shareholders for their continued support and we will continue to operate the business responsibly and sustainably to deliver long term value to all shareholders.”</p>\n<p>With over 45 years of expertise in research, data and technology, MSCI is a leading provider of critical decision support tools and services for the global investment community. The MSCI Global Small Cap Index - China Index is a free float-adjusted market capitalization index that is comprised of 254 constituents, and represents approximately 14% of the China equity universe(1). MSCI indexes are among the most respected and widely used benchmarks in the financial industry. The MSCI China Index is also a widely referenced benchmark among institutional investors.</p>\n<p>(1) Source: MSCI data</p>\n<p><b>About Uxin</b></p>\n<p>Uxin Limited (Nasdaq: UXIN) is a leading nationwide online used car dealer in China. With its offerings of high-quality used cars and best-in-class purchasing services, Uxin’s mission is to enable people to buy the car of their choice online. Uxin’s <a href=\"https://laohu8.com/S/AONE.U\">one</a>-stop online shopping mall provides consumers with a nationwide selection of value-for-money used cars, various value-added products and services as well as comprehensive aftersales services. Its online sales consultants offer professional consulting to facilitate a convenient and efficient car purchase for consumers in a timely fashion. Its comprehensive fulfillment network supports nationwide logistics and delivery as well as title transfers between different cities across China so as to fulfill these online transactions.</p>\n<p><b>Safe Harbor Statement</b></p>\n<p>This press release contains statements that may constitute “forward-looking” statements which are made pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Uxin’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Uxin’s filings with the United States Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Uxin does not undertake any obligation to update any forward-looking statement, except as required under applicable law.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Uxin Announces Inclusion in MSCI Global Small Cap Index</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUxin Announces Inclusion in MSCI Global Small Cap Index\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2021-11-30 13:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Uxin Limited (“Uxin” or the “Company”) (NASDAQ: UXIN), a leading nationwide online used car dealer in China, today announced that it will be included in the MSCI Global Small Cap Index - China Index, effective after the U.S. market close on November 30, 2021.</p>\n<p>Mr. John Lin, Chief Financial Officer of Uxin, commented, “Uxin’s inclusion in the MSCI Global Small Cap Index - China Index represents another key milestone, and a strong testament to the success of our business transformation into an inventory-owning model since last year. Uxin was the first Chinese used vehicle company to be publicly listed in the U.S. Over the past decade since our inception, our unwavering passion and laser-focused mission has been to empower people to easily purchase the car of their choice online. Our customer-centric practices continue to drive the optimization of our business model and we are committed to innovate and provide the best products and services that have made us who we are today. This milestone also reflects the confidence of investors in the Company’s long term growth strategy and solid nationwide leadership. We thank all our shareholders for their continued support and we will continue to operate the business responsibly and sustainably to deliver long term value to all shareholders.”</p>\n<p>With over 45 years of expertise in research, data and technology, MSCI is a leading provider of critical decision support tools and services for the global investment community. The MSCI Global Small Cap Index - China Index is a free float-adjusted market capitalization index that is comprised of 254 constituents, and represents approximately 14% of the China equity universe(1). MSCI indexes are among the most respected and widely used benchmarks in the financial industry. The MSCI China Index is also a widely referenced benchmark among institutional investors.</p>\n<p>(1) Source: MSCI data</p>\n<p><b>About Uxin</b></p>\n<p>Uxin Limited (Nasdaq: UXIN) is a leading nationwide online used car dealer in China. With its offerings of high-quality used cars and best-in-class purchasing services, Uxin’s mission is to enable people to buy the car of their choice online. Uxin’s <a href=\"https://laohu8.com/S/AONE.U\">one</a>-stop online shopping mall provides consumers with a nationwide selection of value-for-money used cars, various value-added products and services as well as comprehensive aftersales services. Its online sales consultants offer professional consulting to facilitate a convenient and efficient car purchase for consumers in a timely fashion. Its comprehensive fulfillment network supports nationwide logistics and delivery as well as title transfers between different cities across China so as to fulfill these online transactions.</p>\n<p><b>Safe Harbor Statement</b></p>\n<p>This press release contains statements that may constitute “forward-looking” statements which are made pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Uxin’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Uxin’s filings with the United States Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Uxin does not undertake any obligation to update any forward-looking statement, except as required under applicable law.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UXIN":"优信","BK4122":"互联网与直销零售","BK4505":"高瓴资本持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187300942","content_text":"BEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Uxin Limited (“Uxin” or the “Company”) (NASDAQ: UXIN), a leading nationwide online used car dealer in China, today announced that it will be included in the MSCI Global Small Cap Index - China Index, effective after the U.S. market close on November 30, 2021.\nMr. John Lin, Chief Financial Officer of Uxin, commented, “Uxin’s inclusion in the MSCI Global Small Cap Index - China Index represents another key milestone, and a strong testament to the success of our business transformation into an inventory-owning model since last year. Uxin was the first Chinese used vehicle company to be publicly listed in the U.S. Over the past decade since our inception, our unwavering passion and laser-focused mission has been to empower people to easily purchase the car of their choice online. Our customer-centric practices continue to drive the optimization of our business model and we are committed to innovate and provide the best products and services that have made us who we are today. This milestone also reflects the confidence of investors in the Company’s long term growth strategy and solid nationwide leadership. We thank all our shareholders for their continued support and we will continue to operate the business responsibly and sustainably to deliver long term value to all shareholders.”\nWith over 45 years of expertise in research, data and technology, MSCI is a leading provider of critical decision support tools and services for the global investment community. The MSCI Global Small Cap Index - China Index is a free float-adjusted market capitalization index that is comprised of 254 constituents, and represents approximately 14% of the China equity universe(1). MSCI indexes are among the most respected and widely used benchmarks in the financial industry. The MSCI China Index is also a widely referenced benchmark among institutional investors.\n(1) Source: MSCI data\nAbout Uxin\nUxin Limited (Nasdaq: UXIN) is a leading nationwide online used car dealer in China. With its offerings of high-quality used cars and best-in-class purchasing services, Uxin’s mission is to enable people to buy the car of their choice online. Uxin’s one-stop online shopping mall provides consumers with a nationwide selection of value-for-money used cars, various value-added products and services as well as comprehensive aftersales services. Its online sales consultants offer professional consulting to facilitate a convenient and efficient car purchase for consumers in a timely fashion. Its comprehensive fulfillment network supports nationwide logistics and delivery as well as title transfers between different cities across China so as to fulfill these online transactions.\nSafe Harbor Statement\nThis press release contains statements that may constitute “forward-looking” statements which are made pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Uxin’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Uxin’s filings with the United States Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Uxin does not undertake any obligation to update any forward-looking statement, except as required under applicable law.","news_type":1},"isVote":1,"tweetType":1,"viewCount":486,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600482290,"gmtCreate":1638188242110,"gmtModify":1638188242406,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600482290","repostId":"2187329491","repostType":4,"repost":{"id":"2187329491","kind":"highlight","pubTimestamp":1638140520,"share":"https://www.laohu8.com/m/news/2187329491?lang=&edition=full","pubTime":"2021-11-29 07:02","market":"us","language":"en","title":"Here's what the Black Friday carnage may mean for the stock market's trade Monday, analysts say","url":"https://stock-news.laohu8.com/highlight/detail?id=2187329491","media":"MarketWatch","summary":"The new, fast-spreading B.1.1.529 strain of coronavirus declared a variant of concern by the World Health Organization roiled global markets on Black Friday, raising concerns about how the economy and Wall Street may perform in the coming week, following a selloff that wiped out November gains for the S&P 500 index and the Nasdaq Composite and sent the Dow Jones Industrial Average down by the most in a day since Oct. 28, 2020.What isn't clear is whether the latest coronavirus development will do","content":"<p>OMG, omicron!</p>\n<p>The new, fast-spreading B.1.1.529 strain of coronavirus declared a variant of concern by the World Health Organization roiled global markets on Black Friday, raising concerns about how the economy and Wall Street may perform in the coming week, following a selloff that wiped out November gains for the S&P 500 index and the Nasdaq Composite and sent the Dow Jones Industrial Average down by the most in a day since Oct. 28, 2020.</p>\n<p>WHO said that the omicron variant, which has been detected in Belgium, Israel, and Hong Kong and was first identified in southern parts of Africa, is more transmissible than the delta strain that is currently dominant world-wide, and other variants.</p>\n<p>The emergence of the new strain led to the White House announcing restrictions, starting on Monday, on travel for non-U.S. citizens and residents from South Africa, as well as from Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique, and Malawi, joining the European Union, the U.K., Singapore and Japan, which also announced similar travel bans.</p>\n<p>The market selloff during the abbreviated Black Friday session and the commensurate flight to assets that investors hope will perform better amid fresh mobility restrictions, helped to overshadow the usual focus on retail, on a day associated with heavy consumer spending ahead of the Christmas holiday. Friday's downturn also offered a crystal clear reminder that the path of the market and economy hinges on the course of COVID.</p>\n<p>What isn't clear is whether the latest coronavirus development will do lasting harm to the complexion of the market. Omicron comes at a fragile time for optimistic investors, with bears pointing to lofty stock market valuations, inflation worries and global economic growth concerns as reasons to expect a drawdown in equities that have managed to avoid a decline from a peak of more than 5%.</p>\n<p>In theory, Friday's post-Thanksgiving environment is traditionally lightly traded and therefore more susceptible to outsize price swings.</p>\n<p>The Nasdaq saw its lowest volume of the year on Black Friday, with 3.479 billion shares trading hands, well below the year-to-date average of 5.099 billion. The total composite volume, including trading on Intercontinental Exchange -owned NYSE platforms, was 8.760 billion, compared with an year-to-date average of 11.196 billion, according to Dow Jones Market Data.</p>\n<p>Still, only time will tell whether the reaction to omicron is a textbook, knee-jerk selloff or something more sinister.</p>\n<p>MarketWatch's Bill Watts wrote, citing Friday research from Mark Arbeter of Arbeter Investments, that the next level of support to watch for the S&P 500 after closing at 4,594,62 on Friday is at 4,570, the 50-day exponential average; 4,566, the 38.2% retracement of the rally; and 4,550, a previous high from early September.</p>\n<p>\"It is too early to know to what extent the new variant will affect economies and markets, and Friday's market moves have probably been exacerbated by reduced liquidity owing to the US Thanksgiving holiday, and the risk that further bad news emerges over the weekend,\" writes Jonas Goltermann senior markets economist at Capital Economics, in a Friday research note.</p>\n<p>J.C. Parets of the All Star Charts blog writes that things could get dicey if the S&P 500 is driven below 4,500, with little support beneath that point.</p>\n<p>\"You know how parents always tell you nothing good ever happens after midnight? Well in the S&P 500, nothing good happens below 4500,\" he writes in a Friday blog.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ccfdc3ebd8825870bc713469baf0d1b2\" tg-width=\"700\" tg-height=\"355\" referrerpolicy=\"no-referrer\"><span>All Star Charts</span></p>\n<p>\"If we're below that then there is a probably a much bigger problem out there, and the heaviest cash positions in 18 months would be warranted,\" Parets writes.</p>\n<p>Some analysts say that there are legitimate reasons for unease, on the public health front.</p>\n<p>\"The fact that this variant seems to be spreading much faster than previous versions (including the Delta variant) bears very careful monitoring,\" wrote Michael Strobaek, global chief investment officer at Credit Suisse, in a research note. There are some questions about the effectiveness of existing COVID vaccines from Pfizer and Moderna due to the number of mutations that the omicron variant bears on the spike protein. The spike protein is the part of the virus targeted by COVID-19 vaccines.</p>\n<p>Analyst at Jefferies led by analyst Sean Darby note that risk-appetite was already edging lower before Black Friday and the selloff may have been a \"tipping point\" in favor of caution and risk moderation.</p>\n<p>\"The news of a new or not so new COVID variant spreading in Southern Africaappears to have been the tipping point in altering risk appetite in the past 24 hours,\" the Jefferies analyst wrote.</p>\n<p>\"However, there has been a sea change in risk variables over the past month -- anincreasing number of 'tailed treasury auctions', declining equity market breadth andthe imperceptible change in US retail appetite that seems to have gone unnoticed.Positioning in global equities is one of the most aggressive in US history,\" according to Darby and his colleagues.</p>\n<p>Jefferies research suggests that investors are now expecting that the Federal Reserve, under renominated Chairman Jerome Powell, will hasten the pace of reductions in the central bank's asset purchases, which will lead to tighter financial conditions that could prove unfavorable to risky assets. Goldman Sachs sees the Fed stepping up tapering to $30 billion a month from a reduction of $15 billion, and estimates three policy interest rate increases in 2022, up from two.</p>\n<p>\"Ultimately the Sharpe ratio -- a measure of return per unit of risk -- isturning for global equities. We expect the gap between the performance of risky and safe haven assets to diminish,\" Jefferies wrote.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5a2b6cd6fadb4dd80d04e06539404155\" tg-width=\"699\" tg-height=\"203\" referrerpolicy=\"no-referrer\"><span>via Jefferies</span></p>\n<p>The situation could still prove a buying opportunity for bold investors, however.</p>\n<p>Strobaek wrote that \"risk assets such as equities are likely to give back some strength, but we would see this as an opportunity in selective and specific areas.\"</p>\n<p>\"At this point, we reiterate our assessment from the latest Investment Committee report, i.e. keeping equities at a small overweight in portfolios and government bonds at an underweight,\" the Credit Suisse CIO writes.</p>\n<p>Analysts at Citigroup also said that \"we would buy into any dip,\" noting that its bearish checklist doesn't indicate significant red flags. \"Valuations look stretched, but other factors (credit spreads, fund flows) are not yet especially extended,\" Citi writes, with 7.5 out of 18 red flags triggered in its measures of global markets while the U.S. is seeing 9.5 of 18.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d4fba734970a8c977a13d6972402b65f\" tg-width=\"700\" tg-height=\"417\" referrerpolicy=\"no-referrer\"><span>Citi Research</span></p>\n<p>Greg Bassuk, CEO at AXS Investments in Port Chester, NY says that the end-of-week selling may have resulted in a Black Friday sale for stock-market investors.</p>\n<p>\"Black Friday is typically the unofficial kick-off to the annual holiday shopping season. But we believe the real shopping is for stocks that are beaten-down from Covid infection spikes, inflation fears, and supply chain woes, but that still possess strong fundamentals that will drive their gains as the economy ultimately reopens,\" he wrote</p>\n<p>That said, some analysts note that the lockdowns playing out in Europe and the spread of COVID, even before the omicron declaration, were reasons to be cautious since they will impact the global growth outlook.</p>\n<p>Either way, it seems that a degree of caveat emptor may be in force next week and could color trading for the remainder of the 2021.</p>\n<p>Trading on Monday will help determine whether bullishness persists or if a bearish phase is crystallizing.</p>\n<p>It will be a week focused on the state of employment, with the November U.S. jobs report due at the end of the week and Powell and others offering their final thoughts before a media blackout period starting ahead of the Federal Open Market Committee's final meeting of 2021 on Dec. 14-15.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's what the Black Friday carnage may mean for the stock market's trade Monday, analysts say</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's what the Black Friday carnage may mean for the stock market's trade Monday, analysts say\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 07:02 GMT+8 <a href=https://www.marketwatch.com/story/heres-what-the-black-friday-carnage-may-mean-for-the-stock-markets-trade-monday-analysts-say-11638021516?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>OMG, omicron!\nThe new, fast-spreading B.1.1.529 strain of coronavirus declared a variant of concern by the World Health Organization roiled global markets on Black Friday, raising concerns about how ...</p>\n\n<a href=\"https://www.marketwatch.com/story/heres-what-the-black-friday-carnage-may-mean-for-the-stock-markets-trade-monday-analysts-say-11638021516?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","PFE":"辉瑞","BK4139":"生物科技","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)","MRNA":"Moderna, Inc.",".DJI":"道琼斯","BK4007":"制药",".SPX":"S&P 500 Index","BK4532":"文艺复兴科技持仓","BK4551":"寇图资本持仓",".IXIC":"NASDAQ Composite","BK4548":"巴美列捷福持仓","ICE":"洲际交易所","BK4112":"金融交易所和数据"},"source_url":"https://www.marketwatch.com/story/heres-what-the-black-friday-carnage-may-mean-for-the-stock-markets-trade-monday-analysts-say-11638021516?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187329491","content_text":"OMG, omicron!\nThe new, fast-spreading B.1.1.529 strain of coronavirus declared a variant of concern by the World Health Organization roiled global markets on Black Friday, raising concerns about how the economy and Wall Street may perform in the coming week, following a selloff that wiped out November gains for the S&P 500 index and the Nasdaq Composite and sent the Dow Jones Industrial Average down by the most in a day since Oct. 28, 2020.\nWHO said that the omicron variant, which has been detected in Belgium, Israel, and Hong Kong and was first identified in southern parts of Africa, is more transmissible than the delta strain that is currently dominant world-wide, and other variants.\nThe emergence of the new strain led to the White House announcing restrictions, starting on Monday, on travel for non-U.S. citizens and residents from South Africa, as well as from Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique, and Malawi, joining the European Union, the U.K., Singapore and Japan, which also announced similar travel bans.\nThe market selloff during the abbreviated Black Friday session and the commensurate flight to assets that investors hope will perform better amid fresh mobility restrictions, helped to overshadow the usual focus on retail, on a day associated with heavy consumer spending ahead of the Christmas holiday. Friday's downturn also offered a crystal clear reminder that the path of the market and economy hinges on the course of COVID.\nWhat isn't clear is whether the latest coronavirus development will do lasting harm to the complexion of the market. Omicron comes at a fragile time for optimistic investors, with bears pointing to lofty stock market valuations, inflation worries and global economic growth concerns as reasons to expect a drawdown in equities that have managed to avoid a decline from a peak of more than 5%.\nIn theory, Friday's post-Thanksgiving environment is traditionally lightly traded and therefore more susceptible to outsize price swings.\nThe Nasdaq saw its lowest volume of the year on Black Friday, with 3.479 billion shares trading hands, well below the year-to-date average of 5.099 billion. The total composite volume, including trading on Intercontinental Exchange -owned NYSE platforms, was 8.760 billion, compared with an year-to-date average of 11.196 billion, according to Dow Jones Market Data.\nStill, only time will tell whether the reaction to omicron is a textbook, knee-jerk selloff or something more sinister.\nMarketWatch's Bill Watts wrote, citing Friday research from Mark Arbeter of Arbeter Investments, that the next level of support to watch for the S&P 500 after closing at 4,594,62 on Friday is at 4,570, the 50-day exponential average; 4,566, the 38.2% retracement of the rally; and 4,550, a previous high from early September.\n\"It is too early to know to what extent the new variant will affect economies and markets, and Friday's market moves have probably been exacerbated by reduced liquidity owing to the US Thanksgiving holiday, and the risk that further bad news emerges over the weekend,\" writes Jonas Goltermann senior markets economist at Capital Economics, in a Friday research note.\nJ.C. Parets of the All Star Charts blog writes that things could get dicey if the S&P 500 is driven below 4,500, with little support beneath that point.\n\"You know how parents always tell you nothing good ever happens after midnight? Well in the S&P 500, nothing good happens below 4500,\" he writes in a Friday blog.\nAll Star Charts\n\"If we're below that then there is a probably a much bigger problem out there, and the heaviest cash positions in 18 months would be warranted,\" Parets writes.\nSome analysts say that there are legitimate reasons for unease, on the public health front.\n\"The fact that this variant seems to be spreading much faster than previous versions (including the Delta variant) bears very careful monitoring,\" wrote Michael Strobaek, global chief investment officer at Credit Suisse, in a research note. There are some questions about the effectiveness of existing COVID vaccines from Pfizer and Moderna due to the number of mutations that the omicron variant bears on the spike protein. The spike protein is the part of the virus targeted by COVID-19 vaccines.\nAnalyst at Jefferies led by analyst Sean Darby note that risk-appetite was already edging lower before Black Friday and the selloff may have been a \"tipping point\" in favor of caution and risk moderation.\n\"The news of a new or not so new COVID variant spreading in Southern Africaappears to have been the tipping point in altering risk appetite in the past 24 hours,\" the Jefferies analyst wrote.\n\"However, there has been a sea change in risk variables over the past month -- anincreasing number of 'tailed treasury auctions', declining equity market breadth andthe imperceptible change in US retail appetite that seems to have gone unnoticed.Positioning in global equities is one of the most aggressive in US history,\" according to Darby and his colleagues.\nJefferies research suggests that investors are now expecting that the Federal Reserve, under renominated Chairman Jerome Powell, will hasten the pace of reductions in the central bank's asset purchases, which will lead to tighter financial conditions that could prove unfavorable to risky assets. Goldman Sachs sees the Fed stepping up tapering to $30 billion a month from a reduction of $15 billion, and estimates three policy interest rate increases in 2022, up from two.\n\"Ultimately the Sharpe ratio -- a measure of return per unit of risk -- isturning for global equities. We expect the gap between the performance of risky and safe haven assets to diminish,\" Jefferies wrote.\nvia Jefferies\nThe situation could still prove a buying opportunity for bold investors, however.\nStrobaek wrote that \"risk assets such as equities are likely to give back some strength, but we would see this as an opportunity in selective and specific areas.\"\n\"At this point, we reiterate our assessment from the latest Investment Committee report, i.e. keeping equities at a small overweight in portfolios and government bonds at an underweight,\" the Credit Suisse CIO writes.\nAnalysts at Citigroup also said that \"we would buy into any dip,\" noting that its bearish checklist doesn't indicate significant red flags. \"Valuations look stretched, but other factors (credit spreads, fund flows) are not yet especially extended,\" Citi writes, with 7.5 out of 18 red flags triggered in its measures of global markets while the U.S. is seeing 9.5 of 18.\nCiti Research\nGreg Bassuk, CEO at AXS Investments in Port Chester, NY says that the end-of-week selling may have resulted in a Black Friday sale for stock-market investors.\n\"Black Friday is typically the unofficial kick-off to the annual holiday shopping season. But we believe the real shopping is for stocks that are beaten-down from Covid infection spikes, inflation fears, and supply chain woes, but that still possess strong fundamentals that will drive their gains as the economy ultimately reopens,\" he wrote\nThat said, some analysts note that the lockdowns playing out in Europe and the spread of COVID, even before the omicron declaration, were reasons to be cautious since they will impact the global growth outlook.\nEither way, it seems that a degree of caveat emptor may be in force next week and could color trading for the remainder of the 2021.\nTrading on Monday will help determine whether bullishness persists or if a bearish phase is crystallizing.\nIt will be a week focused on the state of employment, with the November U.S. jobs report due at the end of the week and Powell and others offering their final thoughts before a media blackout period starting ahead of the Federal Open Market Committee's final meeting of 2021 on Dec. 14-15.","news_type":1},"isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600111238,"gmtCreate":1638087084793,"gmtModify":1638087084929,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600111238","repostId":"2186432895","repostType":4,"repost":{"id":"2186432895","kind":"highlight","pubTimestamp":1638069921,"share":"https://www.laohu8.com/m/news/2186432895?lang=&edition=full","pubTime":"2021-11-28 11:25","market":"us","language":"en","title":"$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2186432895","media":"Motley Fool","summary":"A little money can go a long way.","content":"<p>Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it can generate a 12% annual return. That's slightly better than the average stock market return over the last 50 years of nearly 11%. </p>\n<p>Many companies have a long history of beating the market. Three companies that appear likely to continue doing so in the decades ahead are <a href=\"https://laohu8.com/S/BEP\"><b>Brookfield Renewable</b> </a>, <a href=\"https://laohu8.com/S/CCI\"><b>Crown Castle International</b> </a>, and <a href=\"https://laohu8.com/S/NEE\"><b>NextEra Energy</b> </a>. Because of that, $100 invested in each one every month could grow into a $1 million nest egg by retirement.</p>\n<h2>Benefiting from a powerful megatrend</h2>\n<p>Brookfield Renewable has enriched its investors over the years. Since its inception, the renewable energy producer has generated an annualized total return of 19%. The company had done that by investing billions of dollars into expanding its renewable energy portfolio. That has powered more than 10% annual growth in its cash flow per share, supporting 6% annual dividend increases over the last decade. </p>\n<p>However, Brookfield's best days appear to lie ahead. The global economy needs to invest trillions of dollars to decarbonize the energy sector over the next 30 years. That should enable Brookfield to continue to invest in expanding its renewable energy portfolio.</p>\n<p>The company currently has 36 gigawatts (GW) of renewable energy projects in development. That's bigger than the company's current operating portfolio of about 21 GW. Combined with rising power rates, and its growing scale, these projects should support up to 11% annual cash flow per share growth through at least 2026. </p>\n<p>Meanwhile, Brookfield sees up to another 9% yearly boost from future acquisitions. Add that growing renewable-powered cash flow stream to the company's 3%-yielding dividend, and Brookfield appears to have the power to produce double-digit annual returns for decades to come. </p>\n<h2>Connected to the data supercycle</h2>\n<p>Crown Castle has been an exceptional value creator over the years. The infrastructure-focused real estate investment trust (REIT) has delivered a more than 13% annual total return over the two-plus decades since its initial public offering. </p>\n<p>A major driver of those returns has been the billions of dollars the company has poured into expanding its communications infrastructure portfolio. Over the last decade alone, the REIT spent $31 billion on acquisitions and capital expenditures (capex), powering 9% annual dividend growth since 2014. </p>\n<p>The company still sees significant investment opportunities ahead. Crown Castle noted that the telecom industry's rollout of 5G networks represents a decade-long investment cycle. Meanwhile, some see a 100-year data infrastructure upgrade investment opportunity to support the digital economy. Because of that, Crown Castle has a lot of growth ahead of it, which should drive continued strong returns. </p>\n<p>Crown Castle expects to grow its 3.2%-yielding dividend at a 7% to 8% annual rate in the near term. That suggests the company could deliver double-digit total returns in the coming years. </p>\n<h2>Plugged into several growth catalysts</h2>\n<p>NextEra Energy has also created an enormous amount of wealth for its investors over the years. The utility has generated a roughly 700% total return over the last decade alone, crushing the 276% total return produced by the S&P 500. Powering the company's robust results has been its ability to deliver above-average earnings and dividend growth. It has increased its earnings per share at an 8.7% compound annual rate since 2005, supporting 9.6% compound annual dividend growth. </p>\n<p>A major catalyst has been the company's leadership in renewable energy. It has grown into one of the world's largest wind and solar energy producers. </p>\n<p>That leadership should continue since it has one of the world's biggest backlogs of wind and solar energy development projects. In addition to tried-and-true technologies like wind and solar, NextEra is a leader in emerging technologies, including battery storage and green hydrogen. Meanwhile, it's tapping into other sources of growth like water infrastructure. Because of that, NextEra should have plenty of power to continue growing its earnings and dividend in the decades ahead.</p>\n<h2>Grow rich slowly</h2>\n<p>Compound interest can do wonders for your retirement. Steadily investing a few hundred dollars each month into high-performing stocks can create an enormous amount of wealth. One of the keys to finding stocks that can deliver decades of strong returns is focusing on those benefiting from megatrends. Few are as big and enduring as renewable energy and data, making Brookfield Renewable, Crown Castle, and NextEra Energy stand out as stocks that could mint their share of millionaires in the decades ahead.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 11:25 GMT+8 <a href=https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCI":"冠城","NEE":"新纪元能源","BEP":"Brookfield Renewable Partners LP"},"source_url":"https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186432895","content_text":"Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it can generate a 12% annual return. That's slightly better than the average stock market return over the last 50 years of nearly 11%. \nMany companies have a long history of beating the market. Three companies that appear likely to continue doing so in the decades ahead are Brookfield Renewable , Crown Castle International , and NextEra Energy . Because of that, $100 invested in each one every month could grow into a $1 million nest egg by retirement.\nBenefiting from a powerful megatrend\nBrookfield Renewable has enriched its investors over the years. Since its inception, the renewable energy producer has generated an annualized total return of 19%. The company had done that by investing billions of dollars into expanding its renewable energy portfolio. That has powered more than 10% annual growth in its cash flow per share, supporting 6% annual dividend increases over the last decade. \nHowever, Brookfield's best days appear to lie ahead. The global economy needs to invest trillions of dollars to decarbonize the energy sector over the next 30 years. That should enable Brookfield to continue to invest in expanding its renewable energy portfolio.\nThe company currently has 36 gigawatts (GW) of renewable energy projects in development. That's bigger than the company's current operating portfolio of about 21 GW. Combined with rising power rates, and its growing scale, these projects should support up to 11% annual cash flow per share growth through at least 2026. \nMeanwhile, Brookfield sees up to another 9% yearly boost from future acquisitions. Add that growing renewable-powered cash flow stream to the company's 3%-yielding dividend, and Brookfield appears to have the power to produce double-digit annual returns for decades to come. \nConnected to the data supercycle\nCrown Castle has been an exceptional value creator over the years. The infrastructure-focused real estate investment trust (REIT) has delivered a more than 13% annual total return over the two-plus decades since its initial public offering. \nA major driver of those returns has been the billions of dollars the company has poured into expanding its communications infrastructure portfolio. Over the last decade alone, the REIT spent $31 billion on acquisitions and capital expenditures (capex), powering 9% annual dividend growth since 2014. \nThe company still sees significant investment opportunities ahead. Crown Castle noted that the telecom industry's rollout of 5G networks represents a decade-long investment cycle. Meanwhile, some see a 100-year data infrastructure upgrade investment opportunity to support the digital economy. Because of that, Crown Castle has a lot of growth ahead of it, which should drive continued strong returns. \nCrown Castle expects to grow its 3.2%-yielding dividend at a 7% to 8% annual rate in the near term. That suggests the company could deliver double-digit total returns in the coming years. \nPlugged into several growth catalysts\nNextEra Energy has also created an enormous amount of wealth for its investors over the years. The utility has generated a roughly 700% total return over the last decade alone, crushing the 276% total return produced by the S&P 500. Powering the company's robust results has been its ability to deliver above-average earnings and dividend growth. It has increased its earnings per share at an 8.7% compound annual rate since 2005, supporting 9.6% compound annual dividend growth. \nA major catalyst has been the company's leadership in renewable energy. It has grown into one of the world's largest wind and solar energy producers. \nThat leadership should continue since it has one of the world's biggest backlogs of wind and solar energy development projects. In addition to tried-and-true technologies like wind and solar, NextEra is a leader in emerging technologies, including battery storage and green hydrogen. Meanwhile, it's tapping into other sources of growth like water infrastructure. Because of that, NextEra should have plenty of power to continue growing its earnings and dividend in the decades ahead.\nGrow rich slowly\nCompound interest can do wonders for your retirement. Steadily investing a few hundred dollars each month into high-performing stocks can create an enormous amount of wealth. One of the keys to finding stocks that can deliver decades of strong returns is focusing on those benefiting from megatrends. Few are as big and enduring as renewable energy and data, making Brookfield Renewable, Crown Castle, and NextEra Energy stand out as stocks that could mint their share of millionaires in the decades ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877420523,"gmtCreate":1637974453362,"gmtModify":1637974453459,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877420523","repostId":"1128119268","repostType":4,"repost":{"id":"1128119268","kind":"news","pubTimestamp":1637972590,"share":"https://www.laohu8.com/m/news/1128119268?lang=&edition=full","pubTime":"2021-11-27 08:23","market":"us","language":"en","title":"These 3 Stocks Punished the Dow Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1128119268","media":"Motley Fool","summary":"The stock market was definitely not in a holiday mood on the day after Thanksgiving, as news of the ","content":"<p>The stock market was definitely not in a holiday mood on the day after Thanksgiving, as news of the new Omicron variant of COVID-19 led to widespread concerns about a possible return to lockdown conditions. By the end of the day, the <b>Dow Jones Industrial Average</b>(DJINDICES:^DJI),<b>S&P 500</b>(SNPINDEX:^GSPC), and <b>Nasdaq Composite</b>(NASDAQINDEX:^IXIC)were all down between 2% and 3%.</p>\n<p>Today's news hurt stocks in many different sectors of the market, with a wide variety of factors playing into losses. Because of theDow's price-weighted nature, a few stocks had a disproportionate influence on the average's moves. Below, we'll look at how <b>American Express</b>(NYSE:AXP),<b>Boeing</b>(NYSE:BA), and <b>Goldman Sachs</b>(NYSE:GS)combined to lop about 250 points off the Dow by themselves.</p>\n<p>A double hit for American Express</p>\n<p>American Express was the worst performer in the Dow, falling almost 9%. The financial company saw its stock fall for two different reasons related to the news about the pandemic.</p>\n<p>First and foremost, American Express has historically relied on global travel to drive a substantial part of its business. Its traveler's checks are known around the world as a means of doing business, and its charge cards have prestige in key market destinations. The prospects for further restrictions on travel, therefore, would have a detrimental impact on its business.</p>\n<p>Moreover, as a financial institution,American Express benefits from a steeper yield curve. The recent trend in that direction met an abrupt reversal on Friday, as bond yields plunged on prospects for a possible economic slowdown. Investors anticipate that the company could have problems meeting its own expectations if the pandemic worsens, and that's why the stock cost the Dow about 100 points on Friday.</p>\n<p>Flying lower</p>\n<p>Another company that one would've expected to fare poorly given the news was <b>Boeing</b>(NYSE:BA). The aerospace company fell more than 5%, and its higher-priced shares gave it a big impact on the Dow.</p>\n<p>You won't find airline stocks in the Dow Industrials, but they took even larger hits as a result of the COVID news. Already, the U.S. and other nations have put travel restrictions on South Africa and neighboring countries to try to stem the spread of the Omicron variant. That bodes poorly for airlines serving those markets, and it indirectly affects Boeing by raising the possibility that airlines will have to cancel or postpone orders if they come under additional economic pressure.</p>\n<p>Boeing has suffered substantial losses, but investors were starting to hope that it would turn profitable again in 2022. The latest news threatens that assessment, and investors don't like the prospects for more red ink from the aircraft manufacturer.</p>\n<p>Banking on rate rises</p>\n<p>Goldman Sachs was down 2.5% on Friday. Its nearly $10 decline cost the Dow roughly 70 points on the day.</p>\n<p>Goldman faced some of the same challenges that American Express does. Increasingly,Goldman has tried to boost its retail banking presence through its Marcus unit, and that has exposed the Wall Street financial giant to greater interest rate sensitivity. The flattening yield curve Friday didn't do any favors to the company's consumer banking segment.</p>\n<p>Wall Street has also benefited from huge levels of investment banking activity, where Goldman excels. If a market pullback leads to reduced activity for initial public offerings, acquisitions, and other corporate events, then it could hurt that part of Goldman's business as well.</p>\n<p>Don't panic</p>\n<p>A 900-point plunge for the Dow makes for a scary headline, but it's just part of the natural volatility of the stock market. Don't lose perspective, and if you stick with your long-term investment strategy, things will likely go better for you than if you panic.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Punished the Dow Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Punished the Dow Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-27 08:23 GMT+8 <a href=https://www.fool.com/investing/2021/11/26/these-3-stocks-punished-the-dow-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market was definitely not in a holiday mood on the day after Thanksgiving, as news of the new Omicron variant of COVID-19 led to widespread concerns about a possible return to lockdown ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/26/these-3-stocks-punished-the-dow-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AXP":"美国运通","GS":"高盛","BA":"波音"},"source_url":"https://www.fool.com/investing/2021/11/26/these-3-stocks-punished-the-dow-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128119268","content_text":"The stock market was definitely not in a holiday mood on the day after Thanksgiving, as news of the new Omicron variant of COVID-19 led to widespread concerns about a possible return to lockdown conditions. By the end of the day, the Dow Jones Industrial Average(DJINDICES:^DJI),S&P 500(SNPINDEX:^GSPC), and Nasdaq Composite(NASDAQINDEX:^IXIC)were all down between 2% and 3%.\nToday's news hurt stocks in many different sectors of the market, with a wide variety of factors playing into losses. Because of theDow's price-weighted nature, a few stocks had a disproportionate influence on the average's moves. Below, we'll look at how American Express(NYSE:AXP),Boeing(NYSE:BA), and Goldman Sachs(NYSE:GS)combined to lop about 250 points off the Dow by themselves.\nA double hit for American Express\nAmerican Express was the worst performer in the Dow, falling almost 9%. The financial company saw its stock fall for two different reasons related to the news about the pandemic.\nFirst and foremost, American Express has historically relied on global travel to drive a substantial part of its business. Its traveler's checks are known around the world as a means of doing business, and its charge cards have prestige in key market destinations. The prospects for further restrictions on travel, therefore, would have a detrimental impact on its business.\nMoreover, as a financial institution,American Express benefits from a steeper yield curve. The recent trend in that direction met an abrupt reversal on Friday, as bond yields plunged on prospects for a possible economic slowdown. Investors anticipate that the company could have problems meeting its own expectations if the pandemic worsens, and that's why the stock cost the Dow about 100 points on Friday.\nFlying lower\nAnother company that one would've expected to fare poorly given the news was Boeing(NYSE:BA). The aerospace company fell more than 5%, and its higher-priced shares gave it a big impact on the Dow.\nYou won't find airline stocks in the Dow Industrials, but they took even larger hits as a result of the COVID news. Already, the U.S. and other nations have put travel restrictions on South Africa and neighboring countries to try to stem the spread of the Omicron variant. That bodes poorly for airlines serving those markets, and it indirectly affects Boeing by raising the possibility that airlines will have to cancel or postpone orders if they come under additional economic pressure.\nBoeing has suffered substantial losses, but investors were starting to hope that it would turn profitable again in 2022. The latest news threatens that assessment, and investors don't like the prospects for more red ink from the aircraft manufacturer.\nBanking on rate rises\nGoldman Sachs was down 2.5% on Friday. Its nearly $10 decline cost the Dow roughly 70 points on the day.\nGoldman faced some of the same challenges that American Express does. Increasingly,Goldman has tried to boost its retail banking presence through its Marcus unit, and that has exposed the Wall Street financial giant to greater interest rate sensitivity. The flattening yield curve Friday didn't do any favors to the company's consumer banking segment.\nWall Street has also benefited from huge levels of investment banking activity, where Goldman excels. If a market pullback leads to reduced activity for initial public offerings, acquisitions, and other corporate events, then it could hurt that part of Goldman's business as well.\nDon't panic\nA 900-point plunge for the Dow makes for a scary headline, but it's just part of the natural volatility of the stock market. Don't lose perspective, and if you stick with your long-term investment strategy, things will likely go better for you than if you panic.","news_type":1},"isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":872969975,"gmtCreate":1637395183210,"gmtModify":1637395183308,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/872969975","repostId":"2184384295","repostType":4,"repost":{"id":"2184384295","kind":"news","pubTimestamp":1637391182,"share":"https://www.laohu8.com/m/news/2184384295?lang=&edition=full","pubTime":"2021-11-20 14:53","market":"us","language":"en","title":"NIO Inc. Announces Completion of At-The-Market Offering of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2184384295","media":"GlobeNewswire","summary":"$NIO Inc. $, a pioneer and a leading company in the premium smart electric vehicle market, today announced that it has completed its previously announced at-the-market offering of American depositary shares , each representing $one$ Class A ordinary share of the Company.Through the At-The-Market Offering, the Company has sold 53,292,401 ADSs and raised gross proceeds of US$2 billion, before deducting commissions paid to the distribution agents of approximately US$26 million and certain offering","content":"<p><a href=\"https://laohu8.com/S/NIO\">NIO Inc. </a>, a pioneer and a leading company in the premium smart electric vehicle market, today announced that it has completed its previously announced at-the-market offering (the “At-The-Market Offering”) of American depositary shares (“ADSs”), each representing <a href=\"https://laohu8.com/S/AONE.U\">one</a> Class A ordinary share of the Company.</p>\n<p>Through the At-The-Market Offering, the Company has sold 53,292,401 ADSs and raised gross proceeds of US$2 billion, before deducting commissions paid to the distribution agents of approximately US$26 million and certain offering expenses. The Company currently plans to use the net proceeds from the At-The-Market Offering to further strengthen its balance sheet, as well as for general corporate purposes.</p>\n<p><b>About NIO Inc. </b></p>\n<p>NIO Inc. is a pioneer and a leading company in the premium smart electric vehicle market. Founded in November 2014, NIO’s mission is to shape a joyful lifestyle. NIO aims to build a community starting with smart electric vehicles to share joy and grow together with users.</p>\n<p>NIO designs, develops, jointly manufactures and sells smart premium electric vehicles, driving innovations in next-generation technologies in autonomous driving, digital technologies, electric powertrains and batteries. NIO differentiates itself through its continuous technological breakthroughs and innovations, such as its industry-leading battery swapping technologies, Battery as a Service, or BaaS, as well as its proprietary autonomous driving technologies and Autonomous Driving as a Service, or ADaaS.</p>\n<p>NIO launched the ES8, a seven-seater flagship premium smart electric SUV in December 2017, and began deliveries of the ES8 in June 2018 and its variant, the six-seater ES8, in March 2019. NIO launched the ES6, a five-seater high-performance premium smart electric SUV, in December 2018, and began deliveries of the ES6 in June 2019. NIO launched the EC6, a five-seater premium smart electric coupe SUV, in December 2019, and began deliveries of the EC6 in September 2020. NIO launched the ET7, a flagship premium smart electric sedan, in January 2021.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Inc. Announces Completion of At-The-Market Offering of American Depositary Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Inc. Announces Completion of At-The-Market Offering of American Depositary Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-20 14:53 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=19248921><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NIO Inc. , a pioneer and a leading company in the premium smart electric vehicle market, today announced that it has completed its previously announced at-the-market offering (the “At-The-Market ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19248921\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19248921","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184384295","content_text":"NIO Inc. , a pioneer and a leading company in the premium smart electric vehicle market, today announced that it has completed its previously announced at-the-market offering (the “At-The-Market Offering”) of American depositary shares (“ADSs”), each representing one Class A ordinary share of the Company.\nThrough the At-The-Market Offering, the Company has sold 53,292,401 ADSs and raised gross proceeds of US$2 billion, before deducting commissions paid to the distribution agents of approximately US$26 million and certain offering expenses. The Company currently plans to use the net proceeds from the At-The-Market Offering to further strengthen its balance sheet, as well as for general corporate purposes.\nAbout NIO Inc. \nNIO Inc. is a pioneer and a leading company in the premium smart electric vehicle market. Founded in November 2014, NIO’s mission is to shape a joyful lifestyle. NIO aims to build a community starting with smart electric vehicles to share joy and grow together with users.\nNIO designs, develops, jointly manufactures and sells smart premium electric vehicles, driving innovations in next-generation technologies in autonomous driving, digital technologies, electric powertrains and batteries. NIO differentiates itself through its continuous technological breakthroughs and innovations, such as its industry-leading battery swapping technologies, Battery as a Service, or BaaS, as well as its proprietary autonomous driving technologies and Autonomous Driving as a Service, or ADaaS.\nNIO launched the ES8, a seven-seater flagship premium smart electric SUV in December 2017, and began deliveries of the ES8 in June 2018 and its variant, the six-seater ES8, in March 2019. NIO launched the ES6, a five-seater high-performance premium smart electric SUV, in December 2018, and began deliveries of the ES6 in June 2019. NIO launched the EC6, a five-seater premium smart electric coupe SUV, in December 2019, and began deliveries of the EC6 in September 2020. NIO launched the ET7, a flagship premium smart electric sedan, in January 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":75,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864899919,"gmtCreate":1633083134516,"gmtModify":1633083143221,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Cool] ","listText":"[Cool] ","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/864899919","repostId":"1199143925","repostType":4,"repost":{"id":"1199143925","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633078771,"share":"https://www.laohu8.com/m/news/1199143925?lang=&edition=full","pubTime":"2021-10-01 16:59","market":"us","language":"en","title":"Top 10 stocks that Wall Street’s picks for Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=1199143925","media":"Tiger Newspress","summary":"To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro ide","content":"<p>To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.</p>\n<p>Take a look at CNBC Pro’s list.<img src=\"https://static.tigerbbs.com/5ae083b97e4feaf3496a1e1d77d78429\" tg-width=\"1360\" tg-height=\"1466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&P 500′s 16% gain.</p>\n<p>Alaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.</p>\n<p>Power generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.</p>\n<p>Other names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top 10 stocks that Wall Street’s picks for Q4</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop 10 stocks that Wall Street’s picks for Q4\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-01 16:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.</p>\n<p>Take a look at CNBC Pro’s list.<img src=\"https://static.tigerbbs.com/5ae083b97e4feaf3496a1e1d77d78429\" tg-width=\"1360\" tg-height=\"1466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&P 500′s 16% gain.</p>\n<p>Alaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.</p>\n<p>Power generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.</p>\n<p>Other names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NWSA":"新闻集团","GM":"通用汽车","TMUS":"T-Mobile US Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199143925","content_text":"To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.\nTake a look at CNBC Pro’s list.Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&P 500′s 16% gain.\nAlaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.\nPower generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.\nOther names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.","news_type":1},"isVote":1,"tweetType":1,"viewCount":164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606825496,"gmtCreate":1638860285272,"gmtModify":1638860285467,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606825496","repostId":"2189686612","repostType":4,"repost":{"id":"2189686612","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638826608,"share":"https://www.laohu8.com/m/news/2189686612?lang=&edition=full","pubTime":"2021-12-07 05:36","market":"us","language":"en","title":"Wall Street regains some ground with help from easing virus fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2189686612","media":"Reuters","summary":"Dec 6 - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.Of Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminis","content":"<p>Dec 6 (Reuters) - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.</p>\n<p>Of Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminished gains in the healthcare sector .</p>\n<p>While the Omicron COVID-19 variant has caused alarm and some new restrictions around the world, investors appeared to be reassured by Dr. Anthony Fauci, the top U.S. infectious disease official, who told CNN that \"thus far it does not look like there's a great degree of severity to it.\" However, he did say that more study is needed.</p>\n<p>\"People are less worried about the variant,\" said King Lip, chief investment strategist at Baker Avenue Asset Management in San Francisco.</p>\n<p>Lip also cited a boost from news that China's central bank would cut the amount of cash that banks must hold in reserve, potentially boosting overseas companies that sell products in China as well as China's economy.</p>\n<p>The Dow Jones Industrial Average rose 646.95 points, or 1.87%, to 35,227.03, the S&P 500 gained 53.24 points, or 1.17%, to 4,591.67 and the Nasdaq Composite added 139.68 points, or 0.93%, to 15,225.15.</p>\n<p>The S&P 500 Value Index rose 1.5%, outperforming its growth counterpart , which gained 0.9%.</p>\n<p>The economically sensitive Dow Jones Transportation index outperformed the broader market with a 2.3% gain while the small-cap Russell 2000 climbed 2%.</p>\n<p>Wall Street's major indexes have been swinging wildly since Nov. 26 as investors digested news of the COVID-19 Omicron variant and then Federal Reserve Chair Jerome Powell's hawkish comments last week about a speedier tapering of government bond-buying to tackle surging inflation.</p>\n<p>The S&P's finish on Monday was 2.3% below where it traded before investors started reacting to the Omicron virus.</p>\n<p>\"If today's strength in the blue chips can sort of sustain itself, that might give the rest of the market the ability to start to feel confident,\" said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>Still, Goldman Sachs on Saturday cut its outlook for U.S. economic growth to 3.8% for 2022, citing risks and uncertainty around the emergence of Omicron. Investors had also been bracing for a potential hit to corporate earnings, particularly among retailers, restaurants and travel companies.</p>\n<p>The industrials sector's three biggest percentage gainers were airlines led by United Airlines 8.3% gain while the S&P Airline's index closed up 5.5%.</p>\n<p>Other strong gainers in travel related stocks included Norwegian Cruise Line Holdings , which finished up 9.5%. Vacation rental company Airbnb added 8.5%.</p>\n<p>Big decliners included COVID-19 vaccine makers such as Moderna Inc , down 13.5%, and Pfizer, down 5%, as investors anticipated development of vaccines with protections specific to Omicron could take months.</p>\n<p>Nvidia closed down 2%. Investors have been worried about the outcome of regulatory scrutiny of its deal to buy British chip firm ARM Ltd.</p>\n<p>Kohl's Corp shares closed up 5.4% after hedge fund Engine Capital LP said it was pushing the department-store chain to consider a sale of the company or separate its e-commerce division to improve its lagging stock price.</p>\n<p>JJ Kinahan, chief market strategist at TD Ameritrade, said investors may be preparing for a Dec. 17 expiration of options and futures.</p>\n<p>\"You have a lot of firms that have a double mandate right now. You are trying to take off risk, expiration related, while the same time rebalancing your portfolio heading into 2022,\" he said.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.82-to-1 ratio; on Nasdaq, a 1.71-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 20 new 52-week highs and <a href=\"https://laohu8.com/S/AONE.U\">one</a> new low; the Nasdaq Composite recorded 28 new highs and 600 new lows.</p>\n<p>On U.S. exchanges, 11.96 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street regains some ground with help from easing virus fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street regains some ground with help from easing virus fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-07 05:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 6 (Reuters) - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.</p>\n<p>Of Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminished gains in the healthcare sector .</p>\n<p>While the Omicron COVID-19 variant has caused alarm and some new restrictions around the world, investors appeared to be reassured by Dr. Anthony Fauci, the top U.S. infectious disease official, who told CNN that \"thus far it does not look like there's a great degree of severity to it.\" However, he did say that more study is needed.</p>\n<p>\"People are less worried about the variant,\" said King Lip, chief investment strategist at Baker Avenue Asset Management in San Francisco.</p>\n<p>Lip also cited a boost from news that China's central bank would cut the amount of cash that banks must hold in reserve, potentially boosting overseas companies that sell products in China as well as China's economy.</p>\n<p>The Dow Jones Industrial Average rose 646.95 points, or 1.87%, to 35,227.03, the S&P 500 gained 53.24 points, or 1.17%, to 4,591.67 and the Nasdaq Composite added 139.68 points, or 0.93%, to 15,225.15.</p>\n<p>The S&P 500 Value Index rose 1.5%, outperforming its growth counterpart , which gained 0.9%.</p>\n<p>The economically sensitive Dow Jones Transportation index outperformed the broader market with a 2.3% gain while the small-cap Russell 2000 climbed 2%.</p>\n<p>Wall Street's major indexes have been swinging wildly since Nov. 26 as investors digested news of the COVID-19 Omicron variant and then Federal Reserve Chair Jerome Powell's hawkish comments last week about a speedier tapering of government bond-buying to tackle surging inflation.</p>\n<p>The S&P's finish on Monday was 2.3% below where it traded before investors started reacting to the Omicron virus.</p>\n<p>\"If today's strength in the blue chips can sort of sustain itself, that might give the rest of the market the ability to start to feel confident,\" said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>Still, Goldman Sachs on Saturday cut its outlook for U.S. economic growth to 3.8% for 2022, citing risks and uncertainty around the emergence of Omicron. Investors had also been bracing for a potential hit to corporate earnings, particularly among retailers, restaurants and travel companies.</p>\n<p>The industrials sector's three biggest percentage gainers were airlines led by United Airlines 8.3% gain while the S&P Airline's index closed up 5.5%.</p>\n<p>Other strong gainers in travel related stocks included Norwegian Cruise Line Holdings , which finished up 9.5%. Vacation rental company Airbnb added 8.5%.</p>\n<p>Big decliners included COVID-19 vaccine makers such as Moderna Inc , down 13.5%, and Pfizer, down 5%, as investors anticipated development of vaccines with protections specific to Omicron could take months.</p>\n<p>Nvidia closed down 2%. Investors have been worried about the outcome of regulatory scrutiny of its deal to buy British chip firm ARM Ltd.</p>\n<p>Kohl's Corp shares closed up 5.4% after hedge fund Engine Capital LP said it was pushing the department-store chain to consider a sale of the company or separate its e-commerce division to improve its lagging stock price.</p>\n<p>JJ Kinahan, chief market strategist at TD Ameritrade, said investors may be preparing for a Dec. 17 expiration of options and futures.</p>\n<p>\"You have a lot of firms that have a double mandate right now. You are trying to take off risk, expiration related, while the same time rebalancing your portfolio heading into 2022,\" he said.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.82-to-1 ratio; on Nasdaq, a 1.71-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 20 new 52-week highs and <a href=\"https://laohu8.com/S/AONE.U\">one</a> new low; the Nasdaq Composite recorded 28 new highs and 600 new lows.</p>\n<p>On U.S. exchanges, 11.96 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQQQ":"纳指三倍做空ETF","QQQ":"纳指100ETF","DOG":"道指反向ETF","DDM":"道指两倍做多ETF","DJX":"1/100道琼斯","DXD":"道指两倍做空ETF","QLD":"纳指两倍做多ETF",".DJI":"道琼斯","TQQQ":"纳指三倍做多ETF","PSQ":"纳指反向ETF","UDOW":"道指三倍做多ETF-ProShares",".IXIC":"NASDAQ Composite","SDOW":"道指三倍做空ETF-ProShares","QID":"纳指两倍做空ETF",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189686612","content_text":"Dec 6 (Reuters) - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.\nOf Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminished gains in the healthcare sector .\nWhile the Omicron COVID-19 variant has caused alarm and some new restrictions around the world, investors appeared to be reassured by Dr. Anthony Fauci, the top U.S. infectious disease official, who told CNN that \"thus far it does not look like there's a great degree of severity to it.\" However, he did say that more study is needed.\n\"People are less worried about the variant,\" said King Lip, chief investment strategist at Baker Avenue Asset Management in San Francisco.\nLip also cited a boost from news that China's central bank would cut the amount of cash that banks must hold in reserve, potentially boosting overseas companies that sell products in China as well as China's economy.\nThe Dow Jones Industrial Average rose 646.95 points, or 1.87%, to 35,227.03, the S&P 500 gained 53.24 points, or 1.17%, to 4,591.67 and the Nasdaq Composite added 139.68 points, or 0.93%, to 15,225.15.\nThe S&P 500 Value Index rose 1.5%, outperforming its growth counterpart , which gained 0.9%.\nThe economically sensitive Dow Jones Transportation index outperformed the broader market with a 2.3% gain while the small-cap Russell 2000 climbed 2%.\nWall Street's major indexes have been swinging wildly since Nov. 26 as investors digested news of the COVID-19 Omicron variant and then Federal Reserve Chair Jerome Powell's hawkish comments last week about a speedier tapering of government bond-buying to tackle surging inflation.\nThe S&P's finish on Monday was 2.3% below where it traded before investors started reacting to the Omicron virus.\n\"If today's strength in the blue chips can sort of sustain itself, that might give the rest of the market the ability to start to feel confident,\" said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.\nStill, Goldman Sachs on Saturday cut its outlook for U.S. economic growth to 3.8% for 2022, citing risks and uncertainty around the emergence of Omicron. Investors had also been bracing for a potential hit to corporate earnings, particularly among retailers, restaurants and travel companies.\nThe industrials sector's three biggest percentage gainers were airlines led by United Airlines 8.3% gain while the S&P Airline's index closed up 5.5%.\nOther strong gainers in travel related stocks included Norwegian Cruise Line Holdings , which finished up 9.5%. Vacation rental company Airbnb added 8.5%.\nBig decliners included COVID-19 vaccine makers such as Moderna Inc , down 13.5%, and Pfizer, down 5%, as investors anticipated development of vaccines with protections specific to Omicron could take months.\nNvidia closed down 2%. Investors have been worried about the outcome of regulatory scrutiny of its deal to buy British chip firm ARM Ltd.\nKohl's Corp shares closed up 5.4% after hedge fund Engine Capital LP said it was pushing the department-store chain to consider a sale of the company or separate its e-commerce division to improve its lagging stock price.\nJJ Kinahan, chief market strategist at TD Ameritrade, said investors may be preparing for a Dec. 17 expiration of options and futures.\n\"You have a lot of firms that have a double mandate right now. You are trying to take off risk, expiration related, while the same time rebalancing your portfolio heading into 2022,\" he said.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.82-to-1 ratio; on Nasdaq, a 1.71-to-1 ratio favored advancers.\nThe S&P 500 posted 20 new 52-week highs and one new low; the Nasdaq Composite recorded 28 new highs and 600 new lows.\nOn U.S. exchanges, 11.96 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850038625,"gmtCreate":1634532727292,"gmtModify":1634532727520,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[What] ","listText":"[What] ","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/850038625","repostId":"1185155570","repostType":4,"repost":{"id":"1185155570","kind":"news","pubTimestamp":1634511079,"share":"https://www.laohu8.com/m/news/1185155570?lang=&edition=full","pubTime":"2021-10-18 06:51","market":"us","language":"en","title":"Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1185155570","media":"Barrons","summary":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. ","content":"<p>Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights will include results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.</p>\n<p><img src=\"https://static.tigerbbs.com/685ba1e7f4763c12a3c0159fc2469ded\" tg-width=\"1878\" tg-height=\"2461\" width=\"100%\" height=\"auto\"></p>\n<p>Albertsons and State Street get the ball rolling on Monday.Procter & Gamble,Halliburton,and Johnson & Johnson are Tuesday morning’s highlights, followed by Netflix and United Airlines Holdings after the market closes.</p>\n<p>On Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&T, American Airlines Group,Southwest Airlines,and Chipotle Mexican Grill report on Thursday, then American Express,Schlumberger,and Honeywell International close the week on Friday.</p>\n<p>Economic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and IHS Markit’s Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.</p>\n<p>Other releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.</p>\n<p><b>Monday 10/18</b></p>\n<p><b>The Federal Reserve</b> releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.</p>\n<p>Albertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.</p>\n<p><b>Tuesday 10/19</b></p>\n<p><b>The Census Bureau</b> reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.</p>\n<p>Halliburton, Procter & Gamble, Johnson & Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.</p>\n<p><b>Wednesday 10/20</b></p>\n<p><b>The Federal Reserve</b> releases its beige book about current economic conditions across the central bank’s 12 districts.</p>\n<p>Abbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.</p>\n<p><b>Thursday 10/21</b></p>\n<p><b>The National Association</b> of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.</p>\n<p>Dow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.</p>\n<p><b>The Philadelphia Fed</b> diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.</p>\n<p><b>The Conference Board</b> releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.</p>\n<p><b>Friday 10/22</b></p>\n<p><b>IHS Markit releases</b> the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.</p>\n<p>Whirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-18 06:51 GMT+8 <a href=https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite","UAL":"联合大陆航空",".SPX":"S&P 500 Index","CMG":"墨式烧烤","AXP":"美国运通","HAL":"哈里伯顿","LUV":"西南航空","T":"美国电话电报","INTC":"英特尔","TSLA":"特斯拉","NFLX":"奈飞","JNJ":"强生","IBM":"IBM","AAL":"美国航空"},"source_url":"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185155570","content_text":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights will include results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.\n\nAlbertsons and State Street get the ball rolling on Monday.Procter & Gamble,Halliburton,and Johnson & Johnson are Tuesday morning’s highlights, followed by Netflix and United Airlines Holdings after the market closes.\nOn Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&T, American Airlines Group,Southwest Airlines,and Chipotle Mexican Grill report on Thursday, then American Express,Schlumberger,and Honeywell International close the week on Friday.\nEconomic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and IHS Markit’s Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.\nOther releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.\nMonday 10/18\nThe Federal Reserve releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.\nAlbertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.\nTuesday 10/19\nThe Census Bureau reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.\nHalliburton, Procter & Gamble, Johnson & Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.\nWednesday 10/20\nThe Federal Reserve releases its beige book about current economic conditions across the central bank’s 12 districts.\nAbbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.\nThursday 10/21\nThe National Association of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.\nDow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.\nThe Philadelphia Fed diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.\nThe Conference Board releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.\nFriday 10/22\nIHS Markit releases the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.\nWhirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.","news_type":1},"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840275690,"gmtCreate":1635654237488,"gmtModify":1635654237580,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/840275690","repostId":"2179223073","repostType":4,"repost":{"id":"2179223073","kind":"highlight","pubTimestamp":1635649607,"share":"https://www.laohu8.com/m/news/2179223073?lang=&edition=full","pubTime":"2021-10-31 11:06","market":"hk","language":"en","title":"3 Stocks to Buy Hand Over Fist If a Stock Market Crash Occurs","url":"https://stock-news.laohu8.com/highlight/detail?id=2179223073","media":"Motley Fool","summary":"Trouble may be brewing on Wall Street, but that's actually great news for opportunistic long-term investors.","content":"<p>Whether you realize it or not, Wall Street and investors are enjoying a truly historic run. It took less than 17 months for the benchmark <b>S&P 500</b> (SNPINDEX:^GSPC) to double in value since bottoming out in March 2020. Additionally, the biggest pullback endured by investors over the past 11 months is just 5%. This has been the strongest bounce-back rally from a bear-market bottom of all time.</p>\n<p>Unfortunately, there are also plenty of warning signs that this perfect rally may soon end.<img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F648326%2Fstock-chart-crash-invest-broker-tablet-crypto-plunge-bubble-getty.jpg&w=700&op=resize\" tg-width=\"700\" tg-height=\"464\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Image source: Getty Images.</p>\n<h2>History may not be the market's friend in the near term</h2>\n<p>To preface the commentary below, we're never going to know ahead of time precisely when a stock market crash or steep correction will occur, how long it'll last, or how steep the decline will be. Nevertheless, the data clearly shows that crashes and corrections are a normal part of the investing cycle and the price of admission to <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the greatest wealth creators on the planet.</p>\n<p>For instance, the way the S&P 500 has responded following each of the previous bear-market bottoms, dating back to 1960, is telling. We've witnessed either one or two declines of at least 10% within 36 months following a bear market trough. We've yet to navigate our way through a double-digit percentage decline after the March 2020 bottom (19 months and counting).</p>\n<p>Another telltale warning for investors is the valuation of the S&P 500. As of the close of business on Monday, Oct. 25, the S&P 500's Shiller price-to-earnings (P/E) ratio stood at 38.9, which is well over double its 151-year average (16.9). The bigger concern is that in each of the previous four instances where the S&P 500's Shiller P/E ratio surpassed 30, the index subsequently lost 20% (or more) of its value.</p>\n<p>Even margin debt serves as a focal point of concern. Margin debt describes the amount of money borrowed with interest to purchase or short-sell securities. While it's not abnormal for margin debt to increase over time, it isn't normal for margin debt to increase 60% or more in a single year, as it's done in 2021. The previous two times we've watched margin debt climb at least 60% in a year since 1995 were just before the dot-com bubble burst and months before the financial crisis (2007-2009).</p>\n<p>Long story short, a crash or correction may well be on the horizon.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F648326%2Fbuy-low-sell-high-stock-market-chart-investing-retirement-getty.jpg&w=700&op=resize\" tg-width=\"700\" tg-height=\"486\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>This stock trio offers surefire opportunity during a crash</h2>\n<p>However, there are two sides to every story. While stock market crashes and corrections might lead to some temporary red ink in investors' portfolios, these natural downturns also serve as the perfect opportunity to buy great stocks at bargain prices. If a stock market crash were to occur, investors shouldn't hesitate to buy the following three stocks hand over fist.</p>\n<h2>CrowdStrike Holdings</h2>\n<p>Cybersecurity is easily one of the greatest growth trends over the next decade. Regardless of how well or poorly the stock market or U.S. economy are performing, hackers and robots don't take a day off from trying to steal consumer and enterprise data. That's why any significant dips in <b>CrowdStrike Holdings</b> (NASDAQ:CRWD) are a hand-over-fist buying opportunity.</p>\n<p>What makes CrowdStrike so special is its Falcon security platform. Falcon is a cloud-native solution that relies on artificial intelligence to grow smarter and more efficient at recognizing threats over time. According to the company, Falcon oversees approximately 1 trillion events <i>per day</i>. In many instances, cloud-native solutions are faster and more cost-effective at identifying and responding to threats relative to on-premises security solutions.</p>\n<p>CrowdStrike's operating results show what a monster it's become in the cybersecurity space. The company's subscriber count has grown from 450 to north of 13,000 in less than five years. Likewise, the percentage of subscribers with four or more cloud-module subscriptions has catapulted from under 10% to 66% in the same less-than-five-year time frame. These are high-margin subscriptions, and the company's clients seem more than willing to add on services as they grow.</p>\n<p>Despite still being in its early growth phase, CrowdStrike's subscription gross margin has already hit the company's long-term target of around 80%. This makes CrowdStrike a no-brainer buy for investors on any weakness.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F648326%2Fbank-manager-clients-deal-investment-management-branch-getty.jpg&w=700&op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>Bank of America</h2>\n<p>Bank stocks might not be the first thing that comes to mind during a stock market crash, but in this unique instance, <b>Bank of America</b> (NYSE:BAC) is a company investors can confidently buy hand over fist.</p>\n<p>Generally speaking, bank stocks like BofA benefit from the natural growth of the U.S. economy over time. Even though recessions are an inevitable part of the economic cycle, they often last for a few months to a couple of quarters. Meanwhile, periods of economic growth last for years. These long-winded periods of expansion allow Bank of America to take advantage of the bread-and-butter of banking: Loan and deposit growth.</p>\n<p>The interesting thing about Bank of America is its interest rate sensitivity. No money-center bank will see a bigger windfall from higher interest rates than BofA. According to a third-quarter earnings presentation, a 100-basis-point parallel shift in the interest rate yield curve would add an estimated $7.2 billion in net interest income over 12 months. With yields near historic lows, they pretty much have nowhere to go but up.</p>\n<p>Bank of America has also done an excellent job of promoting digital banking. The number of digital active users has grown by almost 5 million in three years, with 43% of all sales in the third quarter completed online or via mobile app. That's up 16 percentage points from Q3 2018. This online shift has allowed the company to reduce its expenses by consolidating some of its physical branches.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F648326%2Fsquare-card-terminal.png&w=700&op=resize\" tg-width=\"700\" tg-height=\"520\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Square.</p>\n<h2>Square</h2>\n<p>A third and final stock investors can purchase hand over fist if the market crashes or steeply corrects is fintech company <b>Square</b> (NYSE:SQ).</p>\n<p>For more than a decade, Square's seller ecosystem has been its foundational operating segment. The seller ecosystem provides point-of-sale devices, loans, analytics, and other tools to help merchants succeed. After seeing $6.5 billion in gross payment volume (GPV) traverse its platform in 2012, Square's GPV might top $150 billion in 2021.</p>\n<p>An interesting trend within this segment is the shift toward bigger businesses using Square's payment solutions. Whereas Square's merchant solutions have previously catered to small businesses and entrepreneurs, 65% of all seller ecosystem GPV originated with businesses generating $125,000 or more in annual GPV during the second quarter. Bigger businesses should lead to more revenue and gross profit for Square.</p>\n<p>Of course, the more substantive long-term growth driver is peer-to-peer digital payments platform Cash App. In just three years (ended Dec. 31, 2020), Cash App's monthly active user (MAU) count more than quintupled to 36 million. Additionally, gross profit per user has more than doubled to $55 per MAU, as of June 2021. This compares to only $5 in costs to attract each new MAU.</p>\n<p>With Square recently announcing the acquisition of buy now, pay later giant <b>Afterpay</b> for $29 billion, it'll soon have a closed-loop payment system that'll connect Cash App to the seller ecosystem. In other words, growth for Square is still in its early stages.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Buy Hand Over Fist If a Stock Market Crash Occurs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Buy Hand Over Fist If a Stock Market Crash Occurs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-31 11:06 GMT+8 <a href=https://www.fool.com/investing/2021/10/30/3-stocks-buy-hand-over-fist-if-stock-market-crash/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Whether you realize it or not, Wall Street and investors are enjoying a truly historic run. It took less than 17 months for the benchmark S&P 500 (SNPINDEX:^GSPC) to double in value since bottoming ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/30/3-stocks-buy-hand-over-fist-if-stock-market-crash/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF","UPRO":"三倍做多标普500ETF","OEX":"标普100",".SPX":"S&P 500 Index","BAC":"美国银行","OEF":"标普100指数ETF-iShares","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","SQ":"Block","SDS":"两倍做空标普500ETF"},"source_url":"https://www.fool.com/investing/2021/10/30/3-stocks-buy-hand-over-fist-if-stock-market-crash/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179223073","content_text":"Whether you realize it or not, Wall Street and investors are enjoying a truly historic run. It took less than 17 months for the benchmark S&P 500 (SNPINDEX:^GSPC) to double in value since bottoming out in March 2020. Additionally, the biggest pullback endured by investors over the past 11 months is just 5%. This has been the strongest bounce-back rally from a bear-market bottom of all time.\nUnfortunately, there are also plenty of warning signs that this perfect rally may soon end.Image source: Getty Images.\nHistory may not be the market's friend in the near term\nTo preface the commentary below, we're never going to know ahead of time precisely when a stock market crash or steep correction will occur, how long it'll last, or how steep the decline will be. Nevertheless, the data clearly shows that crashes and corrections are a normal part of the investing cycle and the price of admission to one of the greatest wealth creators on the planet.\nFor instance, the way the S&P 500 has responded following each of the previous bear-market bottoms, dating back to 1960, is telling. We've witnessed either one or two declines of at least 10% within 36 months following a bear market trough. We've yet to navigate our way through a double-digit percentage decline after the March 2020 bottom (19 months and counting).\nAnother telltale warning for investors is the valuation of the S&P 500. As of the close of business on Monday, Oct. 25, the S&P 500's Shiller price-to-earnings (P/E) ratio stood at 38.9, which is well over double its 151-year average (16.9). The bigger concern is that in each of the previous four instances where the S&P 500's Shiller P/E ratio surpassed 30, the index subsequently lost 20% (or more) of its value.\nEven margin debt serves as a focal point of concern. Margin debt describes the amount of money borrowed with interest to purchase or short-sell securities. While it's not abnormal for margin debt to increase over time, it isn't normal for margin debt to increase 60% or more in a single year, as it's done in 2021. The previous two times we've watched margin debt climb at least 60% in a year since 1995 were just before the dot-com bubble burst and months before the financial crisis (2007-2009).\nLong story short, a crash or correction may well be on the horizon.\n\nImage source: Getty Images.\nThis stock trio offers surefire opportunity during a crash\nHowever, there are two sides to every story. While stock market crashes and corrections might lead to some temporary red ink in investors' portfolios, these natural downturns also serve as the perfect opportunity to buy great stocks at bargain prices. If a stock market crash were to occur, investors shouldn't hesitate to buy the following three stocks hand over fist.\nCrowdStrike Holdings\nCybersecurity is easily one of the greatest growth trends over the next decade. Regardless of how well or poorly the stock market or U.S. economy are performing, hackers and robots don't take a day off from trying to steal consumer and enterprise data. That's why any significant dips in CrowdStrike Holdings (NASDAQ:CRWD) are a hand-over-fist buying opportunity.\nWhat makes CrowdStrike so special is its Falcon security platform. Falcon is a cloud-native solution that relies on artificial intelligence to grow smarter and more efficient at recognizing threats over time. According to the company, Falcon oversees approximately 1 trillion events per day. In many instances, cloud-native solutions are faster and more cost-effective at identifying and responding to threats relative to on-premises security solutions.\nCrowdStrike's operating results show what a monster it's become in the cybersecurity space. The company's subscriber count has grown from 450 to north of 13,000 in less than five years. Likewise, the percentage of subscribers with four or more cloud-module subscriptions has catapulted from under 10% to 66% in the same less-than-five-year time frame. These are high-margin subscriptions, and the company's clients seem more than willing to add on services as they grow.\nDespite still being in its early growth phase, CrowdStrike's subscription gross margin has already hit the company's long-term target of around 80%. This makes CrowdStrike a no-brainer buy for investors on any weakness.\n\nImage source: Getty Images.\nBank of America\nBank stocks might not be the first thing that comes to mind during a stock market crash, but in this unique instance, Bank of America (NYSE:BAC) is a company investors can confidently buy hand over fist.\nGenerally speaking, bank stocks like BofA benefit from the natural growth of the U.S. economy over time. Even though recessions are an inevitable part of the economic cycle, they often last for a few months to a couple of quarters. Meanwhile, periods of economic growth last for years. These long-winded periods of expansion allow Bank of America to take advantage of the bread-and-butter of banking: Loan and deposit growth.\nThe interesting thing about Bank of America is its interest rate sensitivity. No money-center bank will see a bigger windfall from higher interest rates than BofA. According to a third-quarter earnings presentation, a 100-basis-point parallel shift in the interest rate yield curve would add an estimated $7.2 billion in net interest income over 12 months. With yields near historic lows, they pretty much have nowhere to go but up.\nBank of America has also done an excellent job of promoting digital banking. The number of digital active users has grown by almost 5 million in three years, with 43% of all sales in the third quarter completed online or via mobile app. That's up 16 percentage points from Q3 2018. This online shift has allowed the company to reduce its expenses by consolidating some of its physical branches.\n\nImage source: Square.\nSquare\nA third and final stock investors can purchase hand over fist if the market crashes or steeply corrects is fintech company Square (NYSE:SQ).\nFor more than a decade, Square's seller ecosystem has been its foundational operating segment. The seller ecosystem provides point-of-sale devices, loans, analytics, and other tools to help merchants succeed. After seeing $6.5 billion in gross payment volume (GPV) traverse its platform in 2012, Square's GPV might top $150 billion in 2021.\nAn interesting trend within this segment is the shift toward bigger businesses using Square's payment solutions. Whereas Square's merchant solutions have previously catered to small businesses and entrepreneurs, 65% of all seller ecosystem GPV originated with businesses generating $125,000 or more in annual GPV during the second quarter. Bigger businesses should lead to more revenue and gross profit for Square.\nOf course, the more substantive long-term growth driver is peer-to-peer digital payments platform Cash App. In just three years (ended Dec. 31, 2020), Cash App's monthly active user (MAU) count more than quintupled to 36 million. Additionally, gross profit per user has more than doubled to $55 per MAU, as of June 2021. This compares to only $5 in costs to attract each new MAU.\nWith Square recently announcing the acquisition of buy now, pay later giant Afterpay for $29 billion, it'll soon have a closed-loop payment system that'll connect Cash App to the seller ecosystem. In other words, growth for Square is still in its early stages.","news_type":1},"isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":892676122,"gmtCreate":1628659728966,"gmtModify":1633745294454,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/892676122","repostId":"1189571086","repostType":4,"isVote":1,"tweetType":1,"viewCount":19,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":876400637,"gmtCreate":1637335254776,"gmtModify":1637335255035,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876400637","repostId":"1112678123","repostType":4,"repost":{"id":"1112678123","kind":"news","pubTimestamp":1637334723,"share":"https://www.laohu8.com/m/news/1112678123?lang=&edition=full","pubTime":"2021-11-19 23:12","market":"us","language":"en","title":"Inflation has ‘further to go:’ Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=1112678123","media":"Yahoo","summary":"Inflation remains a cause for concern as data continues to butt heads with the White House and the F","content":"<p>Inflation remains a cause for concern as data continues to butt heads with the White House and the Fed’s claim that the price hikes will be “transitory.” According to a Nov. 13 report released by Goldman Sachs Economic Research (GS) however, though inflation has already reached a 30-year high, it may still have more to run.</p>\n<p>“The US economy largely followed the rapid road to recovery that we expected this year and is on track to round out the recovery next year as most of the remaining effects of the pandemic fade,” the report reads. “But this year also brought a major surprise: a surge in inflation that has already reached a 30-year high and still has further to go.”</p>\n<p>The report suggests that this overshoot in inflation is largely attributable to the rise in durable goods prices caused by the persistentsupply chain crunch. Goldman Sachs Economic Research also expects inflationary pressures from wage and rent growth, but this will only keep inflation “moderately above 2%,” in line with the Fed’s updated framework target.</p>\n<p>“The current inflation surge will get worse this winter before it gets better, but as supply-constrained categories shift from a transitory inflationary boost to a transitory deflationary drag, we expect core PCE inflation to fall from 4.4% at end-2021 to 2.3% at end-2022,” the report reads.</p>\n<p>Goldman also expects the economy to reaccelerate to above a 4% growth rate throughout the next several quarters, citing the reopening of the service sector, consumer spending of pent-up savings, and inventory restocking.</p>\n<p>“These forces will contend with a large and steady headwind from diminishing fiscal support that we expect will ultimately leave GDP growth near potential by late 2022,” the report reads.</p>\n<p><b>Tapering timeline</b></p>\n<p>One of the major implications of these inflation expectations is anupdated timelinefor the Fed’s first rate hikes. The report states that Goldman Sachs would be pulling forward its forecast of the timing of the Fed’s first rate hike to July 2022, shortly after tapering ends.</p>\n<p>The FOMC is currently scheduled tocompletethe tapering process by mid-June of 2022. Policymakers will meet next in mid-December where they will submit updated economic forecasts and expected policy paths. In September, around half of policymakers believed that a rate hike would not be necessary until 2023.</p>\n<p>“Inflation will have run far above target for a while by then, and we think a seamless move from tapering to rate hikes will be the path of least resistance, with a first hike in July and a second in November,” the report reads. “Because we expect growth and inflation to settle down by year-end without a need for aggressive monetary policy tightening, we have penciled in a slower pace of two hikes per year thereafter.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inflation has ‘further to go:’ Goldman Sachs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInflation has ‘further to go:’ Goldman Sachs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-19 23:12 GMT+8 <a href=https://finance.yahoo.com/news/inflation-at-30-year-high-has-further-to-go-goldman-sachs-150441968.html><strong>Yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Inflation remains a cause for concern as data continues to butt heads with the White House and the Fed’s claim that the price hikes will be “transitory.” According to a Nov. 13 report released by ...</p>\n\n<a href=\"https://finance.yahoo.com/news/inflation-at-30-year-high-has-further-to-go-goldman-sachs-150441968.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://finance.yahoo.com/news/inflation-at-30-year-high-has-further-to-go-goldman-sachs-150441968.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112678123","content_text":"Inflation remains a cause for concern as data continues to butt heads with the White House and the Fed’s claim that the price hikes will be “transitory.” According to a Nov. 13 report released by Goldman Sachs Economic Research (GS) however, though inflation has already reached a 30-year high, it may still have more to run.\n“The US economy largely followed the rapid road to recovery that we expected this year and is on track to round out the recovery next year as most of the remaining effects of the pandemic fade,” the report reads. “But this year also brought a major surprise: a surge in inflation that has already reached a 30-year high and still has further to go.”\nThe report suggests that this overshoot in inflation is largely attributable to the rise in durable goods prices caused by the persistentsupply chain crunch. Goldman Sachs Economic Research also expects inflationary pressures from wage and rent growth, but this will only keep inflation “moderately above 2%,” in line with the Fed’s updated framework target.\n“The current inflation surge will get worse this winter before it gets better, but as supply-constrained categories shift from a transitory inflationary boost to a transitory deflationary drag, we expect core PCE inflation to fall from 4.4% at end-2021 to 2.3% at end-2022,” the report reads.\nGoldman also expects the economy to reaccelerate to above a 4% growth rate throughout the next several quarters, citing the reopening of the service sector, consumer spending of pent-up savings, and inventory restocking.\n“These forces will contend with a large and steady headwind from diminishing fiscal support that we expect will ultimately leave GDP growth near potential by late 2022,” the report reads.\nTapering timeline\nOne of the major implications of these inflation expectations is anupdated timelinefor the Fed’s first rate hikes. The report states that Goldman Sachs would be pulling forward its forecast of the timing of the Fed’s first rate hike to July 2022, shortly after tapering ends.\nThe FOMC is currently scheduled tocompletethe tapering process by mid-June of 2022. Policymakers will meet next in mid-December where they will submit updated economic forecasts and expected policy paths. In September, around half of policymakers believed that a rate hike would not be necessary until 2023.\n“Inflation will have run far above target for a while by then, and we think a seamless move from tapering to rate hikes will be the path of least resistance, with a first hike in July and a second in November,” the report reads. “Because we expect growth and inflation to settle down by year-end without a need for aggressive monetary policy tightening, we have penciled in a slower pace of two hikes per year thereafter.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820367620,"gmtCreate":1633354615899,"gmtModify":1633354649359,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Miser] ","listText":"[Miser] ","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/820367620","repostId":"1180932503","repostType":4,"repost":{"id":"1180932503","kind":"news","pubTimestamp":1633353148,"share":"https://www.laohu8.com/m/news/1180932503?lang=&edition=full","pubTime":"2021-10-04 21:12","market":"us","language":"en","title":"Tesla's big quarter does not alter valuation reality - JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=1180932503","media":"seekingalpha","summary":"JPMorgan gives Teslacredit for its stronger-than-expectedQ3 deliveries tallyand raises near-term estimates, but is not getting pushed off its Underweight rating and defends its new price target of $215 .Analyst Ryan Brinkman: \"While our new higher price target continues to imply material potential downside, we do not believe it is ungenerous, including as it values Tesla as the world’s second largest automaker by market capitalization , which is just one notch down vs. its current #1 position d","content":"<ul>\n <li>JPMorgan gives Tesla(NASDAQ:TSLA)credit for its stronger-than-expectedQ3 deliveries tallyand raises near-term estimates, but is not getting pushed off its Underweight rating and defends its new price target of $215 (from $180).</li>\n <li>Analyst Ryan Brinkman: \"While our new higher price target continues to imply material potential downside, we do not believe it is ungenerous, including as it values Tesla as the world’s second largest automaker by market capitalization (behind Toyota and ahead of Volkswagen), which is just one notch down vs. its current (admittedly by far) #1 position despite it ranking as only the 18th largest automaker by unit volume. Tesla fundamentals, including unit volume outlook, continue to improve, although its present valuation in our view continues to demand even more, as made clear when comparing its current market capitalization.\"</li>\n <li>It has been well documented that Tesla's market cap is greater than the combined caps of Toyota, GM, Ford and Honda.</li>\n <li>Brinkman and team also note that technology and execution risk seem substantially less for Tesla than was once feared, but still see expansion into higher volume segments with lower price points fraught with greater risk relative to demand, execution, and competition.</li>\n <li>Shares of Tesla areup 2.53%premarket to $794.80.</li>\n <li>Wedbush Securities was out earlier this morning defending itsOutperform ratingon TSLA and price target of $1,000.</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla's big quarter does not alter valuation reality - JPMorgan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla's big quarter does not alter valuation reality - JPMorgan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-04 21:12 GMT+8 <a href=https://seekingalpha.com/news/3748009-teslas-big-quarter-does-not-alter-valuation-reality-jpmorgan><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JPMorgan gives Tesla(NASDAQ:TSLA)credit for its stronger-than-expectedQ3 deliveries tallyand raises near-term estimates, but is not getting pushed off its Underweight rating and defends its new price ...</p>\n\n<a href=\"https://seekingalpha.com/news/3748009-teslas-big-quarter-does-not-alter-valuation-reality-jpmorgan\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/news/3748009-teslas-big-quarter-does-not-alter-valuation-reality-jpmorgan","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1180932503","content_text":"JPMorgan gives Tesla(NASDAQ:TSLA)credit for its stronger-than-expectedQ3 deliveries tallyand raises near-term estimates, but is not getting pushed off its Underweight rating and defends its new price target of $215 (from $180).\nAnalyst Ryan Brinkman: \"While our new higher price target continues to imply material potential downside, we do not believe it is ungenerous, including as it values Tesla as the world’s second largest automaker by market capitalization (behind Toyota and ahead of Volkswagen), which is just one notch down vs. its current (admittedly by far) #1 position despite it ranking as only the 18th largest automaker by unit volume. Tesla fundamentals, including unit volume outlook, continue to improve, although its present valuation in our view continues to demand even more, as made clear when comparing its current market capitalization.\"\nIt has been well documented that Tesla's market cap is greater than the combined caps of Toyota, GM, Ford and Honda.\nBrinkman and team also note that technology and execution risk seem substantially less for Tesla than was once feared, but still see expansion into higher volume segments with lower price points fraught with greater risk relative to demand, execution, and competition.\nShares of Tesla areup 2.53%premarket to $794.80.\nWedbush Securities was out earlier this morning defending itsOutperform ratingon TSLA and price target of $1,000.","news_type":1},"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868508707,"gmtCreate":1632666283109,"gmtModify":1632798697468,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868508707","repostId":"1142057327","repostType":4,"repost":{"id":"1142057327","kind":"news","pubTimestamp":1632643246,"share":"https://www.laohu8.com/m/news/1142057327?lang=&edition=full","pubTime":"2021-09-26 16:00","market":"us","language":"en","title":"Intel Starts Construction of Two Arizona Computer Chip Factories","url":"https://stock-news.laohu8.com/highlight/detail?id=1142057327","media":"The street","summary":"Intel broke ground on two new computer chip factories in Arizona as part of a $20 billion project to","content":"<p>Intel broke ground on two new computer chip factories in Arizona as part of a $20 billion project to help meet the high demand for semiconductors in the U.S.</p>\n<p>Intel (<b>INTC</b>) -Get Intel Corporation (INTC) Report on Friday broke ground on two new computer chip factories in Arizona as part of a $20 billion project to help alleviate the severe shortage of semiconductors in the U.S.</p>\n<p>The Santa Clara, Calif.-basedsemiconductor chip manufacturer'sCEO Pat Gelsinger led the project's groundbreaking ceremony at the company's Ocotillo campus in Chandler, Ariz., marking the largest private investment in the state's history.</p>\n<p>Intel expects the factories to be fully operational in 2024 to manufacture the company's most advanced process technologies.</p>\n<p>“Today’s celebration marks an important milestone as we work to boost capacity and meet the incredible demand for semiconductors: the foundational technology for the digitization of everything,\" Gelsinger said in acompany statement. \"We are ushering in a new era of innovation – for Intel, for Arizona and for the world. This $20 billion expansion will bring our total investment in Arizona to more than $50 billion since opening the site over 40 years ago.</p>\n<p>\"As the only U.S.-based leading-edge chipmaker, we are committed to building on this long-term investment and helping the United States regain semiconductor leadership,” Gelsinger said.</p>\n<p>Shares of Intel on Friday traded 0.18% higher to $54.32 after hours.</p>\n<p>Gelsinger on Thursday participated in a virtual meeting with tech company executives and Commerce Secretary Gina Raimondo to address the global semiconductor chip shortage, which has interfered with production in the high-tech, electronics and automotive industries.</p>\n<p>The two new factories, to be named Fab 52 and Fab 62, will house a total of six semiconductor fabs. The project will create over 3,000 high-tech, high-wage Intel jobs, 3,000 construction jobs and support an estimated 15,000 additional indirect jobs in the local community.</p>\n<p>Intel rival Taiwan Semiconductor Manufacturing Co.plans to buildits second U.S. chip factory also in Arizona and targets production to begin in 2024.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel Starts Construction of Two Arizona Computer Chip Factories</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel Starts Construction of Two Arizona Computer Chip Factories\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-26 16:00 GMT+8 <a href=https://www.thestreet.com/investing/intel-starts-construction-of-two-arizona-computer-chip-factories><strong>The street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Intel broke ground on two new computer chip factories in Arizona as part of a $20 billion project to help meet the high demand for semiconductors in the U.S.\nIntel (INTC) -Get Intel Corporation (INTC)...</p>\n\n<a href=\"https://www.thestreet.com/investing/intel-starts-construction-of-two-arizona-computer-chip-factories\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INTC":"英特尔"},"source_url":"https://www.thestreet.com/investing/intel-starts-construction-of-two-arizona-computer-chip-factories","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142057327","content_text":"Intel broke ground on two new computer chip factories in Arizona as part of a $20 billion project to help meet the high demand for semiconductors in the U.S.\nIntel (INTC) -Get Intel Corporation (INTC) Report on Friday broke ground on two new computer chip factories in Arizona as part of a $20 billion project to help alleviate the severe shortage of semiconductors in the U.S.\nThe Santa Clara, Calif.-basedsemiconductor chip manufacturer'sCEO Pat Gelsinger led the project's groundbreaking ceremony at the company's Ocotillo campus in Chandler, Ariz., marking the largest private investment in the state's history.\nIntel expects the factories to be fully operational in 2024 to manufacture the company's most advanced process technologies.\n“Today’s celebration marks an important milestone as we work to boost capacity and meet the incredible demand for semiconductors: the foundational technology for the digitization of everything,\" Gelsinger said in acompany statement. \"We are ushering in a new era of innovation – for Intel, for Arizona and for the world. This $20 billion expansion will bring our total investment in Arizona to more than $50 billion since opening the site over 40 years ago.\n\"As the only U.S.-based leading-edge chipmaker, we are committed to building on this long-term investment and helping the United States regain semiconductor leadership,” Gelsinger said.\nShares of Intel on Friday traded 0.18% higher to $54.32 after hours.\nGelsinger on Thursday participated in a virtual meeting with tech company executives and Commerce Secretary Gina Raimondo to address the global semiconductor chip shortage, which has interfered with production in the high-tech, electronics and automotive industries.\nThe two new factories, to be named Fab 52 and Fab 62, will house a total of six semiconductor fabs. The project will create over 3,000 high-tech, high-wage Intel jobs, 3,000 construction jobs and support an estimated 15,000 additional indirect jobs in the local community.\nIntel rival Taiwan Semiconductor Manufacturing Co.plans to buildits second U.S. chip factory also in Arizona and targets production to begin in 2024.","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863583466,"gmtCreate":1632405875855,"gmtModify":1632731819561,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[What] ","listText":"[What] ","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/863583466","repostId":"1136461867","repostType":4,"repost":{"id":"1136461867","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632405237,"share":"https://www.laohu8.com/m/news/1136461867?lang=&edition=full","pubTime":"2021-09-23 21:53","market":"other","language":"en","title":"Novavax surged over 10% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1136461867","media":"Tiger Newspress","summary":"(Sept 23) Novavax surged over 10% in early trading. Novavax Announce Submission to World Health Orga","content":"<p>(Sept 23) <b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a> </b>surged over 10% in early trading. Novavax Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/38fe74a02950ee20c0a498be55a8e0a4\" tg-width=\"958\" tg-height=\"563\" referrerpolicy=\"no-referrer\"></p>\n<p>Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Ltd. (SII), today announced a regulatory submission to the World Health Organization (WHO) for emergency use listing (EUL) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant. The submission to WHO is based on the companies' previous regulatory submission to the Drugs Controller General ofIndia(DCGI).</p>\n<p>\"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world,\" saidStanley C. Erck, President and Chief Executive Officer, Novavax. \"It represents another major milestone in Novavax' transformation into a commercial global vaccine company and reinforces the value of global collaboration and need for multiple approaches to help control the pandemic.\"</p>\n<p>The grant of EUL by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility, which was established to allocate and distribute vaccines equitably to participating countries and economies. In addition to the submission for WHO EUL, SII and Novavax last month completed the submission of modules required by regulatory agencies inIndia,Indonesiaandthe Philippinesfor the initiation of review of the vaccine, including preclinical, clinical, and chemistry, manufacturing and controls (CMC) data.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax surged over 10% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax surged over 10% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-23 21:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 23) <b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a> </b>surged over 10% in early trading. Novavax Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/38fe74a02950ee20c0a498be55a8e0a4\" tg-width=\"958\" tg-height=\"563\" referrerpolicy=\"no-referrer\"></p>\n<p>Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Ltd. (SII), today announced a regulatory submission to the World Health Organization (WHO) for emergency use listing (EUL) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant. The submission to WHO is based on the companies' previous regulatory submission to the Drugs Controller General ofIndia(DCGI).</p>\n<p>\"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world,\" saidStanley C. Erck, President and Chief Executive Officer, Novavax. \"It represents another major milestone in Novavax' transformation into a commercial global vaccine company and reinforces the value of global collaboration and need for multiple approaches to help control the pandemic.\"</p>\n<p>The grant of EUL by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility, which was established to allocate and distribute vaccines equitably to participating countries and economies. In addition to the submission for WHO EUL, SII and Novavax last month completed the submission of modules required by regulatory agencies inIndia,Indonesiaandthe Philippinesfor the initiation of review of the vaccine, including preclinical, clinical, and chemistry, manufacturing and controls (CMC) data.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136461867","content_text":"(Sept 23) Novavax surged over 10% in early trading. Novavax Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine.\n\nNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Ltd. (SII), today announced a regulatory submission to the World Health Organization (WHO) for emergency use listing (EUL) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant. The submission to WHO is based on the companies' previous regulatory submission to the Drugs Controller General ofIndia(DCGI).\n\"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world,\" saidStanley C. Erck, President and Chief Executive Officer, Novavax. \"It represents another major milestone in Novavax' transformation into a commercial global vaccine company and reinforces the value of global collaboration and need for multiple approaches to help control the pandemic.\"\nThe grant of EUL by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility, which was established to allocate and distribute vaccines equitably to participating countries and economies. In addition to the submission for WHO EUL, SII and Novavax last month completed the submission of modules required by regulatory agencies inIndia,Indonesiaandthe Philippinesfor the initiation of review of the vaccine, including preclinical, clinical, and chemistry, manufacturing and controls (CMC) data.","news_type":1},"isVote":1,"tweetType":1,"viewCount":186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812158279,"gmtCreate":1630567095691,"gmtModify":1632472460654,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Cool] ","listText":"[Cool] ","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/812158279","repostId":"2164481914","repostType":4,"repost":{"id":"2164481914","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630529217,"share":"https://www.laohu8.com/m/news/2164481914?lang=&edition=full","pubTime":"2021-09-02 04:46","market":"us","language":"en","title":"Tech stocks send Nasdaq to fresh record close, boost S&P","url":"https://stock-news.laohu8.com/highlight/detail?id=2164481914","media":"Reuters","summary":"Gains for tech stocks, utilities and real estate.\nAugust private jobs growth misses expectations.\nIn","content":"<ul>\n <li>Gains for tech stocks, utilities and real estate.</li>\n <li>August private jobs growth misses expectations.</li>\n <li>Indexes: Dow falls 0.14%, S&P up 0.03%, Nasdaq rises 0.33%.</li>\n</ul>\n<p>Sept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.</p>\n<p>Technology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.</p>\n<p>Utilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.</p>\n<p>\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.</p>\n<p>Wall Street's main indexes have hit record highs recently, with the benchmark S&P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.</p>\n<p>Each new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.</p>\n<p>A report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.</p>\n<p>Another set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.</p>\n<p>\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.</p>\n<p>The Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.</p>\n<p>Falling 1.5% on the day, and down for the third straight session, was the energy index.</p>\n<p>Crude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.</p>\n<p><a href=\"https://laohu8.com/S/PBF\">PBF Energy</a> Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.</p>\n<p>Volume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.</p>\n<p>The S&P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech stocks send Nasdaq to fresh record close, boost S&P</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech stocks send Nasdaq to fresh record close, boost S&P\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-02 04:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Gains for tech stocks, utilities and real estate.</li>\n <li>August private jobs growth misses expectations.</li>\n <li>Indexes: Dow falls 0.14%, S&P up 0.03%, Nasdaq rises 0.33%.</li>\n</ul>\n<p>Sept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.</p>\n<p>Technology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.</p>\n<p>Utilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.</p>\n<p>\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.</p>\n<p>Wall Street's main indexes have hit record highs recently, with the benchmark S&P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.</p>\n<p>Each new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.</p>\n<p>A report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.</p>\n<p>Another set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.</p>\n<p>\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.</p>\n<p>The Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.</p>\n<p>Falling 1.5% on the day, and down for the third straight session, was the energy index.</p>\n<p>Crude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.</p>\n<p><a href=\"https://laohu8.com/S/PBF\">PBF Energy</a> Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.</p>\n<p>Volume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.</p>\n<p>The S&P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164481914","content_text":"Gains for tech stocks, utilities and real estate.\nAugust private jobs growth misses expectations.\nIndexes: Dow falls 0.14%, S&P up 0.03%, Nasdaq rises 0.33%.\n\nSept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.\nTechnology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and Facebook Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.\nUtilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.\n\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.\nWall Street's main indexes have hit record highs recently, with the benchmark S&P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.\nEach new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.\nA report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.\nAnother set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.\n\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.\nThe Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.\nFalling 1.5% on the day, and down for the third straight session, was the energy index.\nCrude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.\nPBF Energy Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.\nVolume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.\nThe S&P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.\n(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)","news_type":1},"isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830146449,"gmtCreate":1629036762381,"gmtModify":1633687845654,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/830146449","repostId":"1127633167","repostType":4,"repost":{"id":"1127633167","kind":"news","pubTimestamp":1628997765,"share":"https://www.laohu8.com/m/news/1127633167?lang=&edition=full","pubTime":"2021-08-15 11:22","market":"us","language":"en","title":"These 10 Standout Stocks Could Be the Next Amazon","url":"https://stock-news.laohu8.com/highlight/detail?id=1127633167","media":"Barrons","summary":"One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors loo","content":"<p>One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of generating double-digit compound growth in revenue and earnings—preferably both—for years to come.</p>\n<p>The idea is that stock prices should compound in line with revenue and profits, enabling investors to generate high returns over a holding period of five to 10 years. The ultimate goal is to find the elusive “10 bagger”—a stock that returns 10 times what you paid for it.</p>\n<p>Wall Street analyst notes and client letters from investment pros are replete with compounder references. Many of the next generation of value managers, identified in a <i>Barron’s</i> cover story in May, are seeking such shares, rather than the traditional value fare of cheap stocks.</p>\n<p>Their search has become more challenging, because buyers are paying lofty prices for high-growth stories. Really big winners are scarce. Only about 35 companies in each of a long series of 10-year periods have compounded their stock prices at 20% or more annually, resulting in at least a sixfold increase, according to Durable Capital Partners.</p>\n<p>Many investors are happy to stick with large, well-known compounders, such as Alphabet(ticker: GOOGL),Mastercard(MA),UnitedHealth Group(UNH), and Eli Lilly(LLY).</p>\n<p><i>Barron’s</i> sought to identify smaller candidates. We talked to investment managers and came up with an eclectic list of 10 stocks, most with market values under $10 billion. Here are the selections, in alphabetical order:</p>\n<p>Strong and Steady Wins the RaceHere are 10 stocks that growth investors have identified as being able to generate consistently high growth in revenues or profits for many years.</p>\n<table>\n <thead>\n <tr>\n <th>Company / Ticker</th>\n <th>Recent Price</th>\n <th>YTD Change</th>\n <th>2021E P/E</th>\n <th>2021E Price/Sales</th>\n <th>2022E P/E</th>\n <th>2022E Price/Sales</th>\n <th>LT Growth Rate*</th>\n <th>Market Value (bil)</th>\n <th>Comment</th>\n </tr>\n </thead>\n <tbody>\n <tr>\n <td>Amedysis / AMED</td>\n <td>$185.15</td>\n <td>-37%</td>\n <td>30.2</td>\n <td>2.7</td>\n <td>27.7</td>\n <td>2.4</td>\n <td>10.5%</td>\n <td>$6.3</td>\n <td>Leader in home health care</td>\n </tr>\n <tr>\n <td>Amyris / AMRS</td>\n <td>13.64</td>\n <td>121</td>\n <td>NM</td>\n <td>10.4</td>\n <td>NM</td>\n <td>9.7</td>\n <td>NA</td>\n <td>4.1</td>\n <td>Leading company in synthetic biology</td>\n </tr>\n <tr>\n <td>Booz Allen Hamilton Holding / BAH</td>\n <td>81.73</td>\n <td>-6</td>\n <td>19.4</td>\n <td>1.3</td>\n <td>17.7</td>\n <td>1.2</td>\n <td>8.6</td>\n <td>11.0</td>\n <td>Defense-department consultant</td>\n </tr>\n <tr>\n <td>J.B. Hunt Transport Services / JBHT</td>\n <td>172.76</td>\n <td>26</td>\n <td>25.8</td>\n <td>1.5</td>\n <td>22.2</td>\n <td>1.4</td>\n <td>18.4</td>\n <td>18.2</td>\n <td>Strong in intermodal freight</td>\n </tr>\n <tr>\n <td>Marriott Vacations Worldwide / VAC</td>\n <td>147.15</td>\n <td>7</td>\n <td>40.9</td>\n <td>1.6</td>\n <td>15.7</td>\n <td>1.4</td>\n <td>NA</td>\n <td>6.3</td>\n <td>Top company in vacation timeshares</td>\n </tr>\n <tr>\n <td>SiteOne Landscape Supply / SITE</td>\n <td>197.10</td>\n <td>24</td>\n <td>45.7</td>\n <td>2.6</td>\n <td>43.5</td>\n <td>2.5</td>\n <td>19.3</td>\n <td>8.8</td>\n <td>Big supplier of landscaping supplies</td>\n </tr>\n <tr>\n <td>Staar Surgical / STAA</td>\n <td>138.19</td>\n <td>74</td>\n <td>192.3</td>\n <td>28.6</td>\n <td>140.8</td>\n <td>22.5</td>\n <td>30.0</td>\n <td>6.6</td>\n <td>Maker of implantable lens for myopia</td>\n </tr>\n <tr>\n <td>Stitch Fix / SFIX</td>\n <td>44.38</td>\n <td>-24</td>\n <td>NM</td>\n <td>1.9</td>\n <td>1890.3</td>\n <td>1.7</td>\n <td>30.0</td>\n <td>4.8</td>\n <td>Data-driven subscription clothing firm</td>\n </tr>\n <tr>\n <td>Trex / TREX</td>\n <td>105.94</td>\n <td>27</td>\n <td>51.9</td>\n <td>10.5</td>\n <td>43.6</td>\n <td>9.3</td>\n <td>18.8</td>\n <td>12.2</td>\n <td>Top maker of synthetic wood decking</td>\n </tr>\n <tr>\n <td>Upwork / UPWK</td>\n <td>44.31</td>\n <td>28</td>\n <td>NM</td>\n <td>11.4</td>\n <td>556.8</td>\n <td>9.2</td>\n <td>NA</td>\n <td>5.7</td>\n <td>Online clearinghouse for free-lancers</td>\n </tr>\n </tbody>\n</table>\n<p>E=Estimate. BAH estimates are for fiscal years ending March 2022 and March 23. SFIX estimates are for fiscal years ending July 2022 and July 2023. NM=Not Meaningful. NA=Not Available. *The annual EPS growth the company can sustain over the next 3-5 years.</p>\n<p>Source: FactSet</p>\n<p>Amedisys(AMED), a provider of home healthcare and hospice services, has a national footprint in a still-fragmented business.</p>\n<p>“There is going to be massive consolidation of the industry” predicts Dan Cole, a manager of the Columbia Small-Cap Growth fund. “Healthcare is moving to the home.”</p>\n<p>Amedisys stock is up more than tenfold in the past decade. But the shares, around $185, are off nearly 30% after the company recently cut 2021 financial guidance, citing Covid-related staffing and cost issues, mostly in acquired hospice operations. The 2021 earnings estimate is now $6.13 a share, down from nearly $7. The stock trades for 30 times projected 2021 profits. Cole says that the company remains capable of generating 10% annual gains in earnings per share.</p>\n<p>Amyris(AMRS) is a leader in synthetic biology. It fans say its opportunity is to supplant, in an eco-friendly way, a range of products now made from petrochemicals, animals, and plants.</p>\n<p>Using genetically re-engineered yeast and sugar cane, Amyris produces such things as squalane, a high-end moisturizer formerly made from shark livers; vanillin, the flavoring for vanilla; and a no-calorie sweetener normally derived from plants. The stock trades around $13.</p>\n<p><i>Barron’s</i> wrote favorably on the company in July. Amyris sees sales reaching $2 billion by 2025, up from an estimated $400 million this year, driven by its consumer brands.</p>\n<p>“The world needs clean chemistry, and Amyris is the point on the spear to create it,” says Randy Baron, a portfolio manager at Pinnacle Associates, which owns Amyris shares. He thinks they could hit $75 by the end of 2022.</p>\n<p>Booz Allen Hamilton Holding(BAH) is an important consultant to the Defense Department and other agencies. The U.S. government accounted for 97% of its revenue in its latest fiscal year. Booz Allen has built robust ties to the government over the years by providing an array of services, like cybersecurity. Its stock trades around $81, for a 1.8% yield.</p>\n<p>“It has built a strong, partnership-like culture and has a long record of steady growth,” says Josh Spencer, manager of the T. Rowe Price New Horizons fund. He sees Booz Allen as capable of generating 9% to 10% annual growth in revenue and yearly gains of 15% to 16% in earnings, in line with its historical performance. The stock is off 20% from its peak of $100, amid concerns about more restrained military spending. Spencer sees the pullback as a buying opportunity, with the stock valued at less than 20 times earnings.</p>\n<p>J.B. Hunt Transport Services(JBHT) is a leader in intermodal freight, which involves the fuel-efficient movement of trucks over rail lines. It has been one of the most successful trucking companies. Its stock has risen 30-fold over the past 20 years, to a recent $173. “It has an incredible franchise,” says Henry Ellenbogen, chief investment officer at Durable Capital Partners and a member of the Barron’s Roundtable.</p>\n<p>J.B. Hunt’s relationship with the Burlington Northern Santa Fe railroad gives it a strong position in intermodal freight, he notes. J.B. Hunt also has a growing business taking over the trucking operations of smaller companies. And it is involved in digital freight brokerage—matching truckers with shipping customers.</p>\n<p>Ellenbogen says the stock is reasonable at 22 times estimated 2022 profits, given a mid-teens annual growth outlook for earnings.</p>\n<p>Marriott Vacations Worldwide(VAC) is one of the top companies in the timeshare industry. It has 700,000 owners, a resilient business model with significant revenue from fees, and more exposure than its peers to luxury properties in places including Hawaii and Orlando, Fla.</p>\n<p>“It has the best customer base, with the highest spending and an impeccable balance sheet,” says David Baron, a manager of the Baron Focused Growth fund. Marriott Vacations, whose shares recently were trading around $145, should reinstate its dividend later this year, he adds.</p>\n<p>The shares, Baron argues, are cheap at a 11% free-cash-flow yield, based on 2022 estimates. He says that the stock, little changed since 2018, could produce 20% annual returns for shareholders in the coming years.</p>\n<p>SiteOne Landscape Supply(SITE) is the country’s top supplier of landscaping products, with ample opportunity to expand, given that it has just a 13% market share in a highly fragmented industry.</p>\n<p></p>\n<p>“It’s growing organically and has lots of acquisition opportunities,” says Columbia’s Cole, who considers the company to be capable of 10% to 15% annual revenue growth.</p>\n<p>The stock, around $197, has a rich valuation, trading for 43 times projected 2022 earnings of $4.54 a share.</p>\n<p>Staar Surgical(STAA) has developed an implantable lens to correct myopia (nearsightedness). That addresses a potentially huge market, given the rising global incidence of that vision problem. The company expects the lens, which has been available in Europe and Asia for at least five years, to be on the U.S. market in the fourth quarter, pending Food and Drug Administration approval.</p>\n<p>“It could do substantial volumes,’’ says Doug Brodie, a global manager at Baillie Gifford. “It’s early in a journey and is largely devoid of competition.”</p>\n<p>Lenses for both eyes can be implanted in less than an hour, and they don’t involve the removal of the natural lenses. The wholesale cost in the U.S. could be around $1,000 per lens.</p>\n<p>At a recent $138, Staar shares are richly valued at more than 20 times projected 2022 sales and 140 times estimated 2022 earnings. But the market opportunity is enormous: Some five billion people worldwide could have myopia by 2050.</p>\n<p>Stitch Fix(SFIX) has developed a subscription service for clothing, shoes, and other accessories and boasts over four million customers.</p>\n<p>“This could be the Nordstrom of the future,” says Mario Cibelli, chief investment officer at Marathon Partners Equity Management, a Stitch Fix holder. “This a potentially huge market and nobody is addressing it in the same way.” Using a staff of 6,000 personal stylists and lots of data, Stitch Fix seeks to identify subscriber tastes to generate high satisfaction and limit returns on packages sent at intervals and determined by subscribers.</p>\n<p>Its shares, around $44, are down 60% from their level earlier in the year, on investors’ worries about potential churn and the business’s ultimate profitability.</p>\n<p>Yet Cibelli sees revenue growth of 20%-plus annually, opportunities outside its current U.S. and U.K. markets, and a potentially very profitable business in two to three years.</p>\n<p>Trex(TREX) is the top producer of a high-end wood alternative for decks that comes from 95% recycled material, making it an eco-friendly housing play. The shares, at $105, trade for 43 times projected 2022 earnings.</p>\n<p>T. Rowe Price’s Spencer views Trex as worth the price, based on his view that it can generate sustainable annual revenue growth of 15% to 20%. Earnings are expected to climb by about 20% in 2022 and at a similar pace in the following years. “If you roll the clock forward three years, it doesn’t look as expensive,” he says.</p>\n<p>Upwork(UPWK), an online marketplace for freelance workers, is favored by Baillie Gifford’s Brodie, who says it offers a play on the greater acceptance of freelancers by businesses.</p>\n<p>The shares, recently around $44, aren’t cheap. Upwork is valued at $5.7 billion, or more than 10 times this year’s projected sales of nearly $500 million. It operates at a slight loss.</p>\n<p>The investment case is about rapid sales growth leading to ample earnings. Sales are expected to rise by 30%-plus this year and 25% for 2022.</p>\n<p>“Freelancers are more accepted by small to midsize business, but they’ve been frowned on by the HR departments at large businesses,” Brodie says. Upwork aims to change that perception by vetting its freelancers and by offering thousands of skill sets. “Upwork could become a trusted partner for an increasing number of enterprise-grade partners,” he says.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 10 Standout Stocks Could Be the Next Amazon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 10 Standout Stocks Could Be the Next Amazon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-15 11:22 GMT+8 <a href=https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of ...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TREX":"Trex Co Inc","UPWK":"Upwork Inc.","AMED":"阿米斯医疗","SFIX":"Stitch Fix Inc.","JBHT":"JB Hunt运输服务","VAC":"万豪度假环球","AMRS":"阿米瑞斯","STAA":"STAAR Surgical Company","BAH":"博思艾伦咨询公司","SITE":"SiteOne Landscape Supply, Inc."},"source_url":"https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127633167","content_text":"One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of generating double-digit compound growth in revenue and earnings—preferably both—for years to come.\nThe idea is that stock prices should compound in line with revenue and profits, enabling investors to generate high returns over a holding period of five to 10 years. The ultimate goal is to find the elusive “10 bagger”—a stock that returns 10 times what you paid for it.\nWall Street analyst notes and client letters from investment pros are replete with compounder references. Many of the next generation of value managers, identified in a Barron’s cover story in May, are seeking such shares, rather than the traditional value fare of cheap stocks.\nTheir search has become more challenging, because buyers are paying lofty prices for high-growth stories. Really big winners are scarce. Only about 35 companies in each of a long series of 10-year periods have compounded their stock prices at 20% or more annually, resulting in at least a sixfold increase, according to Durable Capital Partners.\nMany investors are happy to stick with large, well-known compounders, such as Alphabet(ticker: GOOGL),Mastercard(MA),UnitedHealth Group(UNH), and Eli Lilly(LLY).\nBarron’s sought to identify smaller candidates. We talked to investment managers and came up with an eclectic list of 10 stocks, most with market values under $10 billion. Here are the selections, in alphabetical order:\nStrong and Steady Wins the RaceHere are 10 stocks that growth investors have identified as being able to generate consistently high growth in revenues or profits for many years.\n\n\n\nCompany / Ticker\nRecent Price\nYTD Change\n2021E P/E\n2021E Price/Sales\n2022E P/E\n2022E Price/Sales\nLT Growth Rate*\nMarket Value (bil)\nComment\n\n\n\n\nAmedysis / AMED\n$185.15\n-37%\n30.2\n2.7\n27.7\n2.4\n10.5%\n$6.3\nLeader in home health care\n\n\nAmyris / AMRS\n13.64\n121\nNM\n10.4\nNM\n9.7\nNA\n4.1\nLeading company in synthetic biology\n\n\nBooz Allen Hamilton Holding / BAH\n81.73\n-6\n19.4\n1.3\n17.7\n1.2\n8.6\n11.0\nDefense-department consultant\n\n\nJ.B. Hunt Transport Services / JBHT\n172.76\n26\n25.8\n1.5\n22.2\n1.4\n18.4\n18.2\nStrong in intermodal freight\n\n\nMarriott Vacations Worldwide / VAC\n147.15\n7\n40.9\n1.6\n15.7\n1.4\nNA\n6.3\nTop company in vacation timeshares\n\n\nSiteOne Landscape Supply / SITE\n197.10\n24\n45.7\n2.6\n43.5\n2.5\n19.3\n8.8\nBig supplier of landscaping supplies\n\n\nStaar Surgical / STAA\n138.19\n74\n192.3\n28.6\n140.8\n22.5\n30.0\n6.6\nMaker of implantable lens for myopia\n\n\nStitch Fix / SFIX\n44.38\n-24\nNM\n1.9\n1890.3\n1.7\n30.0\n4.8\nData-driven subscription clothing firm\n\n\nTrex / TREX\n105.94\n27\n51.9\n10.5\n43.6\n9.3\n18.8\n12.2\nTop maker of synthetic wood decking\n\n\nUpwork / UPWK\n44.31\n28\nNM\n11.4\n556.8\n9.2\nNA\n5.7\nOnline clearinghouse for free-lancers\n\n\n\nE=Estimate. BAH estimates are for fiscal years ending March 2022 and March 23. SFIX estimates are for fiscal years ending July 2022 and July 2023. NM=Not Meaningful. NA=Not Available. *The annual EPS growth the company can sustain over the next 3-5 years.\nSource: FactSet\nAmedisys(AMED), a provider of home healthcare and hospice services, has a national footprint in a still-fragmented business.\n“There is going to be massive consolidation of the industry” predicts Dan Cole, a manager of the Columbia Small-Cap Growth fund. “Healthcare is moving to the home.”\nAmedisys stock is up more than tenfold in the past decade. But the shares, around $185, are off nearly 30% after the company recently cut 2021 financial guidance, citing Covid-related staffing and cost issues, mostly in acquired hospice operations. The 2021 earnings estimate is now $6.13 a share, down from nearly $7. The stock trades for 30 times projected 2021 profits. Cole says that the company remains capable of generating 10% annual gains in earnings per share.\nAmyris(AMRS) is a leader in synthetic biology. It fans say its opportunity is to supplant, in an eco-friendly way, a range of products now made from petrochemicals, animals, and plants.\nUsing genetically re-engineered yeast and sugar cane, Amyris produces such things as squalane, a high-end moisturizer formerly made from shark livers; vanillin, the flavoring for vanilla; and a no-calorie sweetener normally derived from plants. The stock trades around $13.\nBarron’s wrote favorably on the company in July. Amyris sees sales reaching $2 billion by 2025, up from an estimated $400 million this year, driven by its consumer brands.\n“The world needs clean chemistry, and Amyris is the point on the spear to create it,” says Randy Baron, a portfolio manager at Pinnacle Associates, which owns Amyris shares. He thinks they could hit $75 by the end of 2022.\nBooz Allen Hamilton Holding(BAH) is an important consultant to the Defense Department and other agencies. The U.S. government accounted for 97% of its revenue in its latest fiscal year. Booz Allen has built robust ties to the government over the years by providing an array of services, like cybersecurity. Its stock trades around $81, for a 1.8% yield.\n“It has built a strong, partnership-like culture and has a long record of steady growth,” says Josh Spencer, manager of the T. Rowe Price New Horizons fund. He sees Booz Allen as capable of generating 9% to 10% annual growth in revenue and yearly gains of 15% to 16% in earnings, in line with its historical performance. The stock is off 20% from its peak of $100, amid concerns about more restrained military spending. Spencer sees the pullback as a buying opportunity, with the stock valued at less than 20 times earnings.\nJ.B. Hunt Transport Services(JBHT) is a leader in intermodal freight, which involves the fuel-efficient movement of trucks over rail lines. It has been one of the most successful trucking companies. Its stock has risen 30-fold over the past 20 years, to a recent $173. “It has an incredible franchise,” says Henry Ellenbogen, chief investment officer at Durable Capital Partners and a member of the Barron’s Roundtable.\nJ.B. Hunt’s relationship with the Burlington Northern Santa Fe railroad gives it a strong position in intermodal freight, he notes. J.B. Hunt also has a growing business taking over the trucking operations of smaller companies. And it is involved in digital freight brokerage—matching truckers with shipping customers.\nEllenbogen says the stock is reasonable at 22 times estimated 2022 profits, given a mid-teens annual growth outlook for earnings.\nMarriott Vacations Worldwide(VAC) is one of the top companies in the timeshare industry. It has 700,000 owners, a resilient business model with significant revenue from fees, and more exposure than its peers to luxury properties in places including Hawaii and Orlando, Fla.\n“It has the best customer base, with the highest spending and an impeccable balance sheet,” says David Baron, a manager of the Baron Focused Growth fund. Marriott Vacations, whose shares recently were trading around $145, should reinstate its dividend later this year, he adds.\nThe shares, Baron argues, are cheap at a 11% free-cash-flow yield, based on 2022 estimates. He says that the stock, little changed since 2018, could produce 20% annual returns for shareholders in the coming years.\nSiteOne Landscape Supply(SITE) is the country’s top supplier of landscaping products, with ample opportunity to expand, given that it has just a 13% market share in a highly fragmented industry.\n\n“It’s growing organically and has lots of acquisition opportunities,” says Columbia’s Cole, who considers the company to be capable of 10% to 15% annual revenue growth.\nThe stock, around $197, has a rich valuation, trading for 43 times projected 2022 earnings of $4.54 a share.\nStaar Surgical(STAA) has developed an implantable lens to correct myopia (nearsightedness). That addresses a potentially huge market, given the rising global incidence of that vision problem. The company expects the lens, which has been available in Europe and Asia for at least five years, to be on the U.S. market in the fourth quarter, pending Food and Drug Administration approval.\n“It could do substantial volumes,’’ says Doug Brodie, a global manager at Baillie Gifford. “It’s early in a journey and is largely devoid of competition.”\nLenses for both eyes can be implanted in less than an hour, and they don’t involve the removal of the natural lenses. The wholesale cost in the U.S. could be around $1,000 per lens.\nAt a recent $138, Staar shares are richly valued at more than 20 times projected 2022 sales and 140 times estimated 2022 earnings. But the market opportunity is enormous: Some five billion people worldwide could have myopia by 2050.\nStitch Fix(SFIX) has developed a subscription service for clothing, shoes, and other accessories and boasts over four million customers.\n“This could be the Nordstrom of the future,” says Mario Cibelli, chief investment officer at Marathon Partners Equity Management, a Stitch Fix holder. “This a potentially huge market and nobody is addressing it in the same way.” Using a staff of 6,000 personal stylists and lots of data, Stitch Fix seeks to identify subscriber tastes to generate high satisfaction and limit returns on packages sent at intervals and determined by subscribers.\nIts shares, around $44, are down 60% from their level earlier in the year, on investors’ worries about potential churn and the business’s ultimate profitability.\nYet Cibelli sees revenue growth of 20%-plus annually, opportunities outside its current U.S. and U.K. markets, and a potentially very profitable business in two to three years.\nTrex(TREX) is the top producer of a high-end wood alternative for decks that comes from 95% recycled material, making it an eco-friendly housing play. The shares, at $105, trade for 43 times projected 2022 earnings.\nT. Rowe Price’s Spencer views Trex as worth the price, based on his view that it can generate sustainable annual revenue growth of 15% to 20%. Earnings are expected to climb by about 20% in 2022 and at a similar pace in the following years. “If you roll the clock forward three years, it doesn’t look as expensive,” he says.\nUpwork(UPWK), an online marketplace for freelance workers, is favored by Baillie Gifford’s Brodie, who says it offers a play on the greater acceptance of freelancers by businesses.\nThe shares, recently around $44, aren’t cheap. Upwork is valued at $5.7 billion, or more than 10 times this year’s projected sales of nearly $500 million. It operates at a slight loss.\nThe investment case is about rapid sales growth leading to ample earnings. Sales are expected to rise by 30%-plus this year and 25% for 2022.\n“Freelancers are more accepted by small to midsize business, but they’ve been frowned on by the HR departments at large businesses,” Brodie says. Upwork aims to change that perception by vetting its freelancers and by offering thousands of skill sets. “Upwork could become a trusted partner for an increasing number of enterprise-grade partners,” he says.","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":604913799,"gmtCreate":1639305191527,"gmtModify":1639305191776,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/604913799","repostId":"2190719916","repostType":4,"isVote":1,"tweetType":1,"viewCount":796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600111238,"gmtCreate":1638087084793,"gmtModify":1638087084929,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600111238","repostId":"2186432895","repostType":4,"repost":{"id":"2186432895","kind":"highlight","pubTimestamp":1638069921,"share":"https://www.laohu8.com/m/news/2186432895?lang=&edition=full","pubTime":"2021-11-28 11:25","market":"us","language":"en","title":"$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2186432895","media":"Motley Fool","summary":"A little money can go a long way.","content":"<p>Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it can generate a 12% annual return. That's slightly better than the average stock market return over the last 50 years of nearly 11%. </p>\n<p>Many companies have a long history of beating the market. Three companies that appear likely to continue doing so in the decades ahead are <a href=\"https://laohu8.com/S/BEP\"><b>Brookfield Renewable</b> </a>, <a href=\"https://laohu8.com/S/CCI\"><b>Crown Castle International</b> </a>, and <a href=\"https://laohu8.com/S/NEE\"><b>NextEra Energy</b> </a>. Because of that, $100 invested in each one every month could grow into a $1 million nest egg by retirement.</p>\n<h2>Benefiting from a powerful megatrend</h2>\n<p>Brookfield Renewable has enriched its investors over the years. Since its inception, the renewable energy producer has generated an annualized total return of 19%. The company had done that by investing billions of dollars into expanding its renewable energy portfolio. That has powered more than 10% annual growth in its cash flow per share, supporting 6% annual dividend increases over the last decade. </p>\n<p>However, Brookfield's best days appear to lie ahead. The global economy needs to invest trillions of dollars to decarbonize the energy sector over the next 30 years. That should enable Brookfield to continue to invest in expanding its renewable energy portfolio.</p>\n<p>The company currently has 36 gigawatts (GW) of renewable energy projects in development. That's bigger than the company's current operating portfolio of about 21 GW. Combined with rising power rates, and its growing scale, these projects should support up to 11% annual cash flow per share growth through at least 2026. </p>\n<p>Meanwhile, Brookfield sees up to another 9% yearly boost from future acquisitions. Add that growing renewable-powered cash flow stream to the company's 3%-yielding dividend, and Brookfield appears to have the power to produce double-digit annual returns for decades to come. </p>\n<h2>Connected to the data supercycle</h2>\n<p>Crown Castle has been an exceptional value creator over the years. The infrastructure-focused real estate investment trust (REIT) has delivered a more than 13% annual total return over the two-plus decades since its initial public offering. </p>\n<p>A major driver of those returns has been the billions of dollars the company has poured into expanding its communications infrastructure portfolio. Over the last decade alone, the REIT spent $31 billion on acquisitions and capital expenditures (capex), powering 9% annual dividend growth since 2014. </p>\n<p>The company still sees significant investment opportunities ahead. Crown Castle noted that the telecom industry's rollout of 5G networks represents a decade-long investment cycle. Meanwhile, some see a 100-year data infrastructure upgrade investment opportunity to support the digital economy. Because of that, Crown Castle has a lot of growth ahead of it, which should drive continued strong returns. </p>\n<p>Crown Castle expects to grow its 3.2%-yielding dividend at a 7% to 8% annual rate in the near term. That suggests the company could deliver double-digit total returns in the coming years. </p>\n<h2>Plugged into several growth catalysts</h2>\n<p>NextEra Energy has also created an enormous amount of wealth for its investors over the years. The utility has generated a roughly 700% total return over the last decade alone, crushing the 276% total return produced by the S&P 500. Powering the company's robust results has been its ability to deliver above-average earnings and dividend growth. It has increased its earnings per share at an 8.7% compound annual rate since 2005, supporting 9.6% compound annual dividend growth. </p>\n<p>A major catalyst has been the company's leadership in renewable energy. It has grown into one of the world's largest wind and solar energy producers. </p>\n<p>That leadership should continue since it has one of the world's biggest backlogs of wind and solar energy development projects. In addition to tried-and-true technologies like wind and solar, NextEra is a leader in emerging technologies, including battery storage and green hydrogen. Meanwhile, it's tapping into other sources of growth like water infrastructure. Because of that, NextEra should have plenty of power to continue growing its earnings and dividend in the decades ahead.</p>\n<h2>Grow rich slowly</h2>\n<p>Compound interest can do wonders for your retirement. Steadily investing a few hundred dollars each month into high-performing stocks can create an enormous amount of wealth. One of the keys to finding stocks that can deliver decades of strong returns is focusing on those benefiting from megatrends. Few are as big and enduring as renewable energy and data, making Brookfield Renewable, Crown Castle, and NextEra Energy stand out as stocks that could mint their share of millionaires in the decades ahead.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 11:25 GMT+8 <a href=https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCI":"冠城","NEE":"新纪元能源","BEP":"Brookfield Renewable Partners LP"},"source_url":"https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186432895","content_text":"Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it can generate a 12% annual return. That's slightly better than the average stock market return over the last 50 years of nearly 11%. \nMany companies have a long history of beating the market. Three companies that appear likely to continue doing so in the decades ahead are Brookfield Renewable , Crown Castle International , and NextEra Energy . Because of that, $100 invested in each one every month could grow into a $1 million nest egg by retirement.\nBenefiting from a powerful megatrend\nBrookfield Renewable has enriched its investors over the years. Since its inception, the renewable energy producer has generated an annualized total return of 19%. The company had done that by investing billions of dollars into expanding its renewable energy portfolio. That has powered more than 10% annual growth in its cash flow per share, supporting 6% annual dividend increases over the last decade. \nHowever, Brookfield's best days appear to lie ahead. The global economy needs to invest trillions of dollars to decarbonize the energy sector over the next 30 years. That should enable Brookfield to continue to invest in expanding its renewable energy portfolio.\nThe company currently has 36 gigawatts (GW) of renewable energy projects in development. That's bigger than the company's current operating portfolio of about 21 GW. Combined with rising power rates, and its growing scale, these projects should support up to 11% annual cash flow per share growth through at least 2026. \nMeanwhile, Brookfield sees up to another 9% yearly boost from future acquisitions. Add that growing renewable-powered cash flow stream to the company's 3%-yielding dividend, and Brookfield appears to have the power to produce double-digit annual returns for decades to come. \nConnected to the data supercycle\nCrown Castle has been an exceptional value creator over the years. The infrastructure-focused real estate investment trust (REIT) has delivered a more than 13% annual total return over the two-plus decades since its initial public offering. \nA major driver of those returns has been the billions of dollars the company has poured into expanding its communications infrastructure portfolio. Over the last decade alone, the REIT spent $31 billion on acquisitions and capital expenditures (capex), powering 9% annual dividend growth since 2014. \nThe company still sees significant investment opportunities ahead. Crown Castle noted that the telecom industry's rollout of 5G networks represents a decade-long investment cycle. Meanwhile, some see a 100-year data infrastructure upgrade investment opportunity to support the digital economy. Because of that, Crown Castle has a lot of growth ahead of it, which should drive continued strong returns. \nCrown Castle expects to grow its 3.2%-yielding dividend at a 7% to 8% annual rate in the near term. That suggests the company could deliver double-digit total returns in the coming years. \nPlugged into several growth catalysts\nNextEra Energy has also created an enormous amount of wealth for its investors over the years. The utility has generated a roughly 700% total return over the last decade alone, crushing the 276% total return produced by the S&P 500. Powering the company's robust results has been its ability to deliver above-average earnings and dividend growth. It has increased its earnings per share at an 8.7% compound annual rate since 2005, supporting 9.6% compound annual dividend growth. \nA major catalyst has been the company's leadership in renewable energy. It has grown into one of the world's largest wind and solar energy producers. \nThat leadership should continue since it has one of the world's biggest backlogs of wind and solar energy development projects. In addition to tried-and-true technologies like wind and solar, NextEra is a leader in emerging technologies, including battery storage and green hydrogen. Meanwhile, it's tapping into other sources of growth like water infrastructure. Because of that, NextEra should have plenty of power to continue growing its earnings and dividend in the decades ahead.\nGrow rich slowly\nCompound interest can do wonders for your retirement. Steadily investing a few hundred dollars each month into high-performing stocks can create an enormous amount of wealth. One of the keys to finding stocks that can deliver decades of strong returns is focusing on those benefiting from megatrends. Few are as big and enduring as renewable energy and data, making Brookfield Renewable, Crown Castle, and NextEra Energy stand out as stocks that could mint their share of millionaires in the decades ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844057101,"gmtCreate":1636380064771,"gmtModify":1636380085138,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[What] ","listText":"[What] ","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844057101","repostId":"1156155834","repostType":4,"repost":{"id":"1156155834","kind":"news","pubTimestamp":1636379472,"share":"https://www.laohu8.com/m/news/1156155834?lang=&edition=full","pubTime":"2021-11-08 21:51","market":"us","language":"en","title":"FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1156155834","media":"Benzinga","summary":"Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Ep","content":"<ul>\n <li><b>Eton Pharmaceuticals Inc</b> and <b>Azurity Pharmaceuticals Inc</b> have announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.</li>\n <li>Eprontia has been approved as a monotherapy for partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.</li>\n <li>The drug has also been approved as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older; and as a preventive treatment of migraine in patients 12 years of age and older.</li>\n <li>Eprontia is the first oral liquid formulation of topiramate to be approved by the FDA.</li>\n <li>Azurity will be responsible for commercializing the product, and it anticipates product availability by the end of 2021.</li>\n <li>Eton will receive a $5 million milestone payment upon Eprontia's commercial launch, a royalty on net sales, and potential commercial milestones.</li>\n <li><b>Price Action:</b> ETON shares are down 3.66% at $6.06 during the premarket session on the last check Monday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-08 21:51 GMT+8 <a href=https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.\nEprontia has been approved as a monotherapy for partial-...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETON":"Eton Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156155834","content_text":"Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.\nEprontia has been approved as a monotherapy for partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.\nThe drug has also been approved as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older; and as a preventive treatment of migraine in patients 12 years of age and older.\nEprontia is the first oral liquid formulation of topiramate to be approved by the FDA.\nAzurity will be responsible for commercializing the product, and it anticipates product availability by the end of 2021.\nEton will receive a $5 million milestone payment upon Eprontia's commercial launch, a royalty on net sales, and potential commercial milestones.\nPrice Action: ETON shares are down 3.66% at $6.06 during the premarket session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857834264,"gmtCreate":1635517149192,"gmtModify":1635517149397,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[What] ","listText":"[What] ","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/857834264","repostId":"1126301304","repostType":4,"repost":{"id":"1126301304","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635514883,"share":"https://www.laohu8.com/m/news/1126301304?lang=&edition=full","pubTime":"2021-10-29 21:41","market":"us","language":"en","title":"Microsoft surpassed Apple in market value and became the most valuable company in the world","url":"https://stock-news.laohu8.com/highlight/detail?id=1126301304","media":"Tiger Newspress","summary":"Microsoft rose nearly 1% while Apple slid more than 3% in morning trading.In the fourth quarter, Apple's total revenue was 83.36 billion US dollars, a year-on-year increase of 29%;Net profit was US $20.551 billion, up 62% year-on-year. Among them, Apple's revenue in Greater China in the fourth quarter was US $14.563 billion, up 83% year-on-year.The iPhone is still Apple's strongest product, with Apple's fourth-quarter iPhone revenue of $38.87 billion, up 47% compared with the same period, but fa","content":"<p>Microsoft rose nearly 1% while Apple slid more than 3% in morning trading.<img src=\"https://static.tigerbbs.com/18016ec3968ef3a9be7c659480b65e63\" tg-width=\"771\" tg-height=\"561\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/270ccfc4afc9a0f6700cd63b51f026ea\" tg-width=\"776\" tg-height=\"564\" width=\"100%\" height=\"auto\">In the fourth quarter, Apple's total revenue was 83.36 billion US dollars, a year-on-year increase of 29%;Net profit was US $20.551 billion, up 62% year-on-year. Among them, Apple's revenue in Greater China in the fourth quarter was US $14.563 billion, up 83% year-on-year.</p>\n<p>The iPhone is still Apple's strongest product, with Apple's fourth-quarter iPhone revenue of $38.87 billion, up 47% compared with the same period, but falling short of the expected $41.6 billion.</p>\n<p>The revenue of Apple service business was 18.28 billion US dollars, a year-on-year increase of 25.6%; Mac revenue was $9.18 billion, up 1.6% year-on-year. Tim Cook, CEO of Apple, said that the revenue of services and Mac reached a record high.</p>\n<p>Apple's wearable and accessories business revenue was 8.79 billion US dollars, a year-on-year increase of 11.5%; Ipad revenue was US $8.25 billion, up 21.4% year-on-year.</p>\n<p>Cook said: \"Although the supply restriction problem is larger than expected, and we estimate that (related losses) are about 6 billion US dollars, our financial performance is very strong. Supply constraints are caused by chip shortages widely discussed in the industry and manufacturing disruptions related to the epidemic in Southeast Asia.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft surpassed Apple in market value and became the most valuable company in the world</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft surpassed Apple in market value and became the most valuable company in the world\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-29 21:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Microsoft rose nearly 1% while Apple slid more than 3% in morning trading.<img src=\"https://static.tigerbbs.com/18016ec3968ef3a9be7c659480b65e63\" tg-width=\"771\" tg-height=\"561\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/270ccfc4afc9a0f6700cd63b51f026ea\" tg-width=\"776\" tg-height=\"564\" width=\"100%\" height=\"auto\">In the fourth quarter, Apple's total revenue was 83.36 billion US dollars, a year-on-year increase of 29%;Net profit was US $20.551 billion, up 62% year-on-year. Among them, Apple's revenue in Greater China in the fourth quarter was US $14.563 billion, up 83% year-on-year.</p>\n<p>The iPhone is still Apple's strongest product, with Apple's fourth-quarter iPhone revenue of $38.87 billion, up 47% compared with the same period, but falling short of the expected $41.6 billion.</p>\n<p>The revenue of Apple service business was 18.28 billion US dollars, a year-on-year increase of 25.6%; Mac revenue was $9.18 billion, up 1.6% year-on-year. Tim Cook, CEO of Apple, said that the revenue of services and Mac reached a record high.</p>\n<p>Apple's wearable and accessories business revenue was 8.79 billion US dollars, a year-on-year increase of 11.5%; Ipad revenue was US $8.25 billion, up 21.4% year-on-year.</p>\n<p>Cook said: \"Although the supply restriction problem is larger than expected, and we estimate that (related losses) are about 6 billion US dollars, our financial performance is very strong. Supply constraints are caused by chip shortages widely discussed in the industry and manufacturing disruptions related to the epidemic in Southeast Asia.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126301304","content_text":"Microsoft rose nearly 1% while Apple slid more than 3% in morning trading.In the fourth quarter, Apple's total revenue was 83.36 billion US dollars, a year-on-year increase of 29%;Net profit was US $20.551 billion, up 62% year-on-year. Among them, Apple's revenue in Greater China in the fourth quarter was US $14.563 billion, up 83% year-on-year.\nThe iPhone is still Apple's strongest product, with Apple's fourth-quarter iPhone revenue of $38.87 billion, up 47% compared with the same period, but falling short of the expected $41.6 billion.\nThe revenue of Apple service business was 18.28 billion US dollars, a year-on-year increase of 25.6%; Mac revenue was $9.18 billion, up 1.6% year-on-year. Tim Cook, CEO of Apple, said that the revenue of services and Mac reached a record high.\nApple's wearable and accessories business revenue was 8.79 billion US dollars, a year-on-year increase of 11.5%; Ipad revenue was US $8.25 billion, up 21.4% year-on-year.\nCook said: \"Although the supply restriction problem is larger than expected, and we estimate that (related losses) are about 6 billion US dollars, our financial performance is very strong. Supply constraints are caused by chip shortages widely discussed in the industry and manufacturing disruptions related to the epidemic in Southeast Asia.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829579614,"gmtCreate":1633530126918,"gmtModify":1633530127097,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[What] ","listText":"[What] ","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829579614","repostId":"2173691081","repostType":4,"isVote":1,"tweetType":1,"viewCount":37,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":837204067,"gmtCreate":1629889741159,"gmtModify":1633681702416,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Miser] ","listText":"[Miser] ","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/837204067","repostId":"1191562313","repostType":4,"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":698993485,"gmtCreate":1640271902398,"gmtModify":1640271902635,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Happy] [Smile] ","listText":"[Happy] [Smile] ","text":"[Happy] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698993485","repostId":"1192623075","repostType":4,"repost":{"id":"1192623075","kind":"news","pubTimestamp":1640269891,"share":"https://www.laohu8.com/m/news/1192623075?lang=&edition=full","pubTime":"2021-12-23 22:31","market":"us","language":"en","title":"U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=1192623075","media":"SeattleTimes","summary":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea","content":"<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p>\n<p>The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p>\n<p>As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p>\n<p>The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p>\n<p>Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p>\n<p>The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p>\n<p>The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p>\n<p>Some experts question whether there will be much of a role for the Merck drug in the U.S.</p>\n<p>“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p>\n<p>For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p>\n<p>The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p>\n<p>Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p>\n<p>The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p>\n<p>Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p>","source":"lsy1640271591192","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. adds Merck pill as 2nd easy-to-use drug against COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:31 GMT+8 <a href=https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/><strong>SeattleTimes</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug ...</p>\n\n<a href=\"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","PFE":"辉瑞"},"source_url":"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192623075","content_text":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.\nAs a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.\nThe Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.\nKnown as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.\nThe restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.\nThe Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.\nSome experts question whether there will be much of a role for the Merck drug in the U.S.\n“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”\nFor now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.\nThe FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.\nFederal officials have agreed to purchase enough of the drug to treat 3.1 million people.\nThe U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.\nMerck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.","news_type":1},"isVote":1,"tweetType":1,"viewCount":804,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608614650,"gmtCreate":1638710565768,"gmtModify":1638710565874,"author":{"id":"4087873768935830","authorId":"4087873768935830","name":"Ong2021","avatar":"https://static.tigerbbs.com/eec6b0f9969a9aab1913945a2c49ea24","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087873768935830","authorIdStr":"4087873768935830"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608614650","repostId":"2189557676","repostType":4,"isVote":1,"tweetType":1,"viewCount":1148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}